Ytyt的个人主页 - 老虎社区

Ytyt

暂无个人介绍

IP属地：未知

278关注

8粉丝

0主题

0勋章

2021-12-30

Pls like

Dow, S&P Close at Record Highs as Omicron Worries Ease

2021-12-28

Pls like

Novavax shares dropped another 4% in premarket trading

2021-12-26

Pls like

3 Best Buffett Stocks to Buy for the Long Haul

2021-12-25

Pls like

2 Top Stocks to Buy for the New Year

2021-12-24

Pls like

S&P 500 hits record close as Omicron fears ebb

2021-12-23

Pls like

Wall St mints strong gains on rosy economic data, encouraging Omicron update

2021-12-22

Pls like

Wall Street closes up strongly with boost from Nike, Micron, following Omicron slide

2021-12-21

Pls like

MRNA, NVAX, OCGN, PFE, BNTX: What Is Going on With Vaccine Stocks Today?

2021-12-20

Pls like

Singapore Stock Market May Give Up Support At 3,100 Points

2021-12-18

Pls like

3 Warren Buffett Stocks I Like Heading Into 2022

2021-12-17

Pls like

After-Hours Stock Movers: Spruce Biosciences,Rivian,FedEx,General Motors and more

2021-12-16

Pls like

After-Hours Stock Movers: IronNet,Verrica Pharmaceuticals,Canoo and more

2021-12-15

Pls like

Wall Street ends down, investors eye inflation and Omicron

2021-12-14

Pls like

5 things to watch for when the Federal Reserve announces its policy decision Wednesday

2021-12-14

$Apple(AAPL)$up or down

2021-12-12

Pls like

Want $1 Million in Retirement? Invest $100,000 in These 2 Stocks and Hold Until 2035

2021-12-11

Pls like

Is It Time to Buy the Dow's 3 Worst Performing Stocks This Year?

2021-12-10

Pls like

抱歉，原内容已删除

2021-12-09

Pls like

3 Growth Stocks Down Over 50% To Buy Now

2021-12-08

Pls like

Dear NIO Stock Fans, Mark Your Calendars for This Potential Catalyst on Dec. 18

去老虎APP查看更多动态

{"i18n":{"language":"zh_CN"},"userPageInfo":{"id":4094269572113460,"uuid":"4094269572113460","gmtCreate":1631257775982,"gmtModify":1631257775982,"name":"Ytyt","pinyin":"ytyt","introduction":"","introductionEn":null,"signature":"","avatar":"https://static.laohu8.com/default-avatar.jpg","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":8,"headSize":278,"tweetSize":69,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.28","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":1,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":2,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":692999360,"gmtCreate":1640821878867,"gmtModify":1640821879094,"author":{"id":"4094269572113460","authorId":"4094269572113460","name":"Ytyt","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"Pls like","listText":"Pls like","text":"Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/692999360","repostId":"2195466435","repostType":4,"repost":{"id":"2195466435","pubTimestamp":1640814752,"share":"https://www.laohu8.com/m/news/2195466435?lang=&edition=full","pubTime":"2021-12-30 05:52","market":"us","language":"en","title":"Dow, S&P Close at Record Highs as Omicron Worries Ease","url":"https://stock-news.laohu8.com/highlight/detail?id=2195466435","media":"Reuters","summary":"Dec 29 (Reuters) - The Dow and S&P 500 closed at all-time highs on Wednesday on a boost from retaile","content":"<html><head></head><body><p>Dec 29 (Reuters) - The Dow and S&amp;P 500 closed at all-time highs on Wednesday on a boost from retailers including Walgreens and Nike, as investors shrugged off concerns on the spreading Omicron variant.</p><p>The Dow has now risen six straight trading days, marking the longest streak of gains since a seven-session run from March 5 to March 15 this year.</p><p><a href=\"https://laohu8.com/S/WBA\">Walgreens Boots Alliance</a> and Nike Inc rose 1.59% and 1.42% respectively against the backdrop of recent reports suggesting holiday sales were strong for U.S. retailers.</p><p>Data on Wednesday showed the U.S. trade deficit in goods mushroomed to the widest ever in November as imports of consumer goods shot to a record, as the coronavirus pandemic has limited spending by Americans on services.</p><p>Some early studies pointing to a reduced risk of hospitalization in Omicron cases have eased some investors concerns over the travel disruptions and powered the S&amp;P 500 to record highs this week.</p><p>&#34;The market started to recognize that the Omicron variant was in a strange way good news, because it will burn itself out more rapidly because it&#39;s easily transmissible, but it&#39;s less likely to overwhelm hospitals,&#34; said Jay Hatfield, founder and chief executive of Infrastructure Capital Management in New York. Still, he said Omicron arguably is going to be a headwind for at least the next month.</p><p>Meanwhile, the S&amp;P 1500 airlines index dipped. Delta Air Lines and Alaska Air Group canceled hundreds of flights again on Tuesday as the daily tally of infections in the United States surged.</p><p>Three of the 11 major S&amp;P sector indexes declined, the energy index, the consumer services sector .SPLRCL and the financial sector are in the red.</p><p>Typically, the final five trading days of the year and the first two of the subsequent year are seasonally strong for U.S. stocks, known as the &#34;Santa Claus Rally.&#34; However, market participants warned against reading too much into daily moves as the holiday season tends to record some of the lowest volume turnovers that can cause exaggerated price action.</p><p>The Dow Jones Industrial Average rose 90.42 points, or 0.25%, to 36,488.63, the S&amp;P 500 gained 6.71 points, or 0.14%, to 4,793.06 and the Nasdaq Composite dropped 15.51 points, or 0.1%, to 15,766.22.</p><p>The S&amp;P 500 dipped on Tuesday in the lowest trading volume session of 2021, snapping a four-day winning streak.</p><p>As 2021 draws to a close, the main U.S. stock indexes are on pace for their third straight year of stunning annual returns, boosted by historic fiscal and monetary stimulus. The S&amp;P 500 is looking at its strongest three-year performance since 1999.</p><p>The focus next year will shift to the U.S. Federal Reserve&#39;s path of interest rate hikes amid a surge in prices caused by supply chain bottlenecks and a strong economic rebound.</p><p>Among other stocks, shares of Victoria’s Secret &amp; Co rose more than 12% after the intimate apparel retailer announced a $250 million accelerated share repurchase program. The retailer also said they had strong sales over the holidays.</p><p>Tesla&#39;s CEO Elon Musk exercised all of his options expiring next year, signaling an end to his stock sales. Its shares dropped 0.21% but were still on course to end about 54% for the year.</p><p>Volume on U.S. exchanges was 7.89 billion shares, compared with the 11.15 billion average for the full session over the last 20 trading days.</p><p>Advancing issues outnumbered declining ones on the NYSE by a 1.20-to-1 ratio; on Nasdaq, a 1.43-to-1 ratio favored decliners.</p><p>The S&amp;P 500 posted 76 new 52-week highs and no new lows; the Nasdaq Composite recorded 77 new highs and 374 new lows.</p></body></html>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Dow, S&P Close at Record Highs as Omicron Worries Ease</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDow, S&P Close at Record Highs as Omicron Worries Ease\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-30 05:52 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/us-stocks-dow-p-close-215232570.html><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Dec 29 (Reuters) - The Dow and S&P 500 closed at all-time highs on Wednesday on a boost from retailers including Walgreens and Nike, as investors shrugged off concerns on the spreading Omicron variant...</p>\n\n<a href=\"https://finance.yahoo.com/news/us-stocks-dow-p-close-215232570.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"161125":"标普500","513500":"标普500ETF","OEF":"标普100指数ETF-iShares","SSO":"两倍做多标普500ETF","BK4539":"次新股","SPXU":"三倍做空标普500ETF","SDS":"两倍做空标普500ETF","BK4504":"桥水持仓","OEX":"标普100","IVV":"标普500指数ETF","SH":"标普500反向ETF","BK4559":"巴菲特持仓","BK4079":"房地产服务","BK4534":"瑞士信贷持仓","BK4550":"红杉资本持仓","SPY":"标普500ETF","UPRO":"三倍做多标普500ETF"},"source_url":"https://finance.yahoo.com/news/us-stocks-dow-p-close-215232570.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2195466435","content_text":"Dec 29 (Reuters) - The Dow and S&P 500 closed at all-time highs on Wednesday on a boost from retailers including Walgreens and Nike, as investors shrugged off concerns on the spreading Omicron variant.The Dow has now risen six straight trading days, marking the longest streak of gains since a seven-session run from March 5 to March 15 this year.Walgreens Boots Alliance and Nike Inc rose 1.59% and 1.42% respectively against the backdrop of recent reports suggesting holiday sales were strong for U.S. retailers.Data on Wednesday showed the U.S. trade deficit in goods mushroomed to the widest ever in November as imports of consumer goods shot to a record, as the coronavirus pandemic has limited spending by Americans on services.Some early studies pointing to a reduced risk of hospitalization in Omicron cases have eased some investors concerns over the travel disruptions and powered the S&P 500 to record highs this week.\"The market started to recognize that the Omicron variant was in a strange way good news, because it will burn itself out more rapidly because it's easily transmissible, but it's less likely to overwhelm hospitals,\" said Jay Hatfield, founder and chief executive of Infrastructure Capital Management in New York. Still, he said Omicron arguably is going to be a headwind for at least the next month.Meanwhile, the S&P 1500 airlines index dipped. Delta Air Lines and Alaska Air Group canceled hundreds of flights again on Tuesday as the daily tally of infections in the United States surged.Three of the 11 major S&P sector indexes declined, the energy index, the consumer services sector .SPLRCL and the financial sector are in the red.Typically, the final five trading days of the year and the first two of the subsequent year are seasonally strong for U.S. stocks, known as the \"Santa Claus Rally.\" However, market participants warned against reading too much into daily moves as the holiday season tends to record some of the lowest volume turnovers that can cause exaggerated price action.The Dow Jones Industrial Average rose 90.42 points, or 0.25%, to 36,488.63, the S&P 500 gained 6.71 points, or 0.14%, to 4,793.06 and the Nasdaq Composite dropped 15.51 points, or 0.1%, to 15,766.22.The S&P 500 dipped on Tuesday in the lowest trading volume session of 2021, snapping a four-day winning streak.As 2021 draws to a close, the main U.S. stock indexes are on pace for their third straight year of stunning annual returns, boosted by historic fiscal and monetary stimulus. The S&P 500 is looking at its strongest three-year performance since 1999.The focus next year will shift to the U.S. Federal Reserve's path of interest rate hikes amid a surge in prices caused by supply chain bottlenecks and a strong economic rebound.Among other stocks, shares of Victoria’s Secret & Co rose more than 12% after the intimate apparel retailer announced a $250 million accelerated share repurchase program. The retailer also said they had strong sales over the holidays.Tesla's CEO Elon Musk exercised all of his options expiring next year, signaling an end to his stock sales. Its shares dropped 0.21% but were still on course to end about 54% for the year.Volume on U.S. exchanges was 7.89 billion shares, compared with the 11.15 billion average for the full session over the last 20 trading days.Advancing issues outnumbered declining ones on the NYSE by a 1.20-to-1 ratio; on Nasdaq, a 1.43-to-1 ratio favored decliners.The S&P 500 posted 76 new 52-week highs and no new lows; the Nasdaq Composite recorded 77 new highs and 374 new lows.","news_type":1},"isVote":1,"tweetType":1,"viewCount":444,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":696664524,"gmtCreate":1640685161869,"gmtModify":1640685637729,"author":{"id":"4094269572113460","authorId":"4094269572113460","name":"Ytyt","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"Pls like","listText":"Pls like","text":"Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/696664524","repostId":"1138246031","repostType":4,"repost":{"id":"1138246031","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1640683578,"share":"https://www.laohu8.com/m/news/1138246031?lang=&edition=full","pubTime":"2021-12-28 17:26","market":"us","language":"en","title":"Novavax shares dropped another 4% in premarket trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1138246031","media":"Tiger Newspress","summary":"Novavax shares dropped another 4% in premarket trading.The stock plunged nearly 11% yesterday.\n\nWhy ","content":"<p>Novavax shares dropped another 4% in premarket trading.The stock plunged&nbsp;nearly 11% yesterday.</p>\n<p><img src=\"https://static.tigerbbs.com/04a11fff9a31214bbcf7595183a5d305\" tg-width=\"843\" tg-height=\"618\" referrerpolicy=\"no-referrer\"></p>\n<p><b>Why Novavax Stock Is Sinking</b></p>\n<p>The company didn't announce any new developments. So what's behind the big decline?</p>\n<p>Other&nbsp;vaccine stocks&nbsp;aren't falling nearly as much. Some were even up a little. That rules out the likelihood that declining concerns about the omicron variant played a major factor behind Novavax's drop.</p>\n<p>Instead, investors are probably growing more anxious about Novavax's planned filing for U.S. Emergency Use Authorization (EUA) of it COVID-19 vaccine NVX-CoV2373. Some investors could also be worried about the quality of Novavax's submission to the Food and Drug Administration (FDA) even if it doesn't experience another delay with the filing.</p>\n<p>CEO Stanley Erck's interview with Yahoo! Finance Live last Thursday likely didn't help reassure investors. When asked about when the FDA filing would be done, Erck replied, \"It's probably going to be next week, but I'm sticking with the claim that we'll be doing this by the end of this year.\"</p>\n<p><b>So what</b></p>\n<p>Yet another delay in a U.S. filing for NVX-CoV2373 wouldn't be catastrophic for Novavax as long as the company completes the submission soon in the new year. However, management's credibility would definitely take another big blow.</p>\n<p>But it's premature at this point to speculate that Novavax won't complete the U.S. EUA filing this week. It's also useless to fret about the quality of the company's FDA package. Novavax recently won European Union authorization for NVX-CoV2373. That shows that the vaccine maker can successfully meet regulators' manufacturing-quality hurdles.</p>\n<p><b>Now what</b></p>\n<p>Investors don't like waiting, but that's exactly what they'll have to do for now with Novavax. The company could complete its EUA filing any day now. It could also pick up new authorizations in other countries where it awaits regulatory decisions.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Novavax shares dropped another 4% in premarket trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNovavax shares dropped another 4% in premarket trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-12-28 17:26</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Novavax shares dropped another 4% in premarket trading.The stock plunged&nbsp;nearly 11% yesterday.</p>\n<p><img src=\"https://static.tigerbbs.com/04a11fff9a31214bbcf7595183a5d305\" tg-width=\"843\" tg-height=\"618\" referrerpolicy=\"no-referrer\"></p>\n<p><b>Why Novavax Stock Is Sinking</b></p>\n<p>The company didn't announce any new developments. So what's behind the big decline?</p>\n<p>Other&nbsp;vaccine stocks&nbsp;aren't falling nearly as much. Some were even up a little. That rules out the likelihood that declining concerns about the omicron variant played a major factor behind Novavax's drop.</p>\n<p>Instead, investors are probably growing more anxious about Novavax's planned filing for U.S. Emergency Use Authorization (EUA) of it COVID-19 vaccine NVX-CoV2373. Some investors could also be worried about the quality of Novavax's submission to the Food and Drug Administration (FDA) even if it doesn't experience another delay with the filing.</p>\n<p>CEO Stanley Erck's interview with Yahoo! Finance Live last Thursday likely didn't help reassure investors. When asked about when the FDA filing would be done, Erck replied, \"It's probably going to be next week, but I'm sticking with the claim that we'll be doing this by the end of this year.\"</p>\n<p><b>So what</b></p>\n<p>Yet another delay in a U.S. filing for NVX-CoV2373 wouldn't be catastrophic for Novavax as long as the company completes the submission soon in the new year. However, management's credibility would definitely take another big blow.</p>\n<p>But it's premature at this point to speculate that Novavax won't complete the U.S. EUA filing this week. It's also useless to fret about the quality of the company's FDA package. Novavax recently won European Union authorization for NVX-CoV2373. That shows that the vaccine maker can successfully meet regulators' manufacturing-quality hurdles.</p>\n<p><b>Now what</b></p>\n<p>Investors don't like waiting, but that's exactly what they'll have to do for now with Novavax. The company could complete its EUA filing any day now. It could also pick up new authorizations in other countries where it awaits regulatory decisions.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVAX":"诺瓦瓦克斯医药"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1138246031","content_text":"Novavax shares dropped another 4% in premarket trading.The stock plunged nearly 11% yesterday.\n\nWhy Novavax Stock Is Sinking\nThe company didn't announce any new developments. So what's behind the big decline?\nOther vaccine stocks aren't falling nearly as much. Some were even up a little. That rules out the likelihood that declining concerns about the omicron variant played a major factor behind Novavax's drop.\nInstead, investors are probably growing more anxious about Novavax's planned filing for U.S. Emergency Use Authorization (EUA) of it COVID-19 vaccine NVX-CoV2373. Some investors could also be worried about the quality of Novavax's submission to the Food and Drug Administration (FDA) even if it doesn't experience another delay with the filing.\nCEO Stanley Erck's interview with Yahoo! Finance Live last Thursday likely didn't help reassure investors. When asked about when the FDA filing would be done, Erck replied, \"It's probably going to be next week, but I'm sticking with the claim that we'll be doing this by the end of this year.\"\nSo what\nYet another delay in a U.S. filing for NVX-CoV2373 wouldn't be catastrophic for Novavax as long as the company completes the submission soon in the new year. However, management's credibility would definitely take another big blow.\nBut it's premature at this point to speculate that Novavax won't complete the U.S. EUA filing this week. It's also useless to fret about the quality of the company's FDA package. Novavax recently won European Union authorization for NVX-CoV2373. That shows that the vaccine maker can successfully meet regulators' manufacturing-quality hurdles.\nNow what\nInvestors don't like waiting, but that's exactly what they'll have to do for now with Novavax. The company could complete its EUA filing any day now. It could also pick up new authorizations in other countries where it awaits regulatory decisions.","news_type":1},"isVote":1,"tweetType":1,"viewCount":535,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":698432662,"gmtCreate":1640488189966,"gmtModify":1640488190120,"author":{"id":"4094269572113460","authorId":"4094269572113460","name":"Ytyt","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"Pls like","listText":"Pls like","text":"Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/698432662","repostId":"2193917872","repostType":4,"repost":{"id":"2193917872","pubTimestamp":1640398248,"share":"https://www.laohu8.com/m/news/2193917872?lang=&edition=full","pubTime":"2021-12-25 10:10","market":"us","language":"en","title":"3 Best Buffett Stocks to Buy for the Long Haul","url":"https://stock-news.laohu8.com/highlight/detail?id=2193917872","media":"Motley Fool","summary":"Each of these three big pharma stocks are featured in Berkshire Hathaway's massive portfolio.","content":"<p>Since Warren Buffett took full control of <b>Berkshire Hathaway</b> in 1965, it became a diversified holding company with investments in publicly traded companies totaling nearly $345 billion at the time of writing.</p>\n<p>The Oracle of Omaha's reputation of buying the highest quality businesses means that many individual investors could also benefit from adding these stocks to their portfolios. Here are three healthcare stocks that Buffett owns, which you may also want to consider buying and holding for the long run.</p>\n<h2>1. Johnson &amp; Johnson</h2>\n<p>The first pharma stock within Berkshire's portfolio to contemplate purchasing is <b>Johnson &amp; Johnson</b> (NYSE:JNJ). While the stock is one of Buffett's smallest holdings, valued at just under $55 million, this doesn't take away from its 59 consecutive years of dividend increases that make the stock a Dividend King.</p>\n<p>J&amp;J will be spinning off its slower-growing and less profitable consumer health segment in the next 18 to 24 months, which should allow the company to focus on its faster-growing, more profitable pharmaceutical segment.</p>\n<p>J&amp;J has a strong existing drug portfolio, which should be able to make up for the upcoming 2025 to 2026 patent expirations for its top-selling drug known, Stelara. Year to date, the immunology drug made up just 9.9% of J&amp;J's $69 billion in net sales.</p>\n<p>These drugs include the immunology blockbuster Tremfya, which received its first of three U.S. Food and Drug Administration (FDA) approvals to date in July 2017. Another drug that was recently approved by the FDA was the oncology blockbuster called Darzalex, which received its first of nine FDA approvals to date in November 2015. These two drugs have grown their year-to-date revenue at high-40% clips year over year and should remain under patent most of this decade.</p>\n<p>J&amp;J's enviable existing drug portfolio and its nearly four dozen indications in late-stage clinical trials explain why analysts anticipate that the stock will deliver 8% annual non-GAAP (adjusted) earnings per share (EPS) growth over the next five years.</p>\n<p>Income investors can scoop up J&amp;J's 2.5% dividend yield at a forward P/E ratio of just 16.2 times, which makes the steady healthcare stock a great buy for the long term.</p>\n<h2>2. Bristol Myers Squibb</h2>\n<p>Another Buffett stock that could be a great fit in your portfolio is <b>Bristol Myers Squibb</b> (NYSE:BMY). Berkshire's Bristol Myers Squibb stake totals nearly $1.4 billion, making it one of the largest healthcare holdings in Berkshire's portfolio.</p>\n<p>Bristol Myers Squibb's oncology blockbusters Revlimid and Opdivo and the anticoagulant blockbuster co-owned with <b>Pfizer</b> (NYSE:PFE) named Eliquis each face patent expirations later this decade. While looming patent expirations on three drugs that account for approximately two-thirds of your company's total revenue sounds frightening, this is nothing new; it's just the nature of Bristol Myers Squibb's industry.</p>\n<p>What matters most is that a company is proactive in developing and acquiring its next generation of blockbuster drugs to absorb key patent expirations. With more than 50 compounds in over 40 different disease areas currently in development at Bristol Myers Squibb, this is exactly what the company has been doing for years now.</p>\n<p>As a result, analysts are projecting that Bristol Myers Squibb will be able to generate 6% annual earnings growth through the next five years.</p>\n<p>Yield-hungry investors can buy Bristol Myers Squibb's market-crushing 3.5% yield at a ridiculously cheap forward P/E ratio of 7.9, which is what makes the stock a buy for those looking to hedge against inflation.</p>\n<h2>3. AbbVie</h2>\n<p>Finally, a Buffett stock that'd also be a good fit for income investors is <b>AbbVie</b> (NYSE:ABBV). Berkshire currently holds about $1.9 billion worth of AbbVie stock.</p>\n<p>It's well known at this point that the biopharmaceutical's top-selling drug in the world, Humira, will be facing intense biosimilar competition in the U.S. beginning in 2023. Even though the immunology drug's U.S. sales made up 31% of AbbVie's $41.24 billion total year-to-date sales, the company's pipeline should be able to stabilize and grow its net revenue beyond 2023.</p>\n<p>AbbVie has 54 compounds in various stages of clinical trials, which is why analysts are forecasting that the stock will grow its adjusted EPS 4.5% annually in the next five years.</p>\n<p>AbbVie's massive 4.4% dividend yield can be picked up at a forward P/E ratio of only 9.3.&nbsp;This is an attractive valuation for a stock with the ability to fight off inflation with healthy dividend hikes.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Best Buffett Stocks to Buy for the Long Haul</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Best Buffett Stocks to Buy for the Long Haul\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-25 10:10 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/12/24/3-best-buffett-stocks-to-buy-for-the-long-haul/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Since Warren Buffett took full control of Berkshire Hathaway in 1965, it became a diversified holding company with investments in publicly traded companies totaling nearly $345 billion at the time of ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/12/24/3-best-buffett-stocks-to-buy-for-the-long-haul/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ABBV":"艾伯维公司","BMY":"施贵宝","JNJ":"强生"},"source_url":"https://www.fool.com/investing/2021/12/24/3-best-buffett-stocks-to-buy-for-the-long-haul/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2193917872","content_text":"Since Warren Buffett took full control of Berkshire Hathaway in 1965, it became a diversified holding company with investments in publicly traded companies totaling nearly $345 billion at the time of writing.\nThe Oracle of Omaha's reputation of buying the highest quality businesses means that many individual investors could also benefit from adding these stocks to their portfolios. Here are three healthcare stocks that Buffett owns, which you may also want to consider buying and holding for the long run.\n1. Johnson & Johnson\nThe first pharma stock within Berkshire's portfolio to contemplate purchasing is Johnson & Johnson (NYSE:JNJ). While the stock is one of Buffett's smallest holdings, valued at just under $55 million, this doesn't take away from its 59 consecutive years of dividend increases that make the stock a Dividend King.\nJ&J will be spinning off its slower-growing and less profitable consumer health segment in the next 18 to 24 months, which should allow the company to focus on its faster-growing, more profitable pharmaceutical segment.\nJ&J has a strong existing drug portfolio, which should be able to make up for the upcoming 2025 to 2026 patent expirations for its top-selling drug known, Stelara. Year to date, the immunology drug made up just 9.9% of J&J's $69 billion in net sales.\nThese drugs include the immunology blockbuster Tremfya, which received its first of three U.S. Food and Drug Administration (FDA) approvals to date in July 2017. Another drug that was recently approved by the FDA was the oncology blockbuster called Darzalex, which received its first of nine FDA approvals to date in November 2015. These two drugs have grown their year-to-date revenue at high-40% clips year over year and should remain under patent most of this decade.\nJ&J's enviable existing drug portfolio and its nearly four dozen indications in late-stage clinical trials explain why analysts anticipate that the stock will deliver 8% annual non-GAAP (adjusted) earnings per share (EPS) growth over the next five years.\nIncome investors can scoop up J&J's 2.5% dividend yield at a forward P/E ratio of just 16.2 times, which makes the steady healthcare stock a great buy for the long term.\n2. Bristol Myers Squibb\nAnother Buffett stock that could be a great fit in your portfolio is Bristol Myers Squibb (NYSE:BMY). Berkshire's Bristol Myers Squibb stake totals nearly $1.4 billion, making it one of the largest healthcare holdings in Berkshire's portfolio.\nBristol Myers Squibb's oncology blockbusters Revlimid and Opdivo and the anticoagulant blockbuster co-owned with Pfizer (NYSE:PFE) named Eliquis each face patent expirations later this decade. While looming patent expirations on three drugs that account for approximately two-thirds of your company's total revenue sounds frightening, this is nothing new; it's just the nature of Bristol Myers Squibb's industry.\nWhat matters most is that a company is proactive in developing and acquiring its next generation of blockbuster drugs to absorb key patent expirations. With more than 50 compounds in over 40 different disease areas currently in development at Bristol Myers Squibb, this is exactly what the company has been doing for years now.\nAs a result, analysts are projecting that Bristol Myers Squibb will be able to generate 6% annual earnings growth through the next five years.\nYield-hungry investors can buy Bristol Myers Squibb's market-crushing 3.5% yield at a ridiculously cheap forward P/E ratio of 7.9, which is what makes the stock a buy for those looking to hedge against inflation.\n3. AbbVie\nFinally, a Buffett stock that'd also be a good fit for income investors is AbbVie (NYSE:ABBV). Berkshire currently holds about $1.9 billion worth of AbbVie stock.\nIt's well known at this point that the biopharmaceutical's top-selling drug in the world, Humira, will be facing intense biosimilar competition in the U.S. beginning in 2023. Even though the immunology drug's U.S. sales made up 31% of AbbVie's $41.24 billion total year-to-date sales, the company's pipeline should be able to stabilize and grow its net revenue beyond 2023.\nAbbVie has 54 compounds in various stages of clinical trials, which is why analysts are forecasting that the stock will grow its adjusted EPS 4.5% annually in the next five years.\nAbbVie's massive 4.4% dividend yield can be picked up at a forward P/E ratio of only 9.3. This is an attractive valuation for a stock with the ability to fight off inflation with healthy dividend hikes.","news_type":1},"isVote":1,"tweetType":1,"viewCount":538,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":698217515,"gmtCreate":1640405186348,"gmtModify":1640405186490,"author":{"id":"4094269572113460","authorId":"4094269572113460","name":"Ytyt","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"Pls like","listText":"Pls like","text":"Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/698217515","repostId":"2193720178","repostType":4,"repost":{"id":"2193720178","pubTimestamp":1640398065,"share":"https://www.laohu8.com/m/news/2193720178?lang=&edition=full","pubTime":"2021-12-25 10:07","market":"us","language":"en","title":"2 Top Stocks to Buy for the New Year","url":"https://stock-news.laohu8.com/highlight/detail?id=2193720178","media":"Motley Fool","summary":"Two very different companies -- one in tech and one in retail -- offer investors long-term growth potential and durable business models.","content":"<p>With talks of likely interest rate hikes from the Federal Reserve in 2022 and the coronavirus pandemic still making the rounds, one key characteristic investors should look for in investments going into the new year is resilience. In other words, some good traits to look for are valuations that make sense relative to a company's growth trajectory and market opportunity, and durable business models with proven track records. While there's no way to avoid volatility, owning resilient companies can at least help investors better weather near-term challenges (mentally and emotionally) since they know their investments have what it takes to endure.</p>\n<p>Two companies that fit this description are <b><a href=\"https://laohu8.com/S/FB\">Meta Platforms</a></b> (NASDAQ:FB) and <b><a href=\"https://laohu8.com/S/TSCO\">Tractor Supply Company</a></b> (NASDAQ:TSCO). Here's a look at why both of these stocks are good bets for 2022 and beyond.</p>\n<h2>Meta Platforms</h2>\n<p>The case for Meta Platforms is straightforward. The tech stock's valuation is very cheap relative to the company's recent growth. Consider that the Facebook parent's trailing-12-month revenue and net income of $112 billion and $40 billion, respectively, are up from $71 billion and $18 billion in 2019. Even with such staggering recent growth, Meta Platforms trades at only 24 times its current level of earnings.</p>\n<p>While the company is running into some near-term growth headwinds related to <b>Apple</b>'s recent changes to advertising tracking and measurement, it's not like the suppressed growth Meta Platforms is expecting is poor. Management guided for fourth-quarter revenue to be between $31.5 billion and $34 billion. The midpoint of this guidance range represents 17% revenue growth. Further, analysts are still modeling for exceptional earnings-per-share growth over the next five years. On average, analysts currently expect Meta Platforms' earnings per share to compound at a growth rate of 21% annually over this period.</p>\n<p>Meta Platforms' network effect of billions of monthly active users makes its business very durable. Not only has the company's core Facebook platform consistently grown larger with no close challenger, but the company's other social networks with more intense competition (namely Instagram) have shown they can easily deploy features that imitate successful competitors, helping them stay relevant.</p>\n<h2>Tractor Supply Company</h2>\n<p>Some city folk may have never even stepped foot in a Tractor Supply store. But investors shouldn't overlook this investment just because they're not familiar with the retailer. Tractor Supply, which specializes in rural lifestyle, has a strong retail niche and is capitalizing well on several different important growth catalysts, including private label and exclusive brands, pet food, and e-commerce. Its balanced business has helped revenue grow 24% year over year in the trailing 12 months, and helped earnings per share grow 22%.</p>\n<p>Tractor Supply is notably mastering e-commerce in a market where many of its customers live farther apart than people do in the city. These communities come with unique challenges that Tractor Supply is able to develop expertise in, and the company's strategy is working. Tractor Supply said on its most recent earnings call that its e-commerce sales increased at a rate faster than 40% year over year.</p>\n<p>While the stock's price-to-earnings ratio of 29 isn't exactly cheap, the company's positioning as the lead retailer for the rural lifestyle makes this business worth paying up for. Given how specialized Tractor Supply is, it would be very difficult for a competitor to topple it. The company also pays a dividend and is regularly repurchasing shares, supplementing shareholder value creation.</p>\n<p>Facebook and Tractor Supply together represent two solid ideas from very different industries that provide meaningful long-term growth potential for investors.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>2 Top Stocks to Buy for the New Year</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n2 Top Stocks to Buy for the New Year\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-25 10:07 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/12/24/2-top-stocks-to-buy-for-the-new-year/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>With talks of likely interest rate hikes from the Federal Reserve in 2022 and the coronavirus pandemic still making the rounds, one key characteristic investors should look for in investments going ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/12/24/2-top-stocks-to-buy-for-the-new-year/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TSCO":"拖拉机供应公司"},"source_url":"https://www.fool.com/investing/2021/12/24/2-top-stocks-to-buy-for-the-new-year/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2193720178","content_text":"With talks of likely interest rate hikes from the Federal Reserve in 2022 and the coronavirus pandemic still making the rounds, one key characteristic investors should look for in investments going into the new year is resilience. In other words, some good traits to look for are valuations that make sense relative to a company's growth trajectory and market opportunity, and durable business models with proven track records. While there's no way to avoid volatility, owning resilient companies can at least help investors better weather near-term challenges (mentally and emotionally) since they know their investments have what it takes to endure.\nTwo companies that fit this description are Meta Platforms (NASDAQ:FB) and Tractor Supply Company (NASDAQ:TSCO). Here's a look at why both of these stocks are good bets for 2022 and beyond.\nMeta Platforms\nThe case for Meta Platforms is straightforward. The tech stock's valuation is very cheap relative to the company's recent growth. Consider that the Facebook parent's trailing-12-month revenue and net income of $112 billion and $40 billion, respectively, are up from $71 billion and $18 billion in 2019. Even with such staggering recent growth, Meta Platforms trades at only 24 times its current level of earnings.\nWhile the company is running into some near-term growth headwinds related to Apple's recent changes to advertising tracking and measurement, it's not like the suppressed growth Meta Platforms is expecting is poor. Management guided for fourth-quarter revenue to be between $31.5 billion and $34 billion. The midpoint of this guidance range represents 17% revenue growth. Further, analysts are still modeling for exceptional earnings-per-share growth over the next five years. On average, analysts currently expect Meta Platforms' earnings per share to compound at a growth rate of 21% annually over this period.\nMeta Platforms' network effect of billions of monthly active users makes its business very durable. Not only has the company's core Facebook platform consistently grown larger with no close challenger, but the company's other social networks with more intense competition (namely Instagram) have shown they can easily deploy features that imitate successful competitors, helping them stay relevant.\nTractor Supply Company\nSome city folk may have never even stepped foot in a Tractor Supply store. But investors shouldn't overlook this investment just because they're not familiar with the retailer. Tractor Supply, which specializes in rural lifestyle, has a strong retail niche and is capitalizing well on several different important growth catalysts, including private label and exclusive brands, pet food, and e-commerce. Its balanced business has helped revenue grow 24% year over year in the trailing 12 months, and helped earnings per share grow 22%.\nTractor Supply is notably mastering e-commerce in a market where many of its customers live farther apart than people do in the city. These communities come with unique challenges that Tractor Supply is able to develop expertise in, and the company's strategy is working. Tractor Supply said on its most recent earnings call that its e-commerce sales increased at a rate faster than 40% year over year.\nWhile the stock's price-to-earnings ratio of 29 isn't exactly cheap, the company's positioning as the lead retailer for the rural lifestyle makes this business worth paying up for. Given how specialized Tractor Supply is, it would be very difficult for a competitor to topple it. The company also pays a dividend and is regularly repurchasing shares, supplementing shareholder value creation.\nFacebook and Tractor Supply together represent two solid ideas from very different industries that provide meaningful long-term growth potential for investors.","news_type":1},"isVote":1,"tweetType":1,"viewCount":627,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":698333952,"gmtCreate":1640302602178,"gmtModify":1640302602541,"author":{"id":"4094269572113460","authorId":"4094269572113460","name":"Ytyt","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"Pls like","listText":"Pls like","text":"Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/698333952","repostId":"2193078140","repostType":4,"repost":{"id":"2193078140","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1640299360,"share":"https://www.laohu8.com/m/news/2193078140?lang=&edition=full","pubTime":"2021-12-24 06:42","market":"us","language":"en","title":"S&P 500 hits record close as Omicron fears ebb","url":"https://stock-news.laohu8.com/highlight/detail?id=2193078140","media":"Reuters","summary":"* Major indexes climb for 3rd straight session\n* Merck's at-home COVID-19 pill gets U.S. approval\n* ","content":"<p>* Major indexes climb for 3rd straight session</p>\n<p>* Merck's at-home COVID-19 pill gets U.S. approval</p>\n<p>* Weekly jobless claims unchanged at 205,000</p>\n<p>* Consumer spending increases 0.6% in November</p>\n<p>* Indexes up: Dow 0.55%, S&amp;P 0.62%, Nasdaq 0.85%</p>\n<p>Dec 23 (Reuters) - Wall Street's main indexes posted solid gains for a third straight session on Thursday, with the S&amp;P 500 marking a record-high close, as encouraging developments gave investors more ease about the economic impact of the Omicron coronavirus variant.</p>\n<p>Stocks ended the holiday-shortened week on a positive note, lifting sentiment heading into Christmas. Gains were broad among S&amp;P 500 sectors, led by consumer discretionary&nbsp;and industrials, which both rose about 1.2%.</p>\n<p>Vaccine makers <a href=\"https://laohu8.com/S/AZNCF\">AstraZeneca Plc</a>&nbsp;and Novavax Inc&nbsp;said their shots protected against Omicron as UK data suggested it may cause proportionally fewer hospital cases than the Delta variant, though public health experts warned the battle against COVID-19 was far from over.</p>\n<p>The arrival of Omicron has helped ratchet up market volatility for much of the last month of 2021, which has been a strong year for equities.</p>\n<p>“There was a lot of negative sentiment coming into the final part of the year, and investors have likely continued to see pretty strong economic growth and pretty positive developments as it relates to healthcare innovation around COVID and that is putting in a bit of a bid into equities and causing investors to look to allocate capital as they close out the year,” said Matthew Miskin, co-chief investment strategist at John Hancock Investment Management.</p>\n<p>The Dow Jones Industrial Average&nbsp;rose 196.67 points, or 0.55%, to 35,950.56, the S&amp;P 500&nbsp;gained 29.23 points, or 0.62%, to 4,725.79 and the Nasdaq Composite&nbsp;added 131.48 points, or 0.85%, to 15,653.37.</p>\n<p>Defensive sectors, which have mostly outperformed in December, generally lagged on Thursday. The real estate sector&nbsp;fell 0.4%.</p>\n<p>The S&amp;P 500 has gained for three days, after falling in the three prior sessions.</p>\n<p>“People are seeing the strength on Tuesday and Wednesday and all of a sudden everybody is more optimistic again,” said Robert Pavlik, senior portfolio manager at Dakota Wealth Management.</p>\n<p>For the week, the S&amp;P 500 rose 2.3%, the Dow gained about 1.7% and the Nasdaq climbed 3.2%.</p>\n<p>Trading volumes were expected to be thinner than usual ahead of the Christmas and New Year holidays. The stock market will be closed on Friday in observance of the Christmas holiday.</p>\n<p>In another medical development against the pandemic, the United States authorized Merck &amp; Co's&nbsp;antiviral pill for COVID-19 for certain high-risk adult patients, a day after giving a broader go-ahead to a similar but more effective treatment from Pfizer Inc. Merck shares fell 0.6%, while Pfizer dropped 1.4%.</p>\n<p>The number of Americans filing new claims for unemployment benefits held below pre-pandemic levels last week as the labor market tightens, while consumer spending increased solidly, putting the economy on track for a strong finish to 2021.</p>\n<p>Tesla Inc&nbsp;shares rose 5.8%, gaining sharply for a second day after Chief Executive Elon Musk said on Wednesday he was \"almost done\" with his stock sales after selling over $15 billion worth since early November.</p>\n<p>The S&amp;P 500 is up about 26% so far this year. Still, the environment for equities could be changing heading into next year as the Federal Reserve is expected to begin raising interest rates in 2022.</p>\n<p>Advancing issues outnumbered declining ones on the NYSE by a 2.40-to-1 ratio; on Nasdaq, a 2.22-to-1 ratio favored advancers.</p>\n<p>The S&amp;P 500 posted 35 new 52-week highs and no new lows; the Nasdaq Composite recorded 62 new highs and 80 new lows.</p>\n<p>About 8 billion shares changed hands in U.S. exchanges, compared with the 11.8 billion daily average over the last 20 sessions.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>S&P 500 hits record close as Omicron fears ebb</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nS&P 500 hits record close as Omicron fears ebb\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-12-24 06:42</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>* Major indexes climb for 3rd straight session</p>\n<p>* Merck's at-home COVID-19 pill gets U.S. approval</p>\n<p>* Weekly jobless claims unchanged at 205,000</p>\n<p>* Consumer spending increases 0.6% in November</p>\n<p>* Indexes up: Dow 0.55%, S&amp;P 0.62%, Nasdaq 0.85%</p>\n<p>Dec 23 (Reuters) - Wall Street's main indexes posted solid gains for a third straight session on Thursday, with the S&amp;P 500 marking a record-high close, as encouraging developments gave investors more ease about the economic impact of the Omicron coronavirus variant.</p>\n<p>Stocks ended the holiday-shortened week on a positive note, lifting sentiment heading into Christmas. Gains were broad among S&amp;P 500 sectors, led by consumer discretionary&nbsp;and industrials, which both rose about 1.2%.</p>\n<p>Vaccine makers <a href=\"https://laohu8.com/S/AZNCF\">AstraZeneca Plc</a>&nbsp;and Novavax Inc&nbsp;said their shots protected against Omicron as UK data suggested it may cause proportionally fewer hospital cases than the Delta variant, though public health experts warned the battle against COVID-19 was far from over.</p>\n<p>The arrival of Omicron has helped ratchet up market volatility for much of the last month of 2021, which has been a strong year for equities.</p>\n<p>“There was a lot of negative sentiment coming into the final part of the year, and investors have likely continued to see pretty strong economic growth and pretty positive developments as it relates to healthcare innovation around COVID and that is putting in a bit of a bid into equities and causing investors to look to allocate capital as they close out the year,” said Matthew Miskin, co-chief investment strategist at John Hancock Investment Management.</p>\n<p>The Dow Jones Industrial Average&nbsp;rose 196.67 points, or 0.55%, to 35,950.56, the S&amp;P 500&nbsp;gained 29.23 points, or 0.62%, to 4,725.79 and the Nasdaq Composite&nbsp;added 131.48 points, or 0.85%, to 15,653.37.</p>\n<p>Defensive sectors, which have mostly outperformed in December, generally lagged on Thursday. The real estate sector&nbsp;fell 0.4%.</p>\n<p>The S&amp;P 500 has gained for three days, after falling in the three prior sessions.</p>\n<p>“People are seeing the strength on Tuesday and Wednesday and all of a sudden everybody is more optimistic again,” said Robert Pavlik, senior portfolio manager at Dakota Wealth Management.</p>\n<p>For the week, the S&amp;P 500 rose 2.3%, the Dow gained about 1.7% and the Nasdaq climbed 3.2%.</p>\n<p>Trading volumes were expected to be thinner than usual ahead of the Christmas and New Year holidays. The stock market will be closed on Friday in observance of the Christmas holiday.</p>\n<p>In another medical development against the pandemic, the United States authorized Merck &amp; Co's&nbsp;antiviral pill for COVID-19 for certain high-risk adult patients, a day after giving a broader go-ahead to a similar but more effective treatment from Pfizer Inc. Merck shares fell 0.6%, while Pfizer dropped 1.4%.</p>\n<p>The number of Americans filing new claims for unemployment benefits held below pre-pandemic levels last week as the labor market tightens, while consumer spending increased solidly, putting the economy on track for a strong finish to 2021.</p>\n<p>Tesla Inc&nbsp;shares rose 5.8%, gaining sharply for a second day after Chief Executive Elon Musk said on Wednesday he was \"almost done\" with his stock sales after selling over $15 billion worth since early November.</p>\n<p>The S&amp;P 500 is up about 26% so far this year. Still, the environment for equities could be changing heading into next year as the Federal Reserve is expected to begin raising interest rates in 2022.</p>\n<p>Advancing issues outnumbered declining ones on the NYSE by a 2.40-to-1 ratio; on Nasdaq, a 2.22-to-1 ratio favored advancers.</p>\n<p>The S&amp;P 500 posted 35 new 52-week highs and no new lows; the Nasdaq Composite recorded 62 new highs and 80 new lows.</p>\n<p>About 8 billion shares changed hands in U.S. exchanges, compared with the 11.8 billion daily average over the last 20 sessions.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"161125":"标普500","513500":"标普500ETF","SDS":"两倍做空标普500ETF","SH":"标普500反向ETF",".DJI":"道琼斯",".IXIC":"NASDAQ Composite","OEX":"标普100","OEF":"标普100指数ETF-iShares",".SPX":"S&P 500 Index","SPXU":"三倍做空标普500ETF","BK4534":"瑞士信贷持仓","SSO":"两倍做多标普500ETF","UPRO":"三倍做多标普500ETF","SPY":"标普500ETF","BK4559":"巴菲特持仓","BK4550":"红杉资本持仓","IVV":"标普500指数ETF","BK4504":"桥水持仓"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2193078140","content_text":"* Major indexes climb for 3rd straight session\n* Merck's at-home COVID-19 pill gets U.S. approval\n* Weekly jobless claims unchanged at 205,000\n* Consumer spending increases 0.6% in November\n* Indexes up: Dow 0.55%, S&P 0.62%, Nasdaq 0.85%\nDec 23 (Reuters) - Wall Street's main indexes posted solid gains for a third straight session on Thursday, with the S&P 500 marking a record-high close, as encouraging developments gave investors more ease about the economic impact of the Omicron coronavirus variant.\nStocks ended the holiday-shortened week on a positive note, lifting sentiment heading into Christmas. Gains were broad among S&P 500 sectors, led by consumer discretionary and industrials, which both rose about 1.2%.\nVaccine makers AstraZeneca Plc and Novavax Inc said their shots protected against Omicron as UK data suggested it may cause proportionally fewer hospital cases than the Delta variant, though public health experts warned the battle against COVID-19 was far from over.\nThe arrival of Omicron has helped ratchet up market volatility for much of the last month of 2021, which has been a strong year for equities.\n“There was a lot of negative sentiment coming into the final part of the year, and investors have likely continued to see pretty strong economic growth and pretty positive developments as it relates to healthcare innovation around COVID and that is putting in a bit of a bid into equities and causing investors to look to allocate capital as they close out the year,” said Matthew Miskin, co-chief investment strategist at John Hancock Investment Management.\nThe Dow Jones Industrial Average rose 196.67 points, or 0.55%, to 35,950.56, the S&P 500 gained 29.23 points, or 0.62%, to 4,725.79 and the Nasdaq Composite added 131.48 points, or 0.85%, to 15,653.37.\nDefensive sectors, which have mostly outperformed in December, generally lagged on Thursday. The real estate sector fell 0.4%.\nThe S&P 500 has gained for three days, after falling in the three prior sessions.\n“People are seeing the strength on Tuesday and Wednesday and all of a sudden everybody is more optimistic again,” said Robert Pavlik, senior portfolio manager at Dakota Wealth Management.\nFor the week, the S&P 500 rose 2.3%, the Dow gained about 1.7% and the Nasdaq climbed 3.2%.\nTrading volumes were expected to be thinner than usual ahead of the Christmas and New Year holidays. The stock market will be closed on Friday in observance of the Christmas holiday.\nIn another medical development against the pandemic, the United States authorized Merck & Co's antiviral pill for COVID-19 for certain high-risk adult patients, a day after giving a broader go-ahead to a similar but more effective treatment from Pfizer Inc. Merck shares fell 0.6%, while Pfizer dropped 1.4%.\nThe number of Americans filing new claims for unemployment benefits held below pre-pandemic levels last week as the labor market tightens, while consumer spending increased solidly, putting the economy on track for a strong finish to 2021.\nTesla Inc shares rose 5.8%, gaining sharply for a second day after Chief Executive Elon Musk said on Wednesday he was \"almost done\" with his stock sales after selling over $15 billion worth since early November.\nThe S&P 500 is up about 26% so far this year. Still, the environment for equities could be changing heading into next year as the Federal Reserve is expected to begin raising interest rates in 2022.\nAdvancing issues outnumbered declining ones on the NYSE by a 2.40-to-1 ratio; on Nasdaq, a 2.22-to-1 ratio favored advancers.\nThe S&P 500 posted 35 new 52-week highs and no new lows; the Nasdaq Composite recorded 62 new highs and 80 new lows.\nAbout 8 billion shares changed hands in U.S. exchanges, compared with the 11.8 billion daily average over the last 20 sessions.","news_type":1},"isVote":1,"tweetType":1,"viewCount":558,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":691270758,"gmtCreate":1640216306020,"gmtModify":1640216306127,"author":{"id":"4094269572113460","authorId":"4094269572113460","name":"Ytyt","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"Pls like","listText":"Pls like","text":"Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/691270758","repostId":"2193113147","repostType":4,"repost":{"id":"2193113147","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1640213688,"share":"https://www.laohu8.com/m/news/2193113147?lang=&edition=full","pubTime":"2021-12-23 06:54","market":"us","language":"en","title":"Wall St mints strong gains on rosy economic data, encouraging Omicron update","url":"https://stock-news.laohu8.com/highlight/detail?id=2193113147","media":"Reuters","summary":"* Tesla jumps as CEO Musk says he has sold 'enough' stock. * Pfizer rises as oral COVID-19 pill wins approval. Dec 22  - Wall Street's main indexes powered higher on Wednesday in a broad rally after upbeat economic data and hopeful developments about the severity of the Omicron coronavirus variant that is sweeping the world.The S&P 500 gained at least 1% for a second straight session, putting it near record levels, as volatility has ratcheted up in the last month of 2021 following the arrival of","content":"<p>* Consumer confidence index increases in December</p>\n<p>* U.S. Q3 economic growth revised slightly higher</p>\n<p>* Tesla jumps as CEO Musk says he has sold 'enough' stock</p>\n<p>* Pfizer rises as oral COVID-19 pill wins approval</p>\n<p>* Indexes up: Dow 0.74%, S&amp;P 1.02%, Nasdaq 1.18% </p>\n<p>Dec 22 (Reuters) - Wall Street's main indexes powered higher on Wednesday in a broad rally after upbeat economic data and hopeful developments about the severity of the Omicron coronavirus variant that is sweeping the world.</p>\n<p>The S&amp;P 500 gained at least 1% for a second straight session, putting it near record levels, as volatility has ratcheted up in the last month of 2021 following the arrival of Omicron and an otherwise strong year for equities.</p>\n<p>A South African study suggested reduced risks of hospitalization and severe disease in people infected with the Omicron variant versus the Delta one, but World Health Organization officials cautioned that it was too soon to draw firm conclusions.</p>\n<p>“We are still struggling for direction in the face of the Omicron outbreak, but in the past few days ... more and more evidence is building that the strain is potentially less severe than prior strains, specifically Delta, which bodes well for economic momentum in 2022,” said Mike Stritch, chief investment officer at BMO Wealth Management.</p>\n<p>The Dow Jones Industrial Average rose 261.19 points, or 0.74%, to 35,753.89, the S&amp;P 500 gained 47.33 points, or 1.02%, to 4,696.56 and the Nasdaq Composite added 180.81 points, or 1.18%, to 15,521.89.</p>\n<p>All major S&amp;P 500 sectors gained, with the consumer discretionary group up 1.7% and technology up 1.3%.</p>\n<p>Tesla Inc shares rose 7.5%, boosting the S&amp;P 500 and Nasdaq. Tesla Chief Executive Elon Musk said in an interview he has sold \"enough stock\" following several weeks of share sales by the billionaire.</p>\n<p>U.S. consumer confidence improved further in December, suggesting the economy would continue to expand in 2022. The survey from the Conference Board showed more consumers planned to buy a house and big-ticket items such as motor vehicles and major household appliances as well as go on vacation over the next six months.</p>\n<p>Other reports showed U.S. home sales increased for a third straight month in November, and that gross domestic product increased at a 2.3% annualized rate in the July-September quarter, revised up from the 2.1% rate estimated last month.</p>\n<p>In another encouraging development against the pandemic, the United States authorized Pfizer Inc's oral antiviral COVID-19 pill for at-risk people aged 12 and above, making it the first at-home treatment for the coronavirus. Pfizer shares rose 1%.</p>\n<p>The benchmark S&amp;P 500 is now up 25% so far in 2021. Still, the environment for equities could be changing heading into next year as the Federal Reserve is expected to begin raising interest rates in 2022 to rein in inflation.</p>\n<p>The market is \"certainly at an extended level of valuation,\" said Rick Meckler, partner at Cherry Lane Investments in New Vernon, New Jersey. “Next year is a more difficult picture, but if inflation is going to be part of the problem, I think investors will certainly choose stocks over bonds.”</p>\n<p>Advancing issues outnumbered declining ones on the NYSE by a 3.17-to-1 ratio; on Nasdaq, a 1.65-to-1 ratio favored advancers.</p>\n<p>The S&amp;P 500 posted 15 new 52-week highs and no new lows; the Nasdaq Composite recorded 35 new highs and 99 new lows.</p>\n<p>About 8.6 billion shares changed hands in U.S. exchanges, below the 11.8 billion daily average over the last 20 sessions.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Wall St mints strong gains on rosy economic data, encouraging Omicron update</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWall St mints strong gains on rosy economic data, encouraging Omicron update\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-12-23 06:54</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>* Consumer confidence index increases in December</p>\n<p>* U.S. Q3 economic growth revised slightly higher</p>\n<p>* Tesla jumps as CEO Musk says he has sold 'enough' stock</p>\n<p>* Pfizer rises as oral COVID-19 pill wins approval</p>\n<p>* Indexes up: Dow 0.74%, S&amp;P 1.02%, Nasdaq 1.18% </p>\n<p>Dec 22 (Reuters) - Wall Street's main indexes powered higher on Wednesday in a broad rally after upbeat economic data and hopeful developments about the severity of the Omicron coronavirus variant that is sweeping the world.</p>\n<p>The S&amp;P 500 gained at least 1% for a second straight session, putting it near record levels, as volatility has ratcheted up in the last month of 2021 following the arrival of Omicron and an otherwise strong year for equities.</p>\n<p>A South African study suggested reduced risks of hospitalization and severe disease in people infected with the Omicron variant versus the Delta one, but World Health Organization officials cautioned that it was too soon to draw firm conclusions.</p>\n<p>“We are still struggling for direction in the face of the Omicron outbreak, but in the past few days ... more and more evidence is building that the strain is potentially less severe than prior strains, specifically Delta, which bodes well for economic momentum in 2022,” said Mike Stritch, chief investment officer at BMO Wealth Management.</p>\n<p>The Dow Jones Industrial Average rose 261.19 points, or 0.74%, to 35,753.89, the S&amp;P 500 gained 47.33 points, or 1.02%, to 4,696.56 and the Nasdaq Composite added 180.81 points, or 1.18%, to 15,521.89.</p>\n<p>All major S&amp;P 500 sectors gained, with the consumer discretionary group up 1.7% and technology up 1.3%.</p>\n<p>Tesla Inc shares rose 7.5%, boosting the S&amp;P 500 and Nasdaq. Tesla Chief Executive Elon Musk said in an interview he has sold \"enough stock\" following several weeks of share sales by the billionaire.</p>\n<p>U.S. consumer confidence improved further in December, suggesting the economy would continue to expand in 2022. The survey from the Conference Board showed more consumers planned to buy a house and big-ticket items such as motor vehicles and major household appliances as well as go on vacation over the next six months.</p>\n<p>Other reports showed U.S. home sales increased for a third straight month in November, and that gross domestic product increased at a 2.3% annualized rate in the July-September quarter, revised up from the 2.1% rate estimated last month.</p>\n<p>In another encouraging development against the pandemic, the United States authorized Pfizer Inc's oral antiviral COVID-19 pill for at-risk people aged 12 and above, making it the first at-home treatment for the coronavirus. Pfizer shares rose 1%.</p>\n<p>The benchmark S&amp;P 500 is now up 25% so far in 2021. Still, the environment for equities could be changing heading into next year as the Federal Reserve is expected to begin raising interest rates in 2022 to rein in inflation.</p>\n<p>The market is \"certainly at an extended level of valuation,\" said Rick Meckler, partner at Cherry Lane Investments in New Vernon, New Jersey. “Next year is a more difficult picture, but if inflation is going to be part of the problem, I think investors will certainly choose stocks over bonds.”</p>\n<p>Advancing issues outnumbered declining ones on the NYSE by a 3.17-to-1 ratio; on Nasdaq, a 1.65-to-1 ratio favored advancers.</p>\n<p>The S&amp;P 500 posted 15 new 52-week highs and no new lows; the Nasdaq Composite recorded 35 new highs and 99 new lows.</p>\n<p>About 8.6 billion shares changed hands in U.S. exchanges, below the 11.8 billion daily average over the last 20 sessions.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4007":"制药",".DJI":"道琼斯","TSLA":"特斯拉","COMP":"Compass, Inc.",".IXIC":"NASDAQ Composite","BK4568":"美国抗疫概念","BK4533":"AQR资本管理(全球第二大对冲基金)","PFE":"辉瑞"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2193113147","content_text":"* Consumer confidence index increases in December\n* U.S. Q3 economic growth revised slightly higher\n* Tesla jumps as CEO Musk says he has sold 'enough' stock\n* Pfizer rises as oral COVID-19 pill wins approval\n* Indexes up: Dow 0.74%, S&P 1.02%, Nasdaq 1.18% \nDec 22 (Reuters) - Wall Street's main indexes powered higher on Wednesday in a broad rally after upbeat economic data and hopeful developments about the severity of the Omicron coronavirus variant that is sweeping the world.\nThe S&P 500 gained at least 1% for a second straight session, putting it near record levels, as volatility has ratcheted up in the last month of 2021 following the arrival of Omicron and an otherwise strong year for equities.\nA South African study suggested reduced risks of hospitalization and severe disease in people infected with the Omicron variant versus the Delta one, but World Health Organization officials cautioned that it was too soon to draw firm conclusions.\n“We are still struggling for direction in the face of the Omicron outbreak, but in the past few days ... more and more evidence is building that the strain is potentially less severe than prior strains, specifically Delta, which bodes well for economic momentum in 2022,” said Mike Stritch, chief investment officer at BMO Wealth Management.\nThe Dow Jones Industrial Average rose 261.19 points, or 0.74%, to 35,753.89, the S&P 500 gained 47.33 points, or 1.02%, to 4,696.56 and the Nasdaq Composite added 180.81 points, or 1.18%, to 15,521.89.\nAll major S&P 500 sectors gained, with the consumer discretionary group up 1.7% and technology up 1.3%.\nTesla Inc shares rose 7.5%, boosting the S&P 500 and Nasdaq. Tesla Chief Executive Elon Musk said in an interview he has sold \"enough stock\" following several weeks of share sales by the billionaire.\nU.S. consumer confidence improved further in December, suggesting the economy would continue to expand in 2022. The survey from the Conference Board showed more consumers planned to buy a house and big-ticket items such as motor vehicles and major household appliances as well as go on vacation over the next six months.\nOther reports showed U.S. home sales increased for a third straight month in November, and that gross domestic product increased at a 2.3% annualized rate in the July-September quarter, revised up from the 2.1% rate estimated last month.\nIn another encouraging development against the pandemic, the United States authorized Pfizer Inc's oral antiviral COVID-19 pill for at-risk people aged 12 and above, making it the first at-home treatment for the coronavirus. Pfizer shares rose 1%.\nThe benchmark S&P 500 is now up 25% so far in 2021. Still, the environment for equities could be changing heading into next year as the Federal Reserve is expected to begin raising interest rates in 2022 to rein in inflation.\nThe market is \"certainly at an extended level of valuation,\" said Rick Meckler, partner at Cherry Lane Investments in New Vernon, New Jersey. “Next year is a more difficult picture, but if inflation is going to be part of the problem, I think investors will certainly choose stocks over bonds.”\nAdvancing issues outnumbered declining ones on the NYSE by a 3.17-to-1 ratio; on Nasdaq, a 1.65-to-1 ratio favored advancers.\nThe S&P 500 posted 15 new 52-week highs and no new lows; the Nasdaq Composite recorded 35 new highs and 99 new lows.\nAbout 8.6 billion shares changed hands in U.S. exchanges, below the 11.8 billion daily average over the last 20 sessions.","news_type":1},"isVote":1,"tweetType":1,"viewCount":524,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":691954726,"gmtCreate":1640130161579,"gmtModify":1640130161850,"author":{"id":"4094269572113460","authorId":"4094269572113460","name":"Ytyt","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"Pls like","listText":"Pls like","text":"Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/691954726","repostId":"2193663561","repostType":4,"repost":{"id":"2193663561","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1640125936,"share":"https://www.laohu8.com/m/news/2193663561?lang=&edition=full","pubTime":"2021-12-22 06:32","market":"us","language":"en","title":"Wall Street closes up strongly with boost from Nike, Micron, following Omicron slide","url":"https://stock-news.laohu8.com/highlight/detail?id=2193663561","media":"Reuters","summary":"Dec 21  - Wall Street's main indexes ended sharply higher on Tuesday, with strength in travel and tech shares as well as in Nike and Micron Technology following their earnings, as stocks rebounded from a coronavirus-fueled rout the session before.The rapidly spreading Omicron variant of the coronavirus has rattled stock markets around the world, triggering volatility in the final month of 2021, which has otherwise been a strong year for equities.Gains in massive technology and tech-related stock","content":"<ul>\n <li>Energy, tech top-gaining S&amp;P 500 sectors</li>\n <li>Travel stocks surge broadly</li>\n <li>Nike up after beating quarterly estimates</li>\n <li>Micron rises as it sees chip shortages easing</li>\n <li>Indexes up: Dow 1.6%, S&amp;P 1.78%, Nasdaq 2.4%</li>\n</ul>\n<p>Dec 21 (Reuters) - Wall Street's main indexes ended sharply higher on Tuesday, with strength in travel and tech shares as well as in Nike and Micron Technology following their earnings, as stocks rebounded from a coronavirus-fueled rout the session before.</p>\n<p>The rapidly spreading Omicron variant of the coronavirus has rattled stock markets around the world, triggering volatility in the final month of 2021, which has otherwise been a strong year for equities.</p>\n<p>Gains in massive technology and tech-related stocks such as Microsoft&nbsp;and Amazon&nbsp;lifted indexes on Tuesday, as did increases in economically sensitive groups such as energy. Travel-related stocks surged, including Carnival Corp, Las Vegas Sands&nbsp;and <a href=\"https://laohu8.com/S/EXPE\">Expedia</a> Group.</p>\n<p>“It is clearly a risk-on day,\" said David Joy, chief market strategist at Ameriprise Financial in Boston. \"This is clearly, at least for the day, investors saying, 'You know what, we are going to be able to ride through this Omicron surge and come out the other side in pretty good shape.’”</p>\n<p>The Dow Jones Industrial Average&nbsp;rose 560.54 points, or 1.6%, to 35,492.7, the S&amp;P 500&nbsp;gained 81.21 points, or 1.78%, to 4,649.23 and the Nasdaq Composite&nbsp;added 360.14 points, or 2.4%, to 15,341.09.</p>\n<p>Defensive sectors, such as consumer staples&nbsp;and utilities&nbsp;that have led in December, lagged on Tuesday.</p>\n<p>Nike&nbsp;shares rose 6.1% after the sports apparel company's results beat quarterly estimates for profit and revenue, and it said it was more confident that supply chain issues would ease in its next fiscal year.</p>\n<p>Micron Technology&nbsp;shares jumped 10.5% after the chip company forecast second-quarter sales and profits will beat estimates with shortages easing in 2022. The Philadelphia SE Semiconductor index&nbsp;rose 3.4%.</p>\n<p>“If Micron’s forecast is strong, that tells us broadly speaking that demand is strong across many different industries,” said King Lip, chief strategist at Baker Avenue Asset Management, adding that Micron's products \"go into so many different industrial applications.\"</p>\n<p>General Mills&nbsp;shares fell 4% after the consumer staples company missed Wall Street estimates for quarterly profit.</p>\n<p>The benchmark S&amp;P 500 has gained 23.8% so far in 2021.</p>\n<p>Some investors are wary about a tougher environment for equities as the Federal Reserve is expected to start raising interest rates next year.</p>\n<p>\"It's good to see green going into the next year but if you just take a step back and look at the broader picture, you're seeing financial conditions change,\" said Joshua Chastant, senior investment analyst at GuideStone Capital Management.</p>\n<p>Advancing issues outnumbered declining ones on the NYSE by a 4.08-to-1 ratio; on Nasdaq, a 2.95-to-1 ratio favored advancers.</p>\n<p>The S&amp;P 500 posted 11 new 52-week highs and no new lows; the Nasdaq Composite recorded 27 new highs and 99 new lows.</p>\n<p>About 10.1 billion shares changed hands in U.S. exchanges, below the daily average of roughly 12 billion over the last 20 sessions.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Wall Street closes up strongly with boost from Nike, Micron, following Omicron slide</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWall Street closes up strongly with boost from Nike, Micron, following Omicron slide\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-12-22 06:32</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<ul>\n <li>Energy, tech top-gaining S&amp;P 500 sectors</li>\n <li>Travel stocks surge broadly</li>\n <li>Nike up after beating quarterly estimates</li>\n <li>Micron rises as it sees chip shortages easing</li>\n <li>Indexes up: Dow 1.6%, S&amp;P 1.78%, Nasdaq 2.4%</li>\n</ul>\n<p>Dec 21 (Reuters) - Wall Street's main indexes ended sharply higher on Tuesday, with strength in travel and tech shares as well as in Nike and Micron Technology following their earnings, as stocks rebounded from a coronavirus-fueled rout the session before.</p>\n<p>The rapidly spreading Omicron variant of the coronavirus has rattled stock markets around the world, triggering volatility in the final month of 2021, which has otherwise been a strong year for equities.</p>\n<p>Gains in massive technology and tech-related stocks such as Microsoft&nbsp;and Amazon&nbsp;lifted indexes on Tuesday, as did increases in economically sensitive groups such as energy. Travel-related stocks surged, including Carnival Corp, Las Vegas Sands&nbsp;and <a href=\"https://laohu8.com/S/EXPE\">Expedia</a> Group.</p>\n<p>“It is clearly a risk-on day,\" said David Joy, chief market strategist at Ameriprise Financial in Boston. \"This is clearly, at least for the day, investors saying, 'You know what, we are going to be able to ride through this Omicron surge and come out the other side in pretty good shape.’”</p>\n<p>The Dow Jones Industrial Average&nbsp;rose 560.54 points, or 1.6%, to 35,492.7, the S&amp;P 500&nbsp;gained 81.21 points, or 1.78%, to 4,649.23 and the Nasdaq Composite&nbsp;added 360.14 points, or 2.4%, to 15,341.09.</p>\n<p>Defensive sectors, such as consumer staples&nbsp;and utilities&nbsp;that have led in December, lagged on Tuesday.</p>\n<p>Nike&nbsp;shares rose 6.1% after the sports apparel company's results beat quarterly estimates for profit and revenue, and it said it was more confident that supply chain issues would ease in its next fiscal year.</p>\n<p>Micron Technology&nbsp;shares jumped 10.5% after the chip company forecast second-quarter sales and profits will beat estimates with shortages easing in 2022. The Philadelphia SE Semiconductor index&nbsp;rose 3.4%.</p>\n<p>“If Micron’s forecast is strong, that tells us broadly speaking that demand is strong across many different industries,” said King Lip, chief strategist at Baker Avenue Asset Management, adding that Micron's products \"go into so many different industrial applications.\"</p>\n<p>General Mills&nbsp;shares fell 4% after the consumer staples company missed Wall Street estimates for quarterly profit.</p>\n<p>The benchmark S&amp;P 500 has gained 23.8% so far in 2021.</p>\n<p>Some investors are wary about a tougher environment for equities as the Federal Reserve is expected to start raising interest rates next year.</p>\n<p>\"It's good to see green going into the next year but if you just take a step back and look at the broader picture, you're seeing financial conditions change,\" said Joshua Chastant, senior investment analyst at GuideStone Capital Management.</p>\n<p>Advancing issues outnumbered declining ones on the NYSE by a 4.08-to-1 ratio; on Nasdaq, a 2.95-to-1 ratio favored advancers.</p>\n<p>The S&amp;P 500 posted 11 new 52-week highs and no new lows; the Nasdaq Composite recorded 27 new highs and 99 new lows.</p>\n<p>About 10.1 billion shares changed hands in U.S. exchanges, below the daily average of roughly 12 billion over the last 20 sessions.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"SQQQ":"纳指三倍做空ETF","BK4534":"瑞士信贷持仓","BK4146":"鞋类","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4558":"双十一","BK4566":"资本集团","DDM":"道指两倍做多ETF","QID":"纳指两倍做空ETF","DJX":"1/100道琼斯","DOG":"道指反向ETF","UDOW":"道指三倍做多ETF-ProShares","NKE":"耐克","DXD":"道指两倍做空ETF","PSQ":"纳指反向ETF","BK4561":"索罗斯持仓","QLD":"纳指两倍做多ETF","QQQ":"纳指100ETF","MU":"美光科技","TQQQ":"纳指三倍做多ETF",".DJI":"道琼斯","SDOW":"道指三倍做空ETF-ProShares",".IXIC":"NASDAQ Composite",".SPX":"S&P 500 Index"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2193663561","content_text":"Energy, tech top-gaining S&P 500 sectors\nTravel stocks surge broadly\nNike up after beating quarterly estimates\nMicron rises as it sees chip shortages easing\nIndexes up: Dow 1.6%, S&P 1.78%, Nasdaq 2.4%\n\nDec 21 (Reuters) - Wall Street's main indexes ended sharply higher on Tuesday, with strength in travel and tech shares as well as in Nike and Micron Technology following their earnings, as stocks rebounded from a coronavirus-fueled rout the session before.\nThe rapidly spreading Omicron variant of the coronavirus has rattled stock markets around the world, triggering volatility in the final month of 2021, which has otherwise been a strong year for equities.\nGains in massive technology and tech-related stocks such as Microsoft and Amazon lifted indexes on Tuesday, as did increases in economically sensitive groups such as energy. Travel-related stocks surged, including Carnival Corp, Las Vegas Sands and Expedia Group.\n“It is clearly a risk-on day,\" said David Joy, chief market strategist at Ameriprise Financial in Boston. \"This is clearly, at least for the day, investors saying, 'You know what, we are going to be able to ride through this Omicron surge and come out the other side in pretty good shape.’”\nThe Dow Jones Industrial Average rose 560.54 points, or 1.6%, to 35,492.7, the S&P 500 gained 81.21 points, or 1.78%, to 4,649.23 and the Nasdaq Composite added 360.14 points, or 2.4%, to 15,341.09.\nDefensive sectors, such as consumer staples and utilities that have led in December, lagged on Tuesday.\nNike shares rose 6.1% after the sports apparel company's results beat quarterly estimates for profit and revenue, and it said it was more confident that supply chain issues would ease in its next fiscal year.\nMicron Technology shares jumped 10.5% after the chip company forecast second-quarter sales and profits will beat estimates with shortages easing in 2022. The Philadelphia SE Semiconductor index rose 3.4%.\n“If Micron’s forecast is strong, that tells us broadly speaking that demand is strong across many different industries,” said King Lip, chief strategist at Baker Avenue Asset Management, adding that Micron's products \"go into so many different industrial applications.\"\nGeneral Mills shares fell 4% after the consumer staples company missed Wall Street estimates for quarterly profit.\nThe benchmark S&P 500 has gained 23.8% so far in 2021.\nSome investors are wary about a tougher environment for equities as the Federal Reserve is expected to start raising interest rates next year.\n\"It's good to see green going into the next year but if you just take a step back and look at the broader picture, you're seeing financial conditions change,\" said Joshua Chastant, senior investment analyst at GuideStone Capital Management.\nAdvancing issues outnumbered declining ones on the NYSE by a 4.08-to-1 ratio; on Nasdaq, a 2.95-to-1 ratio favored advancers.\nThe S&P 500 posted 11 new 52-week highs and no new lows; the Nasdaq Composite recorded 27 new highs and 99 new lows.\nAbout 10.1 billion shares changed hands in U.S. exchanges, below the daily average of roughly 12 billion over the last 20 sessions.","news_type":1},"isVote":1,"tweetType":1,"viewCount":642,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":693724197,"gmtCreate":1640085463691,"gmtModify":1640085463794,"author":{"id":"4094269572113460","authorId":"4094269572113460","name":"Ytyt","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"Pls like","listText":"Pls like","text":"Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/693724197","repostId":"1173202355","repostType":2,"repost":{"id":"1173202355","pubTimestamp":1640053734,"share":"https://www.laohu8.com/m/news/1173202355?lang=&edition=full","pubTime":"2021-12-21 10:28","market":"us","language":"en","title":"MRNA, NVAX, OCGN, PFE, BNTX: What Is Going on With Vaccine Stocks Today?","url":"https://stock-news.laohu8.com/highlight/detail?id=1173202355","media":"InvestorPlace","summary":"As another week kicks off on Wall Street, it’s clear that the ominous coverage of the spreading omic","content":"<p>As another week kicks off on Wall Street, it’s clear that the ominous coverage of the spreading omicron variant is still casting shadows over markets. This week has started off with mixed news surrounding the companies who are working around the clock to get ahead in the vaccine race. This has been making it difficult for the overall sector to gain the type of momentum it needs for all vaccine stocks to start moving upward. While one company has an encouraging update regarding its vaccine’s effectiveness against the variant, most of its peers haven’t been so lucky.</p>\n<p>What’s Going on With Vaccine Stocks?</p>\n<p>For the companies embedded in the race to beat the variant, this week isn’t off to a good start. Indeed, vaccine stocks are facing noticeable turbulence.<b>Moderna</b>(NASDAQ:<b><u>MRNA</u></b>) began the day with the announcement that a third dose of its Covid-19 vaccine has been proven to&nbsp;increase antibodies against the new variant. Even with such reassuring news, MRNA stock is down 6.25% today. That said, it did cause shares to surge this morning, putting MRNA stock up almost 10% for the week.</p>\n<p>Meanwhile, most of its peers aren’t fairing much better.<b>Novavax</b>(NASDAQ:<b><u>NVAX</u></b>) just received&nbsp;authorization&nbsp;from the European Union to begin distributing its vaccine throughout Europe during the first half of 2022. While this news sent the stock up in premarket trading today, it hasn’t done much since then. NVAX stock is down more than 7% today. Additionally,&nbsp;<b>Ocugen</b>(NASDAQ:<b><u>OCGN</u></b>) is also falling after an initial&nbsp;early day rise&nbsp;driven by superficial catalysts.</p>\n<p>The only vaccine stock in the green this morning is&nbsp;<b>Pfizer</b>(NYSE:<b><u>PFE</u></b>), which is up more than 2% today despite the&nbsp;recent setback&nbsp;the company experienced regarding its vaccine for children five years old and younger. Meanwhile, Pfizer’s vaccine production partner, Germany-based&nbsp;<b>BioNTech</b>(NASDAQ:<b><u>BNTX</u></b>) is down 4.19% so far, despite the&nbsp;recent news&nbsp;that the two companies will be providing more than 200 million additional vaccine doses to the EU in 2022.</p>\n<p>Why It Matters</p>\n<p>While the week is off to a rough start, every company on this list is still up for the week. The only exception is OCGN, which seems more like a meme stock that is losing momentum.</p>\n<p>However, every other name on this list is fair game for a bullish play on vaccine stocks. The new data from Moderna is highly encouraging, in no small part because it likely means that Pfizer won’t be far behind in tailoring its own vaccine to effectively fight the omicron variant. Novavax’s news is also cause for optimism. While it hasn’t helped the stock rise this morning, it does suggest that global vaccine efforts are moving forward. The same could be said for the recent EU news regarding Pfizer and BioNTech. Novavax has been working hard to gain its place among the vaccine producers that helped us beat the pandemic’s earlier waves. And this looks like an opportunity for it to do exactly that.</p>\n<p>What It Means</p>\n<p>Despite today’s downturn, we will likely see another vaccine stock boom in 2022. Indeed, this will come as companies make real strides against the omicron variant.</p>\n<p>Regardless of exactly how that shakes out, world leaders are going to be working hard to speed up global vaccination efforts to ensure that new variants don’t emerge and complicate matters further. Every stock on this list, with the exception of OCGN, is worth watching as the new year takes shape.</p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>MRNA, NVAX, OCGN, PFE, BNTX: What Is Going on With Vaccine Stocks Today?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMRNA, NVAX, OCGN, PFE, BNTX: What Is Going on With Vaccine Stocks Today?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-21 10:28 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/12/mrna-nvax-ocgn-pfe-bntx-what-is-going-on-with-vaccine-stocks-today/><strong>InvestorPlace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>As another week kicks off on Wall Street, it’s clear that the ominous coverage of the spreading omicron variant is still casting shadows over markets. This week has started off with mixed news ...</p>\n\n<a href=\"https://investorplace.com/2021/12/mrna-nvax-ocgn-pfe-bntx-what-is-going-on-with-vaccine-stocks-today/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BNTX":"BioNTech SE","PFE":"辉瑞","NVAX":"诺瓦瓦克斯医药","MRNA":"Moderna, Inc.","OCGN":"Ocugen"},"source_url":"https://investorplace.com/2021/12/mrna-nvax-ocgn-pfe-bntx-what-is-going-on-with-vaccine-stocks-today/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1173202355","content_text":"As another week kicks off on Wall Street, it’s clear that the ominous coverage of the spreading omicron variant is still casting shadows over markets. This week has started off with mixed news surrounding the companies who are working around the clock to get ahead in the vaccine race. This has been making it difficult for the overall sector to gain the type of momentum it needs for all vaccine stocks to start moving upward. While one company has an encouraging update regarding its vaccine’s effectiveness against the variant, most of its peers haven’t been so lucky.\nWhat’s Going on With Vaccine Stocks?\nFor the companies embedded in the race to beat the variant, this week isn’t off to a good start. Indeed, vaccine stocks are facing noticeable turbulence.Moderna(NASDAQ:MRNA) began the day with the announcement that a third dose of its Covid-19 vaccine has been proven to increase antibodies against the new variant. Even with such reassuring news, MRNA stock is down 6.25% today. That said, it did cause shares to surge this morning, putting MRNA stock up almost 10% for the week.\nMeanwhile, most of its peers aren’t fairing much better.Novavax(NASDAQ:NVAX) just received authorization from the European Union to begin distributing its vaccine throughout Europe during the first half of 2022. While this news sent the stock up in premarket trading today, it hasn’t done much since then. NVAX stock is down more than 7% today. Additionally, Ocugen(NASDAQ:OCGN) is also falling after an initial early day rise driven by superficial catalysts.\nThe only vaccine stock in the green this morning is Pfizer(NYSE:PFE), which is up more than 2% today despite the recent setback the company experienced regarding its vaccine for children five years old and younger. Meanwhile, Pfizer’s vaccine production partner, Germany-based BioNTech(NASDAQ:BNTX) is down 4.19% so far, despite the recent news that the two companies will be providing more than 200 million additional vaccine doses to the EU in 2022.\nWhy It Matters\nWhile the week is off to a rough start, every company on this list is still up for the week. The only exception is OCGN, which seems more like a meme stock that is losing momentum.\nHowever, every other name on this list is fair game for a bullish play on vaccine stocks. The new data from Moderna is highly encouraging, in no small part because it likely means that Pfizer won’t be far behind in tailoring its own vaccine to effectively fight the omicron variant. Novavax’s news is also cause for optimism. While it hasn’t helped the stock rise this morning, it does suggest that global vaccine efforts are moving forward. The same could be said for the recent EU news regarding Pfizer and BioNTech. Novavax has been working hard to gain its place among the vaccine producers that helped us beat the pandemic’s earlier waves. And this looks like an opportunity for it to do exactly that.\nWhat It Means\nDespite today’s downturn, we will likely see another vaccine stock boom in 2022. Indeed, this will come as companies make real strides against the omicron variant.\nRegardless of exactly how that shakes out, world leaders are going to be working hard to speed up global vaccination efforts to ensure that new variants don’t emerge and complicate matters further. Every stock on this list, with the exception of OCGN, is worth watching as the new year takes shape.","news_type":1},"isVote":1,"tweetType":1,"viewCount":507,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":693917743,"gmtCreate":1639960563499,"gmtModify":1639960563638,"author":{"id":"4094269572113460","authorId":"4094269572113460","name":"Ytyt","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"Pls like","listText":"Pls like","text":"Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/693917743","repostId":"1154958924","repostType":4,"repost":{"id":"1154958924","pubTimestamp":1639958978,"share":"https://www.laohu8.com/m/news/1154958924?lang=&edition=full","pubTime":"2021-12-20 08:09","market":"sg","language":"en","title":"Singapore Stock Market May Give Up Support At 3,100 Points","url":"https://stock-news.laohu8.com/highlight/detail?id=1154958924","media":"RTTNews","summary":"The Singapore stock market has alternated between positive and negative finishes through the last fo","content":"<p>The Singapore stock market has alternated between positive and negative finishes through the last four trading days since the end of the two-day slide in which it had fallen more than 20 points or 0.7 percent. The Straits Times Index now sits just above the 3,110-point plateau and it may take further damage again on Monday.</p>\n<p>The global forecast for the Asian&nbsp;markets&nbsp;is soft on omicron coronavirus concerns and sinking oil prices. The European markets were mixed and the U.S. bourses were down and the Asian markets figure to split the difference.</p>\n<p>The STI finished modestly lower on Friday following losses from the industrials and properties, while the financials came in mixed.</p>\n<p>For the day, the index lost 17.17 points or 0.55 percent to finish at the daily low of 3,111.63 after peaking at 3,134.99. Volume was 1.2 billion shares worth 1.5 billion Singapore dollars. There were 280 decliners and 188 gainers.</p>\n<p>Among the actives, CapitaLand Integrated Commercial Trust and Mapletree Commercial Trust both slumped 0.50 percent, while City Developments tanked 1.45 percent, Comfort DelGro lost 0.72 percent, Dairy Farm International slid 0.36 percent, DBS Group collected 0.34 percent, Genting Singapore fell 0.65 percent, Hongkong Land plummeted 2.07 percent, Keppel Corp and Venture Corporation both sank 0.97 percent, Mapletree Logistics Trust weakened 0.53 percent, Oversea-Chinese Banking Corporation eased 0.09 percent, SATS skidded 1.03 percent, SembCorp Industries plunged 1.49 percent, Singapore Airlines dropped 0.81 percent, Singapore Exchange tumbled 1.39 percent, Singapore Press Holdings added 0.43 percent, Singapore Technologies Engineering retreated 1.06 percent, SingTel stumbled 0.63 percent, Thai Beverage shed 0.75 percent, United Overseas Bank dipped 0.30 percent, Wilmar International declined 1.21 percent and Yangzijiang Shipbuilding and Ascendas REIT were unchanged.</p>\n<p>The lead from Wall Street is negative as the major averages opened lower on a volatile Friday. The NASDAQ peeked briefly into the green but the markets all still finished in the red.</p>\n<p>The Dow plunged 532.16 points or 1.48 percent to finish at 35,365.44, while the NASDAQ dipped 10.72 points or 0.07 percent to close at 15,169.68 and the S&amp;P 500 sank 48.03 points or 1.03 percent to end at 4,620.64. For the week, the NASDAQ plunged 2.9 percent, the Dow lost 1.7 percent and the S&amp;P was down 1.9 percent.</p>\n<p>The volatility on Wall Street came on a quadruple witching day, with stock options, index options, stock futures and index futures all expiring.</p>\n<p>Concerns about the impact of the Omicron variant of the&nbsp;coronavirus&nbsp;also weighed on the markets along with worries about ongoing supply chain issues.</p>\n<p>Crude oil prices tumbled Friday on concerns for energy demand due to a rapid surge in Omicron variant of the coronavirus and reimposition of restrictions. West Texas Intermediate Crude oil futures for January sank $1.52 or 2.1 percent at $70.86 a barrel. WTI crude futures shed 1.1 percent in the week.</p>","source":"lsy1626938412129","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Singapore Stock Market May Give Up Support At 3,100 Points</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSingapore Stock Market May Give Up Support At 3,100 Points\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-20 08:09 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.rttnews.com/3250329/singapore-stock-market-may-give-up-support-at-3100-points.aspx><strong>RTTNews</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The Singapore stock market has alternated between positive and negative finishes through the last four trading days since the end of the two-day slide in which it had fallen more than 20 points or 0.7...</p>\n\n<a href=\"https://www.rttnews.com/3250329/singapore-stock-market-may-give-up-support-at-3100-points.aspx\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"STI.SI":"富时新加坡海峡指数"},"source_url":"https://www.rttnews.com/3250329/singapore-stock-market-may-give-up-support-at-3100-points.aspx","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1154958924","content_text":"The Singapore stock market has alternated between positive and negative finishes through the last four trading days since the end of the two-day slide in which it had fallen more than 20 points or 0.7 percent. The Straits Times Index now sits just above the 3,110-point plateau and it may take further damage again on Monday.\nThe global forecast for the Asian markets is soft on omicron coronavirus concerns and sinking oil prices. The European markets were mixed and the U.S. bourses were down and the Asian markets figure to split the difference.\nThe STI finished modestly lower on Friday following losses from the industrials and properties, while the financials came in mixed.\nFor the day, the index lost 17.17 points or 0.55 percent to finish at the daily low of 3,111.63 after peaking at 3,134.99. Volume was 1.2 billion shares worth 1.5 billion Singapore dollars. There were 280 decliners and 188 gainers.\nAmong the actives, CapitaLand Integrated Commercial Trust and Mapletree Commercial Trust both slumped 0.50 percent, while City Developments tanked 1.45 percent, Comfort DelGro lost 0.72 percent, Dairy Farm International slid 0.36 percent, DBS Group collected 0.34 percent, Genting Singapore fell 0.65 percent, Hongkong Land plummeted 2.07 percent, Keppel Corp and Venture Corporation both sank 0.97 percent, Mapletree Logistics Trust weakened 0.53 percent, Oversea-Chinese Banking Corporation eased 0.09 percent, SATS skidded 1.03 percent, SembCorp Industries plunged 1.49 percent, Singapore Airlines dropped 0.81 percent, Singapore Exchange tumbled 1.39 percent, Singapore Press Holdings added 0.43 percent, Singapore Technologies Engineering retreated 1.06 percent, SingTel stumbled 0.63 percent, Thai Beverage shed 0.75 percent, United Overseas Bank dipped 0.30 percent, Wilmar International declined 1.21 percent and Yangzijiang Shipbuilding and Ascendas REIT were unchanged.\nThe lead from Wall Street is negative as the major averages opened lower on a volatile Friday. The NASDAQ peeked briefly into the green but the markets all still finished in the red.\nThe Dow plunged 532.16 points or 1.48 percent to finish at 35,365.44, while the NASDAQ dipped 10.72 points or 0.07 percent to close at 15,169.68 and the S&P 500 sank 48.03 points or 1.03 percent to end at 4,620.64. For the week, the NASDAQ plunged 2.9 percent, the Dow lost 1.7 percent and the S&P was down 1.9 percent.\nThe volatility on Wall Street came on a quadruple witching day, with stock options, index options, stock futures and index futures all expiring.\nConcerns about the impact of the Omicron variant of the coronavirus also weighed on the markets along with worries about ongoing supply chain issues.\nCrude oil prices tumbled Friday on concerns for energy demand due to a rapid surge in Omicron variant of the coronavirus and reimposition of restrictions. West Texas Intermediate Crude oil futures for January sank $1.52 or 2.1 percent at $70.86 a barrel. WTI crude futures shed 1.1 percent in the week.","news_type":1},"isVote":1,"tweetType":1,"viewCount":508,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":699154850,"gmtCreate":1639758518349,"gmtModify":1639758518490,"author":{"id":"4094269572113460","authorId":"4094269572113460","name":"Ytyt","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"Pls like","listText":"Pls like","text":"Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/699154850","repostId":"2192497854","repostType":4,"repost":{"id":"2192497854","pubTimestamp":1639746681,"share":"https://www.laohu8.com/m/news/2192497854?lang=&edition=full","pubTime":"2021-12-17 21:11","market":"us","language":"en","title":"3 Warren Buffett Stocks I Like Heading Into 2022","url":"https://stock-news.laohu8.com/highlight/detail?id=2192497854","media":"Motley Fool","summary":"Three of Buffett's largest holdings look strong heading into 2022.","content":"<p>Warren Buffett and his company&nbsp;<b>Berkshire Hathaway</b> (NYSE:BRK.A)(NYSE:BRK.B) are well known for their stock-picking abilities that have been proven over many decades. For this prowess, along with Berkshire's success in the other businesses the conglomerate operates in, the stock has consistently been a winner.</p>\n<p>Between 1965 and 2020, Berkshire's stock has generated compounded annual gains of 20%, compared to the <b>S&amp;P 500</b>'s compounded annual gain of 10.2%, including dividends, over the same timeframe. It's for this very reason that investors watch Buffett and Berkshire's stock picks so closely. Here are three Buffett stocks I like heading into 2022.</p>\n<h2>1. Bank of America</h2>\n<p>America's second-largest bank by assets,&nbsp;<b>Bank of America</b> (NYSE:BAC), also happens to be the second-largest position in Buffett and Berkshire's equities portfolio. Buffett first got in on Bank of America coming out of the Great Recession and currently owns more than 1 billion shares worth nearly $45.8 billion. Early in the pandemic in the middle of 2020, Buffett took advantage of the beaten-down bank sector to plow another $2 billion into Bank of America and now owns nearly 12% of the financial institution's outstanding shares.</p>\n<p>Shares of Bank of America have climbed more than 47% this year and are up more than double from pandemic lows. While the valuation has gotten high, I like Bank of America because it is well-positioned to deal with higher inflation, higher interest rates, and more difficult market conditions that could be seen next year. Higher interest rates benefit Bank of America tremendously because the yields on many of the loans at the bank will increase along with the rate hikes. The consumer is currently in great shape. Since banking is linked to the overall economy and gross domestic product in the U.S. is expected to grow about 4% next year, I think the bank is going to have a good year.</p>\n<h2>2. American Express</h2>\n<p>Berkshire owns more than 151 million shares of the credit card company <b>American Express</b> (NYSE:AXP) for a total value of roughly $24.7 billion, making it the third-largest holding in Berkshire's portfolio. American Express has also had a nice year with the stock price up more than 38%.</p>\n<p>There are two main reasons I like American Express heading into 2022. For one, because the consumer has been so healthy, Americans have been paying off their credit card bills and haven't had as much need to take on debt. As money and benefits from previous stimulus bills run down, that won't always be the case. At the beginning of December, <i>The Wall Street Journal</i> reported that credit card applications had recently hit a pandemic high.</p>\n<p>American Express is also big in the travel, airlines, and lodging businesses, so the more the world continues to recover from the pandemic and COVID-19, the more its business will benefit. Some of those travel-related sectors still aren't fully back yet, especially when you think about international travel.</p>\n<h2>3. U.S. Bancorp</h2>\n<p>Buffett and Berkshire own more than 144 million shares valued at nearly $8.3 billion of the large regional bank <b>U.S. Bancorp </b>(NYSE:USB). The bank is a high-performing commercial bank. It also runs a unique payments business that includes retail credit, debit, prepaid cards, global merchant acquiring, and corporate payment solutions in sectors such as aviation, fleet, transportation, and travel.</p>\n<p>Because the payments business operates in these sectors, the segment could still recover further in 2022 as the world rebounds from COVID-19. Additionally, management is very focused on further integrating the payments and commercial banking businesses because 72% of the bank's business banking customers still don't have a payments product, and half of U.S. Bancorp's payments customers don't have a banking product.</p>\n<p>There's a lot of opportunity for cross-selling. U.S. Bancorp also recently announced its intention to acquire the U.S. banking division of <b>Mitsubishi UFJ Financial Group</b>. This deal will give U.S. Bancorp an additional 190,000 business banking customers and more scale in California, both things that are in line with U.S. Bancorp's current strategy.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Warren Buffett Stocks I Like Heading Into 2022</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Warren Buffett Stocks I Like Heading Into 2022\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-17 21:11 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/12/17/3-warren-buffett-stocks-i-like-heading-into-2022/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Warren Buffett and his company Berkshire Hathaway (NYSE:BRK.A)(NYSE:BRK.B) are well known for their stock-picking abilities that have been proven over many decades. For this prowess, along with ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/12/17/3-warren-buffett-stocks-i-like-heading-into-2022/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4559":"巴菲特持仓","BRK.A":"伯克希尔","BK4166":"消费信贷","USB":"美国合众银行","BK4534":"瑞士信贷持仓","BK4176":"多领域控股","BK4550":"红杉资本持仓","BRK.B":"伯克希尔B","BK4504":"桥水持仓","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4553":"喜马拉雅资本持仓","AXP":"美国运通","BK4207":"综合性银行","BAC":"美国银行"},"source_url":"https://www.fool.com/investing/2021/12/17/3-warren-buffett-stocks-i-like-heading-into-2022/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2192497854","content_text":"Warren Buffett and his company Berkshire Hathaway (NYSE:BRK.A)(NYSE:BRK.B) are well known for their stock-picking abilities that have been proven over many decades. For this prowess, along with Berkshire's success in the other businesses the conglomerate operates in, the stock has consistently been a winner.\nBetween 1965 and 2020, Berkshire's stock has generated compounded annual gains of 20%, compared to the S&P 500's compounded annual gain of 10.2%, including dividends, over the same timeframe. It's for this very reason that investors watch Buffett and Berkshire's stock picks so closely. Here are three Buffett stocks I like heading into 2022.\n1. Bank of America\nAmerica's second-largest bank by assets, Bank of America (NYSE:BAC), also happens to be the second-largest position in Buffett and Berkshire's equities portfolio. Buffett first got in on Bank of America coming out of the Great Recession and currently owns more than 1 billion shares worth nearly $45.8 billion. Early in the pandemic in the middle of 2020, Buffett took advantage of the beaten-down bank sector to plow another $2 billion into Bank of America and now owns nearly 12% of the financial institution's outstanding shares.\nShares of Bank of America have climbed more than 47% this year and are up more than double from pandemic lows. While the valuation has gotten high, I like Bank of America because it is well-positioned to deal with higher inflation, higher interest rates, and more difficult market conditions that could be seen next year. Higher interest rates benefit Bank of America tremendously because the yields on many of the loans at the bank will increase along with the rate hikes. The consumer is currently in great shape. Since banking is linked to the overall economy and gross domestic product in the U.S. is expected to grow about 4% next year, I think the bank is going to have a good year.\n2. American Express\nBerkshire owns more than 151 million shares of the credit card company American Express (NYSE:AXP) for a total value of roughly $24.7 billion, making it the third-largest holding in Berkshire's portfolio. American Express has also had a nice year with the stock price up more than 38%.\nThere are two main reasons I like American Express heading into 2022. For one, because the consumer has been so healthy, Americans have been paying off their credit card bills and haven't had as much need to take on debt. As money and benefits from previous stimulus bills run down, that won't always be the case. At the beginning of December, The Wall Street Journal reported that credit card applications had recently hit a pandemic high.\nAmerican Express is also big in the travel, airlines, and lodging businesses, so the more the world continues to recover from the pandemic and COVID-19, the more its business will benefit. Some of those travel-related sectors still aren't fully back yet, especially when you think about international travel.\n3. U.S. Bancorp\nBuffett and Berkshire own more than 144 million shares valued at nearly $8.3 billion of the large regional bank U.S. Bancorp (NYSE:USB). The bank is a high-performing commercial bank. It also runs a unique payments business that includes retail credit, debit, prepaid cards, global merchant acquiring, and corporate payment solutions in sectors such as aviation, fleet, transportation, and travel.\nBecause the payments business operates in these sectors, the segment could still recover further in 2022 as the world rebounds from COVID-19. Additionally, management is very focused on further integrating the payments and commercial banking businesses because 72% of the bank's business banking customers still don't have a payments product, and half of U.S. Bancorp's payments customers don't have a banking product.\nThere's a lot of opportunity for cross-selling. U.S. Bancorp also recently announced its intention to acquire the U.S. banking division of Mitsubishi UFJ Financial Group. This deal will give U.S. Bancorp an additional 190,000 business banking customers and more scale in California, both things that are in line with U.S. Bancorp's current strategy.","news_type":1},"isVote":1,"tweetType":1,"viewCount":503,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":690400755,"gmtCreate":1639698264965,"gmtModify":1639698265074,"author":{"id":"4094269572113460","authorId":"4094269572113460","name":"Ytyt","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"Pls like&nbsp;","listText":"Pls like&nbsp;","text":"Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/690400755","repostId":"2192942001","repostType":4,"repost":{"id":"2192942001","pubTimestamp":1639697332,"share":"https://www.laohu8.com/m/news/2192942001?lang=&edition=full","pubTime":"2021-12-17 07:28","market":"us","language":"en","title":"After-Hours Stock Movers: Spruce Biosciences,Rivian,FedEx,General Motors and more","url":"https://stock-news.laohu8.com/highlight/detail?id=2192942001","media":"StreetInsider","summary":"After-Hours Stock Movers:\nSpruce Biosciences, Inc. (NASDAQ: SPRB) 26.6% HIGHER; Oppenheimer initiate","content":"<p>After-Hours Stock Movers:</p>\n<p><a href=\"https://laohu8.com/S/SPRB\">Spruce Biosciences, Inc.</a> (NASDAQ: SPRB) 26.6% HIGHER; Oppenheimer initiates coverage with an Outperform rating and a price target of $15.00.</p>\n<p>Eloxx Pharma (NASDAQ: ELOX) 7.7% HIGHER; Oppenheimer initiates coverage with an Outperform rating and a price target of $4.00.</p>\n<p>Rivian Automotive (NASDAQ: RIVN) 10.2% LOWER; reported Q3 EPS of ($12.21), versus ($2.88) reported last year. Announces 71K net preorders for R1 in U.S. and Canada. Sees planned ~200K annual capacity at Normal, IL, and estimated 400K annual capacity at Georgia facility.</p>\n<p>Steelcase (NYSE: SCS) 6.2% LOWER; reported Q3 EPS of $0.08, $0.01 worse than the analyst estimate of $0.09. Revenue for the quarter came in at $738.2 million versus the consensus estimate of $767.62 million. Steelcase sees Q4 2022 EPS of $0.00, versus the consensus of $0.12. Steelcase sees Q4 2022 revenue of $740-765 million, versus the consensus of $770.77 million.</p>\n<p>FedEx (NYSE: FDX) 4.8% HIGHER; reported Q2 EPS of $4.83, $0.56 better than the analyst estimate of $4.27. Revenue for the quarter came in at $23.5 billion versus the consensus estimate of $22.44 billion. FedEx (NYSE: FDX) sees FY 2022 EPS of $20.50 to $21.50, versus the consensus of $19.64.</p>\n<p><a href=\"https://laohu8.com/S/FOUR\">Shift4 Payments, Inc.</a> (NYSE: FOUR) 3.8% HIGHER; authorized the commencement of a stock repurchase program. The stock repurchase program authorizes the Company to repurchase up to $100 million of the Companys Class A common stock, par value $0.0001 (Common Stock) and will expire on December 31, 2022, subject to market conditions, contractual restrictions and other factors.</p>\n<p>General Motors Company (NYSE: GM) 2.9% LOWER; Dan Ammann, the CEO of the self-driving division Cruise, is leaving the company, with Kyle Vogt, the President and CTO of Cruise to serve as an interim CEO.</p>\n<p>United States Steel Corporation (NYSE: X) 5.3% LOWER; provided fourth quarter 2021 guidance. Fourth quarter 2021 adjusted EBITDA is expected to be approximately $1.65 billion.</p>\n<p>Biomea Fusion Inc. (NASDAQ: BMEA) 2.8% HIGHER; Oppenheimer initiates coverage with an Outperform rating and a price target of $22.00.</p>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>After-Hours Stock Movers: Spruce Biosciences,Rivian,FedEx,General Motors and more</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAfter-Hours Stock Movers: Spruce Biosciences,Rivian,FedEx,General Motors and more\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-17 07:28 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/dr/news.php?id=19364278><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>After-Hours Stock Movers:\nSpruce Biosciences, Inc. (NASDAQ: SPRB) 26.6% HIGHER; Oppenheimer initiates coverage with an Outperform rating and a price target of $15.00.\nEloxx Pharma (NASDAQ: ELOX) 7.7% ...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=19364278\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"SCS":"Steelcase Inc.","RIVN":"Rivian Automotive, Inc.","GM":"通用汽车","X":"美国钢铁","BK4135":"资产管理与托管银行","BK4007":"制药","BK4099":"汽车制造商","ELOX":"Eloxx制药","SPRB":"Spruce Biosciences, Inc.","FOUR":"Shift4 Payments, Inc.","BK4516":"特朗普概念","BK4211":"区域性银行","BK4139":"生物科技","FDX":"联邦快递","OWL":"Blue Owl Capital Inc."},"source_url":"https://www.streetinsider.com/dr/news.php?id=19364278","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2192942001","content_text":"After-Hours Stock Movers:\nSpruce Biosciences, Inc. (NASDAQ: SPRB) 26.6% HIGHER; Oppenheimer initiates coverage with an Outperform rating and a price target of $15.00.\nEloxx Pharma (NASDAQ: ELOX) 7.7% HIGHER; Oppenheimer initiates coverage with an Outperform rating and a price target of $4.00.\nRivian Automotive (NASDAQ: RIVN) 10.2% LOWER; reported Q3 EPS of ($12.21), versus ($2.88) reported last year. Announces 71K net preorders for R1 in U.S. and Canada. Sees planned ~200K annual capacity at Normal, IL, and estimated 400K annual capacity at Georgia facility.\nSteelcase (NYSE: SCS) 6.2% LOWER; reported Q3 EPS of $0.08, $0.01 worse than the analyst estimate of $0.09. Revenue for the quarter came in at $738.2 million versus the consensus estimate of $767.62 million. Steelcase sees Q4 2022 EPS of $0.00, versus the consensus of $0.12. Steelcase sees Q4 2022 revenue of $740-765 million, versus the consensus of $770.77 million.\nFedEx (NYSE: FDX) 4.8% HIGHER; reported Q2 EPS of $4.83, $0.56 better than the analyst estimate of $4.27. Revenue for the quarter came in at $23.5 billion versus the consensus estimate of $22.44 billion. FedEx (NYSE: FDX) sees FY 2022 EPS of $20.50 to $21.50, versus the consensus of $19.64.\nShift4 Payments, Inc. (NYSE: FOUR) 3.8% HIGHER; authorized the commencement of a stock repurchase program. The stock repurchase program authorizes the Company to repurchase up to $100 million of the Companys Class A common stock, par value $0.0001 (Common Stock) and will expire on December 31, 2022, subject to market conditions, contractual restrictions and other factors.\nGeneral Motors Company (NYSE: GM) 2.9% LOWER; Dan Ammann, the CEO of the self-driving division Cruise, is leaving the company, with Kyle Vogt, the President and CTO of Cruise to serve as an interim CEO.\nUnited States Steel Corporation (NYSE: X) 5.3% LOWER; provided fourth quarter 2021 guidance. Fourth quarter 2021 adjusted EBITDA is expected to be approximately $1.65 billion.\nBiomea Fusion Inc. (NASDAQ: BMEA) 2.8% HIGHER; Oppenheimer initiates coverage with an Outperform rating and a price target of $22.00.","news_type":1},"isVote":1,"tweetType":1,"viewCount":63,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":690090549,"gmtCreate":1639611551274,"gmtModify":1639611551369,"author":{"id":"4094269572113460","authorId":"4094269572113460","name":"Ytyt","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"Pls like","listText":"Pls like","text":"Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":4,"repostSize":0,"link":"https://laohu8.com/post/690090549","repostId":"2191997591","repostType":4,"repost":{"id":"2191997591","pubTimestamp":1639611085,"share":"https://www.laohu8.com/m/news/2191997591?lang=&edition=full","pubTime":"2021-12-16 07:31","market":"us","language":"en","title":"After-Hours Stock Movers: IronNet,Verrica Pharmaceuticals,Canoo and more","url":"https://stock-news.laohu8.com/highlight/detail?id=2191997591","media":"StreetInsider","summary":"After-Hours Stock Movers:\nIronNet (NYSE: IRNT) 19.9% LOWER; reported Q3 EPS of ($2.22), $2.07 worse ","content":"<p>After-Hours Stock Movers:</p>\n<p>IronNet (NYSE: IRNT) 19.9% LOWER; reported Q3 EPS of ($2.22), $2.07 worse than the analyst estimate of ($0.15). Revenue for the quarter came in at $6.9 million versus the consensus estimate of $11.79 million.</p>\n<p><a href=\"https://laohu8.com/S/VRCA\">Verrica Pharmaceuticals Inc.</a> (Nasdaq: VRCA) 13% HIGHER; announced that the U.S. Food and Drug Administration (FDA) acknowledged that Verrica’s resubmitted New Drug Application (NDA) for <a href=\"https://laohu8.com/S/VP..UK\">VP</a>-102 for the treatment of molluscum contagiosum (molluscum) was complete and assigned a Prescription Drug User Fee Act (PDUFA) goal date of May 24, 2022.</p>\n<p><a href=\"https://laohu8.com/S/NAVB\">Navidea Biopharmaceuticals</a>, Inc. (NYSE: NAVB) 9.5% HIGHER; announced that it has terminated the Stock Purchase Agreement that was executed on August 30, 2020.</p>\n<p><a href=\"https://laohu8.com/S/SNDX\">Syndax Pharmaceuticals, Inc. </a>(Nasdaq: SNDX) 6.7% LOWER; announced that it plans to offer and sell, subject to market and other conditions, shares of its common stock in an underwritten public offering</p>\n<p>Canoo(Nasdaq:&nbsp;GOEV)&nbsp;6%&nbsp;HIGHER;announced that&nbsp;it was accelerating its production plans in the United States while ending its deal for VDL Nedcar in Netherlands to serve as its contract manufacturer in Europe.</p>\n<p>Lennar Corp. (NYSE: LEN) 5.6% LOWER; reported Q4 EPS of $4.36, ex-items, $0.21 better than the analyst estimate of $4.15. Revenue for the quarter came in at $8.4 billion versus the consensus estimate of $8.2 billion.</p>\n<p><a href=\"https://laohu8.com/S/SYF\">Synchrony Financial</a> (NYSE: SYF) 1.7% HIGHER; announced today that its Board of Directors has increased the Company's share repurchase authorization by $1.0 billion. The Company had $1.2 billion remaining under its prior authorization as of September 30, 2021, so this increase will bring the amount available to $2.2 billion through the period ending June 30, 2022.</p>\n<p><a href=\"https://laohu8.com/S/FOCS\">Focus Financial Partners Inc.</a> (NASDAQ: FOCS) 1% LOWER; launched an underwritten offering (the \"Offering\") of 3,204,448 shares of its Class A common stock. This amount includes 2,500,000 shares being offered by Focus for its own account and 704,448 shares being offered by Focus on behalf of certain of the existing unitholders of Focus Financial Partners, LLC (\"Focus LLC\"), its operating subsidiary. Focus intends to grant the underwriters a 30-day option to purchase up to an additional 480,667 shares of Focus' Class A common stock.</p>\n<p>Nordson Corp. (NASDAQ: NDSN) 2.9% LOWER; reported Q4 EPS of $1.88, $0.21 worse than the analyst estimate of $2.09. Revenue for the quarter came in at $599 million versus the consensus estimate of $617.45 million. Nordson Corp. sees Q1 2022 EPS of $1.80-$1.95, versus the consensus of $1.71. First quarter 2022 sales growth of 14% to 16% over prior year first quarter. Fiscal 2022 sales growth of 6% to 10% and earnings growth of 8% to 18% over the record fiscal 2021 results</p>\n<p><a href=\"https://laohu8.com/S/V\">Visa</a> (NYSE: V) 1% HIGHER; the board of directors of Visa Inc. authorized a new $12.0 billion share repurchase program.</p>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>After-Hours Stock Movers: IronNet,Verrica Pharmaceuticals,Canoo and more</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAfter-Hours Stock Movers: IronNet,Verrica Pharmaceuticals,Canoo and more\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-16 07:31 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/dr/news.php?id=19357773><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>After-Hours Stock Movers:\nIronNet (NYSE: IRNT) 19.9% LOWER; reported Q3 EPS of ($2.22), $2.07 worse than the analyst estimate of ($0.15). Revenue for the quarter came in at $6.9 million versus the ...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=19357773\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4166":"消费信贷","LEN":"莱纳建筑公司","NDSN":"Nordson Corporation","NAVB":"Navidea生物制药","BK4504":"桥水持仓","V":"Visa","SNDX":"Syndax Pharmaceuticals, Inc. ","BK4088":"住宅建筑","VRCA":"Verrica Pharmaceuticals Inc.","GOEV":"Canoo Inc.","SYF":"Synchrony Financial","BK4561":"索罗斯持仓","FOCS":"Focus Financial Partners Inc.","BK4097":"系统软件"},"source_url":"https://www.streetinsider.com/dr/news.php?id=19357773","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2191997591","content_text":"After-Hours Stock Movers:\nIronNet (NYSE: IRNT) 19.9% LOWER; reported Q3 EPS of ($2.22), $2.07 worse than the analyst estimate of ($0.15). Revenue for the quarter came in at $6.9 million versus the consensus estimate of $11.79 million.\nVerrica Pharmaceuticals Inc. (Nasdaq: VRCA) 13% HIGHER; announced that the U.S. Food and Drug Administration (FDA) acknowledged that Verrica’s resubmitted New Drug Application (NDA) for VP-102 for the treatment of molluscum contagiosum (molluscum) was complete and assigned a Prescription Drug User Fee Act (PDUFA) goal date of May 24, 2022.\nNavidea Biopharmaceuticals, Inc. (NYSE: NAVB) 9.5% HIGHER; announced that it has terminated the Stock Purchase Agreement that was executed on August 30, 2020.\nSyndax Pharmaceuticals, Inc. (Nasdaq: SNDX) 6.7% LOWER; announced that it plans to offer and sell, subject to market and other conditions, shares of its common stock in an underwritten public offering\nCanoo(Nasdaq: GOEV) 6% HIGHER;announced that it was accelerating its production plans in the United States while ending its deal for VDL Nedcar in Netherlands to serve as its contract manufacturer in Europe.\nLennar Corp. (NYSE: LEN) 5.6% LOWER; reported Q4 EPS of $4.36, ex-items, $0.21 better than the analyst estimate of $4.15. Revenue for the quarter came in at $8.4 billion versus the consensus estimate of $8.2 billion.\nSynchrony Financial (NYSE: SYF) 1.7% HIGHER; announced today that its Board of Directors has increased the Company's share repurchase authorization by $1.0 billion. The Company had $1.2 billion remaining under its prior authorization as of September 30, 2021, so this increase will bring the amount available to $2.2 billion through the period ending June 30, 2022.\nFocus Financial Partners Inc. (NASDAQ: FOCS) 1% LOWER; launched an underwritten offering (the \"Offering\") of 3,204,448 shares of its Class A common stock. This amount includes 2,500,000 shares being offered by Focus for its own account and 704,448 shares being offered by Focus on behalf of certain of the existing unitholders of Focus Financial Partners, LLC (\"Focus LLC\"), its operating subsidiary. Focus intends to grant the underwriters a 30-day option to purchase up to an additional 480,667 shares of Focus' Class A common stock.\nNordson Corp. (NASDAQ: NDSN) 2.9% LOWER; reported Q4 EPS of $1.88, $0.21 worse than the analyst estimate of $2.09. Revenue for the quarter came in at $599 million versus the consensus estimate of $617.45 million. Nordson Corp. sees Q1 2022 EPS of $1.80-$1.95, versus the consensus of $1.71. First quarter 2022 sales growth of 14% to 16% over prior year first quarter. Fiscal 2022 sales growth of 6% to 10% and earnings growth of 8% to 18% over the record fiscal 2021 results\nVisa (NYSE: V) 1% HIGHER; the board of directors of Visa Inc. authorized a new $12.0 billion share repurchase program.","news_type":1},"isVote":1,"tweetType":1,"viewCount":242,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":607882573,"gmtCreate":1639525208395,"gmtModify":1639525208529,"author":{"id":"4094269572113460","authorId":"4094269572113460","name":"Ytyt","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"Pls like","listText":"Pls like","text":"Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/607882573","repostId":"2191784951","repostType":4,"repost":{"id":"2191784951","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1639522244,"share":"https://www.laohu8.com/m/news/2191784951?lang=&edition=full","pubTime":"2021-12-15 06:50","market":"us","language":"en","title":"Wall Street ends down, investors eye inflation and Omicron","url":"https://stock-news.laohu8.com/highlight/detail?id=2191784951","media":"Reuters","summary":"* Fed policy decision awaited on Wednesday\n* November PPI logs highest rise since 2010\n* Tech leads ","content":"<p>* Fed policy decision awaited on Wednesday</p>\n<p>* November PPI logs highest rise since 2010</p>\n<p>* Tech leads declines, financials rally</p>\n<p>* Indexes: Dow -0.30%, S&amp;P 500 -0.75%, Nasdaq -1.14%</p>\n<p>Dec 14 (Reuters) - Wall Street ended lower on Tuesday after data showed producer prices increased more than expected in November, solidifying expectations the Federal Reserve this week will announce a faster wind-down of asset purchases.</p>\n<p>The fast-spreading Omicron coronavirus variant also dampened investor sentiment after the S&amp;P 500 index hit an all-time closing high late last week.</p>\n<p>Declines were led by megacap tech-related stocks, with <a href=\"https://laohu8.com/S/CRM\">Salesforce</a>.com, Microsoft Corp, <a href=\"https://laohu8.com/S/ADBE\">Adobe</a> and Alphabet Inc pulling down the S&amp;P 500 and Nasdaq.</p>\n<p>Apple Inc ended down 0.8%, but off its session lows, after the iPhone maker said it would require customers and employees to wear masks at its U.S. retail stores as COVID-19 cases surge.</p>\n<p>The Dow Jones Industrial Average fell 0.3% to end at 35,544.18 points, while the S&amp;P 500 lost 0.75% to 4,634.09.</p>\n<p>The Nasdaq Composite dropped 1.14% to 15,237.64.</p>\n<p>Data from the Labor Department showed the producer price index (PPI) for final demand in the 12 months through November shot up 9.6%, clocking its largest gain since November 2010. That followed an 8.8% increase in October.</p>\n<p>About two-thirds of Nasdaq stocks traded below their 200-day moving average, according to Refinitiv data, suggesting many stocks within the index are struggling, even as the overall index remains only about 6% below its November record high close.</p>\n<p>\"COVID plus inflation is the Grinch that stole Christmas,\" said Jake Dollarhide, chief executive officer at Longbow Asset Management. \"I don’t underestimate the fact that there are some big Nasdaq names giving up some of their big gains. When the leaders sell off, it's not a good sign.\"</p>\n<p>Ten of the 11 major S&amp;P 500 sector indexes fell, with tech putting on the worst performance, down 1.6%. Financials gained 0.6% as investors bet on a hawkish tone from the Fed at the end of its two-day meeting on Wednesday.</p>\n<p>Berkshire Hathaway and Bank of America both gained more than 1% and helped keep the S&amp;P 500 from falling further.</p>\n<p>Many investors expect the U.S. central bank to signal a faster wind-down of asset purchases, and thus, a quicker start to interest rate hikes in order to contain the rapid rise in prices.</p>\n<p>\"I would say this meeting is when we start to get some clarity on how they're (the Fed) going to address this idea of inflation that has remained elevated and most likely will remain an issue going into next year,\" said David Keller, chief market strategist at StockCharts.com.</p>\n<p>A Reuters poll of economists sees the central bank hiking interest rates from near zero to 0.25%-0.50% in the third quarter of next year, followed by another in the fourth quarter.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/a6ea56cda700f032a3421aa26db08524\" tg-width=\"596\" tg-height=\"500\" width=\"100%\" height=\"auto\"><span>Inflation</span></p>\n<p>Beyond Meat Inc rallied 9.3% after Piper Sandler upgraded the plant-based meat maker's stock to \"neutral\" from \"underweight.\"</p>\n<p>Pfizer gained 0.6% after saying its antiviral COVID-19 pill showed near 90% efficacy in preventing hospitalizations and deaths in high-risk patients, and that lab data suggests the drug retains its effectiveness against the Omicron variant.</p>\n<p>Declining issues outnumbered advancing ones on the NYSE by a 2.70-to-1 ratio; on Nasdaq, a 2.59-to-1 ratio favored decliners.</p>\n<p>The S&amp;P 500 posted 15 new 52-week highs and 2 new lows; the Nasdaq Composite recorded 18 new highs and 408 new lows.</p>\n<p>Volume on U.S. exchanges was 10.8 billion shares, compared with the 11.5 billion average over the last 20 trading days.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Wall Street ends down, investors eye inflation and Omicron</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWall Street ends down, investors eye inflation and Omicron\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-12-15 06:50</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>* Fed policy decision awaited on Wednesday</p>\n<p>* November PPI logs highest rise since 2010</p>\n<p>* Tech leads declines, financials rally</p>\n<p>* Indexes: Dow -0.30%, S&amp;P 500 -0.75%, Nasdaq -1.14%</p>\n<p>Dec 14 (Reuters) - Wall Street ended lower on Tuesday after data showed producer prices increased more than expected in November, solidifying expectations the Federal Reserve this week will announce a faster wind-down of asset purchases.</p>\n<p>The fast-spreading Omicron coronavirus variant also dampened investor sentiment after the S&amp;P 500 index hit an all-time closing high late last week.</p>\n<p>Declines were led by megacap tech-related stocks, with <a href=\"https://laohu8.com/S/CRM\">Salesforce</a>.com, Microsoft Corp, <a href=\"https://laohu8.com/S/ADBE\">Adobe</a> and Alphabet Inc pulling down the S&amp;P 500 and Nasdaq.</p>\n<p>Apple Inc ended down 0.8%, but off its session lows, after the iPhone maker said it would require customers and employees to wear masks at its U.S. retail stores as COVID-19 cases surge.</p>\n<p>The Dow Jones Industrial Average fell 0.3% to end at 35,544.18 points, while the S&amp;P 500 lost 0.75% to 4,634.09.</p>\n<p>The Nasdaq Composite dropped 1.14% to 15,237.64.</p>\n<p>Data from the Labor Department showed the producer price index (PPI) for final demand in the 12 months through November shot up 9.6%, clocking its largest gain since November 2010. That followed an 8.8% increase in October.</p>\n<p>About two-thirds of Nasdaq stocks traded below their 200-day moving average, according to Refinitiv data, suggesting many stocks within the index are struggling, even as the overall index remains only about 6% below its November record high close.</p>\n<p>\"COVID plus inflation is the Grinch that stole Christmas,\" said Jake Dollarhide, chief executive officer at Longbow Asset Management. \"I don’t underestimate the fact that there are some big Nasdaq names giving up some of their big gains. When the leaders sell off, it's not a good sign.\"</p>\n<p>Ten of the 11 major S&amp;P 500 sector indexes fell, with tech putting on the worst performance, down 1.6%. Financials gained 0.6% as investors bet on a hawkish tone from the Fed at the end of its two-day meeting on Wednesday.</p>\n<p>Berkshire Hathaway and Bank of America both gained more than 1% and helped keep the S&amp;P 500 from falling further.</p>\n<p>Many investors expect the U.S. central bank to signal a faster wind-down of asset purchases, and thus, a quicker start to interest rate hikes in order to contain the rapid rise in prices.</p>\n<p>\"I would say this meeting is when we start to get some clarity on how they're (the Fed) going to address this idea of inflation that has remained elevated and most likely will remain an issue going into next year,\" said David Keller, chief market strategist at StockCharts.com.</p>\n<p>A Reuters poll of economists sees the central bank hiking interest rates from near zero to 0.25%-0.50% in the third quarter of next year, followed by another in the fourth quarter.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/a6ea56cda700f032a3421aa26db08524\" tg-width=\"596\" tg-height=\"500\" width=\"100%\" height=\"auto\"><span>Inflation</span></p>\n<p>Beyond Meat Inc rallied 9.3% after Piper Sandler upgraded the plant-based meat maker's stock to \"neutral\" from \"underweight.\"</p>\n<p>Pfizer gained 0.6% after saying its antiviral COVID-19 pill showed near 90% efficacy in preventing hospitalizations and deaths in high-risk patients, and that lab data suggests the drug retains its effectiveness against the Omicron variant.</p>\n<p>Declining issues outnumbered advancing ones on the NYSE by a 2.70-to-1 ratio; on Nasdaq, a 2.59-to-1 ratio favored decliners.</p>\n<p>The S&amp;P 500 posted 15 new 52-week highs and 2 new lows; the Nasdaq Composite recorded 18 new highs and 408 new lows.</p>\n<p>Volume on U.S. exchanges was 10.8 billion shares, compared with the 11.5 billion average over the last 20 trading days.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4534":"瑞士信贷持仓","SPY":"标普500ETF","SH":"标普500反向ETF","BK4559":"巴菲特持仓","IVV":"标普500指数ETF","BK4550":"红杉资本持仓","UPRO":"三倍做多标普500ETF","OEF":"标普100指数ETF-iShares","BK4079":"房地产服务","COMP":"Compass, Inc.","SSO":"两倍做多标普500ETF","BK4504":"桥水持仓","SPXU":"三倍做空标普500ETF","AAPL":"苹果",".DJI":"道琼斯","BK4539":"次新股",".IXIC":"NASDAQ Composite","SDS":"两倍做空标普500ETF",".SPX":"S&P 500 Index","OEX":"标普100"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2191784951","content_text":"* Fed policy decision awaited on Wednesday\n* November PPI logs highest rise since 2010\n* Tech leads declines, financials rally\n* Indexes: Dow -0.30%, S&P 500 -0.75%, Nasdaq -1.14%\nDec 14 (Reuters) - Wall Street ended lower on Tuesday after data showed producer prices increased more than expected in November, solidifying expectations the Federal Reserve this week will announce a faster wind-down of asset purchases.\nThe fast-spreading Omicron coronavirus variant also dampened investor sentiment after the S&P 500 index hit an all-time closing high late last week.\nDeclines were led by megacap tech-related stocks, with Salesforce.com, Microsoft Corp, Adobe and Alphabet Inc pulling down the S&P 500 and Nasdaq.\nApple Inc ended down 0.8%, but off its session lows, after the iPhone maker said it would require customers and employees to wear masks at its U.S. retail stores as COVID-19 cases surge.\nThe Dow Jones Industrial Average fell 0.3% to end at 35,544.18 points, while the S&P 500 lost 0.75% to 4,634.09.\nThe Nasdaq Composite dropped 1.14% to 15,237.64.\nData from the Labor Department showed the producer price index (PPI) for final demand in the 12 months through November shot up 9.6%, clocking its largest gain since November 2010. That followed an 8.8% increase in October.\nAbout two-thirds of Nasdaq stocks traded below their 200-day moving average, according to Refinitiv data, suggesting many stocks within the index are struggling, even as the overall index remains only about 6% below its November record high close.\n\"COVID plus inflation is the Grinch that stole Christmas,\" said Jake Dollarhide, chief executive officer at Longbow Asset Management. \"I don’t underestimate the fact that there are some big Nasdaq names giving up some of their big gains. When the leaders sell off, it's not a good sign.\"\nTen of the 11 major S&P 500 sector indexes fell, with tech putting on the worst performance, down 1.6%. Financials gained 0.6% as investors bet on a hawkish tone from the Fed at the end of its two-day meeting on Wednesday.\nBerkshire Hathaway and Bank of America both gained more than 1% and helped keep the S&P 500 from falling further.\nMany investors expect the U.S. central bank to signal a faster wind-down of asset purchases, and thus, a quicker start to interest rate hikes in order to contain the rapid rise in prices.\n\"I would say this meeting is when we start to get some clarity on how they're (the Fed) going to address this idea of inflation that has remained elevated and most likely will remain an issue going into next year,\" said David Keller, chief market strategist at StockCharts.com.\nA Reuters poll of economists sees the central bank hiking interest rates from near zero to 0.25%-0.50% in the third quarter of next year, followed by another in the fourth quarter.\nInflation\nBeyond Meat Inc rallied 9.3% after Piper Sandler upgraded the plant-based meat maker's stock to \"neutral\" from \"underweight.\"\nPfizer gained 0.6% after saying its antiviral COVID-19 pill showed near 90% efficacy in preventing hospitalizations and deaths in high-risk patients, and that lab data suggests the drug retains its effectiveness against the Omicron variant.\nDeclining issues outnumbered advancing ones on the NYSE by a 2.70-to-1 ratio; on Nasdaq, a 2.59-to-1 ratio favored decliners.\nThe S&P 500 posted 15 new 52-week highs and 2 new lows; the Nasdaq Composite recorded 18 new highs and 408 new lows.\nVolume on U.S. exchanges was 10.8 billion shares, compared with the 11.5 billion average over the last 20 trading days.","news_type":1},"isVote":1,"tweetType":1,"viewCount":281,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":607018788,"gmtCreate":1639456582644,"gmtModify":1639456582739,"author":{"id":"4094269572113460","authorId":"4094269572113460","name":"Ytyt","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"Pls like","listText":"Pls like","text":"Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/607018788","repostId":"2191811539","repostType":4,"repost":{"id":"2191811539","weMediaInfo":{"introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"media_name":"Dow Jones","id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"pubTimestamp":1639440605,"share":"https://www.laohu8.com/m/news/2191811539?lang=&edition=full","pubTime":"2021-12-14 08:10","market":"hk","language":"en","title":"5 things to watch for when the Federal Reserve announces its policy decision Wednesday","url":"https://stock-news.laohu8.com/highlight/detail?id=2191811539","media":"Dow Jones","summary":"There are limits to how hawkish a dove can be\nA pivot is defined as a turn or a twist. Its safe to s","content":"<p>There are limits to how hawkish a dove can be</p>\n<p>A pivot is defined as a turn or a twist. Its safe to say there will be twists and turns on Wednesday as Fed Chairman Jerome Powell is widely expected to adopt a more hawkish stance in his postmeeting news conference Wednesday.</p>\n<p>On display will be \"the limits of Fed hawkishness,\" said David Kelly, chief global strategist at JPMorgan Funds. Central bankers are often described as either inflation-wary hawks, eager to tighten monetary policy, or more growth-focused doves.</p>\n<p>\"Fed members have displayed their dovish feathers too often at this stage for us to mistake them for a flock of hawks,\" Kelly said.</p>\n<p>It is widely assumed the Fed will double the pace at which it is tapering its bond purchases at the end of the December Federal Open Market Committee meeting. The Fed is also expected to pencil in more rate hikes over the next three years.</p>\n<p>Beyond those important headlines, here's a look at open-ended questions whose answers will be key for economists and investors to understand the Fed's true colors when policy makers conclude their two-day meeting Wednesday.</p>\n<p>Stocks DJIA, -0.89% SPX, -0.91% were lower on Monday ahead of the Fed's decision. The yield on the 10-year Treasury note was well below 1.5%.</p>\n<p><b>Could there be a dovish taper?</b></p>\n<p>Steve Englander, head of North American macro strategy at Standard Chartered Bank, sees the possibility of a dovish taper that ends in mid-April. At the moment, economists expect the Fed to reduce bond purchases by $30 billion a month, rather than the current $15 billion a month pace. Doubling the pace of the taper would end purchases altogether by mid-March. Englander argued that reducing purchases by $25 billion a month would gain the most support. The resulting mid-April end to purchases would be dovish because \"the faster the taper, the faster investors are likely to expect subsequent [rate] hikes,\" said Englander, in a note to clients.</p>\n<p><b>What's the forecast for next year?</b></p>\n<p>Markets will key on what the Fed projects for the economy in 2022, according to Steven Ricchiuto, chief economist at Mizuho Securities USA. The Fed now sees the economy expanding at a 3.8% rate next year, and this could be revised lower. Inflation is forecast to drop to 2.2% in 2022. This should be raised. The Fed's forecast for the unemployment rate -- also at 3.8% -- should hold steady, he said. Ricchiuto said that how much the Fed revises inflation up next year will be key for what the market will discount for rate hikes next year. At the moment, markets are discounting about 2 1/2 rate hikes next year. How these projections are revised \"will lead to a lot of conclusions about whether or not, in the market's mind-set, two [rate hikes] becomes three or three [rate hikes] becomes four.\"</p>\n<p><b>Goodbye 'transitory,' hello...?</b></p>\n<p>Powell has signaled that the Fed is going to delete the word \"transitory.\" How will the Fed describe the inflation outlook? Neil Dutta, head of economics at Renaissance Macro, believes the Fed will simply say inflation is \"elevated\" but not try to explain it away. Ricchiuto thinks Powell will try to describe inflation as a \"<a href=\"https://laohu8.com/S/AONE.U\">one</a>-time permanent adjustment in prices that doesn't become an annual event.\" Michael Gapen, chief U.S. economist at Barclays, thinks the Fed will settle on \"persistent.\" At the November Fed press conference, Powell said: \"certainly we should see inflation moving down by the second or third quarter.\"</p>\n<p>See: El-Erian says Fed use of 'transitory' to describe inflation was its worst call ever</p>\n<p><b>How many rate hikes exactly?</b></p>\n<p>In September, the Fed's so-called dot plot, which tracks individual policy makers' expectations for future rate moves, penciled in a total of six hikes by the end of 2024, bringing its benchmark rate up to 1.8%. Analysts now expect the Fed to boost the number of rate hikes up to a total of nine over the same period. That would place the median dot close to the Fed's assessment of the neutral rate of 2.5% -- where Fed policy is neither helping the economy expand or trying to slow it down.</p>\n<p><b>Any change in the forward guidance about rate hikes?</b></p>\n<p>An open question is whether the Fed will feel the need to change the language that set out conditions for the first rate increase. Ricchiuto thinks it is too soon for the Fed to change the guidance. Currently, the Fed has said benchmark rates will remain near zero until labor market conditions have reached full employment and inflation has risen to 2% and is on track to exceed 2% for some time. Fed officials have said the latter two conditions are satisfied. \"If the FOMC feels the need to update this language, it will probably do so by putting more emphasis on the labor market as a catalyst for liftoff,\" said Roberto Perli, head of global policy at Cornerstone Macro.</p>\n<p><b>What to do about the balance sheet?</b></p>\n<p>Economists will be listening to whether Powell gives any guidance on how much benchmark short term rates need to be raised before officials start tightening by allowing the balance sheet to shrink. \"We don't expect a clear signal yet,\" said Jim O'Sullivan, chief U.S. macro strategist at TD Securities. In the last cycle, the Fed started shrinking the balance sheet when short-term rates reached the 1%-1.25% range.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>5 things to watch for when the Federal Reserve announces its policy decision Wednesday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n5 things to watch for when the Federal Reserve announces its policy decision Wednesday\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2021-12-14 08:10</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<p>There are limits to how hawkish a dove can be</p>\n<p>A pivot is defined as a turn or a twist. Its safe to say there will be twists and turns on Wednesday as Fed Chairman Jerome Powell is widely expected to adopt a more hawkish stance in his postmeeting news conference Wednesday.</p>\n<p>On display will be \"the limits of Fed hawkishness,\" said David Kelly, chief global strategist at JPMorgan Funds. Central bankers are often described as either inflation-wary hawks, eager to tighten monetary policy, or more growth-focused doves.</p>\n<p>\"Fed members have displayed their dovish feathers too often at this stage for us to mistake them for a flock of hawks,\" Kelly said.</p>\n<p>It is widely assumed the Fed will double the pace at which it is tapering its bond purchases at the end of the December Federal Open Market Committee meeting. The Fed is also expected to pencil in more rate hikes over the next three years.</p>\n<p>Beyond those important headlines, here's a look at open-ended questions whose answers will be key for economists and investors to understand the Fed's true colors when policy makers conclude their two-day meeting Wednesday.</p>\n<p>Stocks DJIA, -0.89% SPX, -0.91% were lower on Monday ahead of the Fed's decision. The yield on the 10-year Treasury note was well below 1.5%.</p>\n<p><b>Could there be a dovish taper?</b></p>\n<p>Steve Englander, head of North American macro strategy at Standard Chartered Bank, sees the possibility of a dovish taper that ends in mid-April. At the moment, economists expect the Fed to reduce bond purchases by $30 billion a month, rather than the current $15 billion a month pace. Doubling the pace of the taper would end purchases altogether by mid-March. Englander argued that reducing purchases by $25 billion a month would gain the most support. The resulting mid-April end to purchases would be dovish because \"the faster the taper, the faster investors are likely to expect subsequent [rate] hikes,\" said Englander, in a note to clients.</p>\n<p><b>What's the forecast for next year?</b></p>\n<p>Markets will key on what the Fed projects for the economy in 2022, according to Steven Ricchiuto, chief economist at Mizuho Securities USA. The Fed now sees the economy expanding at a 3.8% rate next year, and this could be revised lower. Inflation is forecast to drop to 2.2% in 2022. This should be raised. The Fed's forecast for the unemployment rate -- also at 3.8% -- should hold steady, he said. Ricchiuto said that how much the Fed revises inflation up next year will be key for what the market will discount for rate hikes next year. At the moment, markets are discounting about 2 1/2 rate hikes next year. How these projections are revised \"will lead to a lot of conclusions about whether or not, in the market's mind-set, two [rate hikes] becomes three or three [rate hikes] becomes four.\"</p>\n<p><b>Goodbye 'transitory,' hello...?</b></p>\n<p>Powell has signaled that the Fed is going to delete the word \"transitory.\" How will the Fed describe the inflation outlook? Neil Dutta, head of economics at Renaissance Macro, believes the Fed will simply say inflation is \"elevated\" but not try to explain it away. Ricchiuto thinks Powell will try to describe inflation as a \"<a href=\"https://laohu8.com/S/AONE.U\">one</a>-time permanent adjustment in prices that doesn't become an annual event.\" Michael Gapen, chief U.S. economist at Barclays, thinks the Fed will settle on \"persistent.\" At the November Fed press conference, Powell said: \"certainly we should see inflation moving down by the second or third quarter.\"</p>\n<p>See: El-Erian says Fed use of 'transitory' to describe inflation was its worst call ever</p>\n<p><b>How many rate hikes exactly?</b></p>\n<p>In September, the Fed's so-called dot plot, which tracks individual policy makers' expectations for future rate moves, penciled in a total of six hikes by the end of 2024, bringing its benchmark rate up to 1.8%. Analysts now expect the Fed to boost the number of rate hikes up to a total of nine over the same period. That would place the median dot close to the Fed's assessment of the neutral rate of 2.5% -- where Fed policy is neither helping the economy expand or trying to slow it down.</p>\n<p><b>Any change in the forward guidance about rate hikes?</b></p>\n<p>An open question is whether the Fed will feel the need to change the language that set out conditions for the first rate increase. Ricchiuto thinks it is too soon for the Fed to change the guidance. Currently, the Fed has said benchmark rates will remain near zero until labor market conditions have reached full employment and inflation has risen to 2% and is on track to exceed 2% for some time. Fed officials have said the latter two conditions are satisfied. \"If the FOMC feels the need to update this language, it will probably do so by putting more emphasis on the labor market as a catalyst for liftoff,\" said Roberto Perli, head of global policy at Cornerstone Macro.</p>\n<p><b>What to do about the balance sheet?</b></p>\n<p>Economists will be listening to whether Powell gives any guidance on how much benchmark short term rates need to be raised before officials start tightening by allowing the balance sheet to shrink. \"We don't expect a clear signal yet,\" said Jim O'Sullivan, chief U.S. macro strategist at TD Securities. In the last cycle, the Fed started shrinking the balance sheet when short-term rates reached the 1%-1.25% range.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".SPX":"S&P 500 Index",".DJI":"道琼斯"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2191811539","content_text":"There are limits to how hawkish a dove can be\nA pivot is defined as a turn or a twist. Its safe to say there will be twists and turns on Wednesday as Fed Chairman Jerome Powell is widely expected to adopt a more hawkish stance in his postmeeting news conference Wednesday.\nOn display will be \"the limits of Fed hawkishness,\" said David Kelly, chief global strategist at JPMorgan Funds. Central bankers are often described as either inflation-wary hawks, eager to tighten monetary policy, or more growth-focused doves.\n\"Fed members have displayed their dovish feathers too often at this stage for us to mistake them for a flock of hawks,\" Kelly said.\nIt is widely assumed the Fed will double the pace at which it is tapering its bond purchases at the end of the December Federal Open Market Committee meeting. The Fed is also expected to pencil in more rate hikes over the next three years.\nBeyond those important headlines, here's a look at open-ended questions whose answers will be key for economists and investors to understand the Fed's true colors when policy makers conclude their two-day meeting Wednesday.\nStocks DJIA, -0.89% SPX, -0.91% were lower on Monday ahead of the Fed's decision. The yield on the 10-year Treasury note was well below 1.5%.\nCould there be a dovish taper?\nSteve Englander, head of North American macro strategy at Standard Chartered Bank, sees the possibility of a dovish taper that ends in mid-April. At the moment, economists expect the Fed to reduce bond purchases by $30 billion a month, rather than the current $15 billion a month pace. Doubling the pace of the taper would end purchases altogether by mid-March. Englander argued that reducing purchases by $25 billion a month would gain the most support. The resulting mid-April end to purchases would be dovish because \"the faster the taper, the faster investors are likely to expect subsequent [rate] hikes,\" said Englander, in a note to clients.\nWhat's the forecast for next year?\nMarkets will key on what the Fed projects for the economy in 2022, according to Steven Ricchiuto, chief economist at Mizuho Securities USA. The Fed now sees the economy expanding at a 3.8% rate next year, and this could be revised lower. Inflation is forecast to drop to 2.2% in 2022. This should be raised. The Fed's forecast for the unemployment rate -- also at 3.8% -- should hold steady, he said. Ricchiuto said that how much the Fed revises inflation up next year will be key for what the market will discount for rate hikes next year. At the moment, markets are discounting about 2 1/2 rate hikes next year. How these projections are revised \"will lead to a lot of conclusions about whether or not, in the market's mind-set, two [rate hikes] becomes three or three [rate hikes] becomes four.\"\nGoodbye 'transitory,' hello...?\nPowell has signaled that the Fed is going to delete the word \"transitory.\" How will the Fed describe the inflation outlook? Neil Dutta, head of economics at Renaissance Macro, believes the Fed will simply say inflation is \"elevated\" but not try to explain it away. Ricchiuto thinks Powell will try to describe inflation as a \"one-time permanent adjustment in prices that doesn't become an annual event.\" Michael Gapen, chief U.S. economist at Barclays, thinks the Fed will settle on \"persistent.\" At the November Fed press conference, Powell said: \"certainly we should see inflation moving down by the second or third quarter.\"\nSee: El-Erian says Fed use of 'transitory' to describe inflation was its worst call ever\nHow many rate hikes exactly?\nIn September, the Fed's so-called dot plot, which tracks individual policy makers' expectations for future rate moves, penciled in a total of six hikes by the end of 2024, bringing its benchmark rate up to 1.8%. Analysts now expect the Fed to boost the number of rate hikes up to a total of nine over the same period. That would place the median dot close to the Fed's assessment of the neutral rate of 2.5% -- where Fed policy is neither helping the economy expand or trying to slow it down.\nAny change in the forward guidance about rate hikes?\nAn open question is whether the Fed will feel the need to change the language that set out conditions for the first rate increase. Ricchiuto thinks it is too soon for the Fed to change the guidance. Currently, the Fed has said benchmark rates will remain near zero until labor market conditions have reached full employment and inflation has risen to 2% and is on track to exceed 2% for some time. Fed officials have said the latter two conditions are satisfied. \"If the FOMC feels the need to update this language, it will probably do so by putting more emphasis on the labor market as a catalyst for liftoff,\" said Roberto Perli, head of global policy at Cornerstone Macro.\nWhat to do about the balance sheet?\nEconomists will be listening to whether Powell gives any guidance on how much benchmark short term rates need to be raised before officials start tightening by allowing the balance sheet to shrink. \"We don't expect a clear signal yet,\" said Jim O'Sullivan, chief U.S. macro strategist at TD Securities. In the last cycle, the Fed started shrinking the balance sheet when short-term rates reached the 1%-1.25% range.","news_type":1},"isVote":1,"tweetType":1,"viewCount":181,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":607018423,"gmtCreate":1639456552564,"gmtModify":1639456552655,"author":{"id":"4094269572113460","authorId":"4094269572113460","name":"Ytyt","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/AAPL\">$Apple(AAPL)$</a>up or down","listText":"<a href=\"https://laohu8.com/S/AAPL\">$Apple(AAPL)$</a>up or down","text":"$Apple(AAPL)$up or down","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/607018423","isVote":1,"tweetType":1,"viewCount":236,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":604981931,"gmtCreate":1639308573334,"gmtModify":1639308573430,"author":{"id":"4094269572113460","authorId":"4094269572113460","name":"Ytyt","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"Pls like&nbsp;","listText":"Pls like&nbsp;","text":"Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/604981931","repostId":"2190679207","repostType":4,"repost":{"id":"2190679207","pubTimestamp":1639281804,"share":"https://www.laohu8.com/m/news/2190679207?lang=&edition=full","pubTime":"2021-12-12 12:03","market":"us","language":"en","title":"Want $1 Million in Retirement? Invest $100,000 in These 2 Stocks and Hold Until 2035","url":"https://stock-news.laohu8.com/highlight/detail?id=2190679207","media":"Motley Fool","summary":"These two stocks could change your retirement.","content":"<p>Over the past 15 years, the <b>S&amp;P 500</b> has risen in price 232%, which results in a 9.8% compound annual growth rate without inflation. If this continued for the next 15 years, you would have over $300,000 in savings to retire on if you invested $100,000, which is bigger than the average 60-year-old American's 401(k) balance.</p>\n<p>While this strategy could produce solid returns, there are two stocks that could crush that average by 2035. Here's why I think <b>Latch</b> (NASDAQ:LTCH) and <b>Lemonade</b> (NYSE:LMND) have the potential to provide high-quality returns so that you can retire right.</p>\n<h2>1. Latch: Smart security</h2>\n<p>This smart lock manufacturer is taking the industry by storm with its software. With LatchOS, apartment managers can get a birds-eye view of all their apartments on <a href=\"https://laohu8.com/S/AONE.U\">one</a> platform, making sure all of their tenants are safe and secure. Moreover, managers can let in workers or delivery people from that platform. Latch is the only company that can offer a combination of smart, keyless locks and innovative software, so it's no wonder it is rapidly being adopted by apartment buildings across America.</p>\n<p>Nearly a third of new apartment buildings are being built today with Latch installed in them, and once Latch's locks are in, it can be incredibly hard to replace them with a competitor. Additionally, when customers agree to use Latch, they sign six- to 10-year contracts to use LatchOS. These two factors provide amazingly high switching costs, so once Latch is installed, it's likely that its users will stay Latch users for a long time. Latch has experienced zero turnovers since it started operations in 2017, and that will probably continue to be the case.</p>\n<p>Latch's market is massive, and the high switching costs and first-mover advantage will likely allow the company to capitalize on it. Latch sees a market opportunity of $54 billion in the U.S. alone, and if the company is able to expand internationally in a few years, that adds another $90 billion.</p>\n<p>Latch's partnerships will be another integral part of the company's success. Since Latch customers sign agreements with Latch to use its products before the apartments are even built, it is crucial that Latch is in talks with apartment managers before the construction team breaks ground. That is why Latch has partnered with some of the largest apartment builders in the U.S., like <b>Brookfield</b> (NYSE:BAM) and <b>Avalon Bay</b> (NYSE:AVB).</p>\n<p>This company has only been operational since 2017, so there are plenty of risks with this business. The primary risk is that it is losing lots of cash.</p>\n<table border=\"1\">\n <tbody>\n  <tr>\n   <th>Metric</th>\n   <th>Q3 2020</th>\n   <th>Q3 2021</th>\n   <th>Change</th>\n  </tr>\n  <tr>\n   <td>Net loss</td>\n   <td>$15.9 million</td>\n   <td>$34.2 million</td>\n   <td>115%</td>\n  </tr>\n  <tr>\n   <td>Net loss as a percentage of revenue</td>\n   <td>311.5%</td>\n   <td>305.7%</td>\n   <td>N/A</td>\n  </tr>\n </tbody>\n</table>\n<p>The company is making most of its money today on its locks, which it sells at a loss. These losses are bad today, but Latch's profitability can improve. Latch has noted that the timeframe it takes from construction to a builder beginning their subscription services is 24 months. The contracts the company has seen could finally turn into reportable revenue within the next couple of years. Analysts see the potential as well with growth forecasts of nearly 50% for the next five years.</p>\n<p>Also, as its customers stay with the company longer and pay more in its subscription fees for the software -- which has gross margins of 90% -- the company's losses will likely improve to provide a pathway to profitability. This could be a multi-year effort, but if it can use its differentiated product and strong partnerships to attract customers and its high switching costs to retain them, Latch could give investors immense returns by 2035.</p>\n<h2>2. Lemonade: An insurance provider anyone can love</h2>\n<p>Lemonade is making insurance enjoyable. Whether applying for insurance or getting a claim, Lemonade's process is easy and hassle-free with its artificial intelligence (AI)-based bots that can approve applicants and claims in seconds. The company is also aligning its interest with its consumers: Lemonade charges a flat fee, and any money from leftover claims that went unpaid goes to charities that Lemonade customers choose. So far in 2021, Lemonade has donated over $2.2 million in unpaid claims on behalf of its customers.</p>\n<p>Lemonade's incentive alignment structure can hurt its bottom line, but it has resulted in amazing customer attraction. Lemonade has over 1.3 million customers, and it has been one of the fastest-growing insurance stocks ever.</p>\n<p>The company started in renters insurance, targeting young renters. However, just as its customers have moved on in life, Lemonade has expanded. Now it offers homeowners, pet, life, and even car insurance. Lemonade hopes to attract young customers with small offerings like renters and car insurance, then integrate them deeper into the ecosystem with its fast and delightful service.</p>\n<table border=\"1\">\n <tbody>\n  <tr>\n   <th>Metric</th>\n   <th>First Nine Months of 2020</th>\n   <th>First Nine Months of 2021</th>\n   <th>Change</th>\n  </tr>\n  <tr>\n   <td>Net loss</td>\n   <td>$88.4 million</td>\n   <td>$171.0 million</td>\n   <td>93.4%</td>\n  </tr>\n  <tr>\n   <td>Net loss as a percentage of revenue</td>\n   <td>119.6%</td>\n   <td>195.6%</td>\n   <td><p>N/A</p></td>\n  </tr>\n </tbody>\n</table>\n<p>This major uptick in net losses has primarily been because of the company's loss ratio. Lemonade's net loss ratio -- which represents the amount of premium paid out on claims -- was 77% in the third quarter. A ratio of 75% or below is the long-term goal that management is targeting, but it has been consistently higher in 2021 because of the new products that Lemonade has launched this year and in 2020.</p>\n<p>Lemonade's AI can often take time to learn and collect data about its new markets, resulting in poor short-term performance but long-term opportunities. As its AI obtains more data, it should become more accurate, lowering its loss ratio and its net loss. With the lowered loss ratio, investors could expect the company to generate a profit, which would provide optimism beyond its environmental, social, and governance (ESG) efforts.</p>\n<p>Both of these companies are incredibly young and are quite risky today, which is clearly noted in the stock decreases of more than 25% for each year-to-date. But in a balanced portfolio, these stocks could define someone's future investing success. If both companies can use their competitive edges to rapidly grow their business over the next 15 years and become profitable, they could reward investors by 2035.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Want $1 Million in Retirement? Invest $100,000 in These 2 Stocks and Hold Until 2035</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWant $1 Million in Retirement? Invest $100,000 in These 2 Stocks and Hold Until 2035\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-12 12:03 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/12/11/want-1-million-in-retirement-invest-100000-in-thes/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Over the past 15 years, the S&P 500 has risen in price 232%, which results in a 9.8% compound annual growth rate without inflation. If this continued for the next 15 years, you would have over $300,...</p>\n\n<a href=\"https://www.fool.com/investing/2021/12/11/want-1-million-in-retirement-invest-100000-in-thes/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4535":"淡马锡持仓","BK4543":"AI","BK4107":"财产与意外伤害保险","BAM":"布鲁克菲尔德资产管理","BK4528":"SaaS概念","BK4023":"应用软件","AI":"C3.ai, Inc.","BK4135":"资产管理与托管银行","ESG":"FlexShares STOXX US ESG Select Index Fund","AVB":"阿湾物产","BK4549":"软银资本持仓","BK4548":"巴美列捷福持仓","LTCH":"Latch, Inc.","LMND":"Lemonade, Inc.","BK4551":"寇图资本持仓","BK4215":"住宅房地产投资信托"},"source_url":"https://www.fool.com/investing/2021/12/11/want-1-million-in-retirement-invest-100000-in-thes/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2190679207","content_text":"Over the past 15 years, the S&P 500 has risen in price 232%, which results in a 9.8% compound annual growth rate without inflation. If this continued for the next 15 years, you would have over $300,000 in savings to retire on if you invested $100,000, which is bigger than the average 60-year-old American's 401(k) balance.\nWhile this strategy could produce solid returns, there are two stocks that could crush that average by 2035. Here's why I think Latch (NASDAQ:LTCH) and Lemonade (NYSE:LMND) have the potential to provide high-quality returns so that you can retire right.\n1. Latch: Smart security\nThis smart lock manufacturer is taking the industry by storm with its software. With LatchOS, apartment managers can get a birds-eye view of all their apartments on one platform, making sure all of their tenants are safe and secure. Moreover, managers can let in workers or delivery people from that platform. Latch is the only company that can offer a combination of smart, keyless locks and innovative software, so it's no wonder it is rapidly being adopted by apartment buildings across America.\nNearly a third of new apartment buildings are being built today with Latch installed in them, and once Latch's locks are in, it can be incredibly hard to replace them with a competitor. Additionally, when customers agree to use Latch, they sign six- to 10-year contracts to use LatchOS. These two factors provide amazingly high switching costs, so once Latch is installed, it's likely that its users will stay Latch users for a long time. Latch has experienced zero turnovers since it started operations in 2017, and that will probably continue to be the case.\nLatch's market is massive, and the high switching costs and first-mover advantage will likely allow the company to capitalize on it. Latch sees a market opportunity of $54 billion in the U.S. alone, and if the company is able to expand internationally in a few years, that adds another $90 billion.\nLatch's partnerships will be another integral part of the company's success. Since Latch customers sign agreements with Latch to use its products before the apartments are even built, it is crucial that Latch is in talks with apartment managers before the construction team breaks ground. That is why Latch has partnered with some of the largest apartment builders in the U.S., like Brookfield (NYSE:BAM) and Avalon Bay (NYSE:AVB).\nThis company has only been operational since 2017, so there are plenty of risks with this business. The primary risk is that it is losing lots of cash.\n\n\n\nMetric\nQ3 2020\nQ3 2021\nChange\n\n\nNet loss\n$15.9 million\n$34.2 million\n115%\n\n\nNet loss as a percentage of revenue\n311.5%\n305.7%\nN/A\n\n\n\nThe company is making most of its money today on its locks, which it sells at a loss. These losses are bad today, but Latch's profitability can improve. Latch has noted that the timeframe it takes from construction to a builder beginning their subscription services is 24 months. The contracts the company has seen could finally turn into reportable revenue within the next couple of years. Analysts see the potential as well with growth forecasts of nearly 50% for the next five years.\nAlso, as its customers stay with the company longer and pay more in its subscription fees for the software -- which has gross margins of 90% -- the company's losses will likely improve to provide a pathway to profitability. This could be a multi-year effort, but if it can use its differentiated product and strong partnerships to attract customers and its high switching costs to retain them, Latch could give investors immense returns by 2035.\n2. Lemonade: An insurance provider anyone can love\nLemonade is making insurance enjoyable. Whether applying for insurance or getting a claim, Lemonade's process is easy and hassle-free with its artificial intelligence (AI)-based bots that can approve applicants and claims in seconds. The company is also aligning its interest with its consumers: Lemonade charges a flat fee, and any money from leftover claims that went unpaid goes to charities that Lemonade customers choose. So far in 2021, Lemonade has donated over $2.2 million in unpaid claims on behalf of its customers.\nLemonade's incentive alignment structure can hurt its bottom line, but it has resulted in amazing customer attraction. Lemonade has over 1.3 million customers, and it has been one of the fastest-growing insurance stocks ever.\nThe company started in renters insurance, targeting young renters. However, just as its customers have moved on in life, Lemonade has expanded. Now it offers homeowners, pet, life, and even car insurance. Lemonade hopes to attract young customers with small offerings like renters and car insurance, then integrate them deeper into the ecosystem with its fast and delightful service.\n\n\n\nMetric\nFirst Nine Months of 2020\nFirst Nine Months of 2021\nChange\n\n\nNet loss\n$88.4 million\n$171.0 million\n93.4%\n\n\nNet loss as a percentage of revenue\n119.6%\n195.6%\nN/A\n\n\n\nThis major uptick in net losses has primarily been because of the company's loss ratio. Lemonade's net loss ratio -- which represents the amount of premium paid out on claims -- was 77% in the third quarter. A ratio of 75% or below is the long-term goal that management is targeting, but it has been consistently higher in 2021 because of the new products that Lemonade has launched this year and in 2020.\nLemonade's AI can often take time to learn and collect data about its new markets, resulting in poor short-term performance but long-term opportunities. As its AI obtains more data, it should become more accurate, lowering its loss ratio and its net loss. With the lowered loss ratio, investors could expect the company to generate a profit, which would provide optimism beyond its environmental, social, and governance (ESG) efforts.\nBoth of these companies are incredibly young and are quite risky today, which is clearly noted in the stock decreases of more than 25% for each year-to-date. But in a balanced portfolio, these stocks could define someone's future investing success. If both companies can use their competitive edges to rapidly grow their business over the next 15 years and become profitable, they could reward investors by 2035.","news_type":1},"isVote":1,"tweetType":1,"viewCount":174,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":605560500,"gmtCreate":1639191679818,"gmtModify":1639191679952,"author":{"id":"4094269572113460","authorId":"4094269572113460","name":"Ytyt","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"Pls like","listText":"Pls like","text":"Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/605560500","repostId":"1122303970","repostType":4,"repost":{"id":"1122303970","pubTimestamp":1639135689,"share":"https://www.laohu8.com/m/news/1122303970?lang=&edition=full","pubTime":"2021-12-10 19:28","market":"us","language":"en","title":"Is It Time to Buy the Dow's 3 Worst Performing Stocks This Year?","url":"https://stock-news.laohu8.com/highlight/detail?id=1122303970","media":"Motley Fool","summary":"Take a look to see if these dogs of the Dow are worth buying.","content":"<p>The&nbsp;<b>Dow Jones Industrial Average</b>&nbsp;is an index made up of 30 of the largest and most influential companies on U.S. stock exchanges. The index has historically returned around 7.5% each year, so being up over 15% makes 2021 a year to celebrate.</p>\n<p>Not every stock in the Dow Jones has performed well. The three stocks we'll discuss are all down and have been since the beginning of 2021, despite the index being up so much. We'll look at each one to determine whether they represent an opportunity or are down for a good reason.</p>\n<p><b>1. Amgen</b></p>\n<p>Biotech company&nbsp;<b>Amgen</b>&nbsp;has been down about 7% since the beginning of 2021. The company develops and sells drugs aimed at inflammation, cancer, bone health, heart disease, and more.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/115c1a57215446a5a83d447ffbb995ca\" tg-width=\"2000\" tg-height=\"1333\" width=\"100%\" height=\"auto\"><span>Image source: Getty Images.</span></p>\n<p>When a company invents a successful drug, its formula is patented, protecting it from direct competition for many years. Medications can cost millions of dollars to research and develop but can fail when tested in trials. A successful drug sometimes referred to as a blockbuster, can bring in billions in revenue over the length of its patent.</p>\n<p>Investors can get a feel for the trajectory of a drug company by following when its key products lose their patent protection. Once this happens, generic competitors flood the market at lower prices, significantly reducing the original drug's sales.</p>\n<p>Many of Amgen's primary products could lose sales when their patents expire:</p>\n<ul>\n <li>Enbrel (19% of revenue) expires in the U.S. in 2029.</li>\n <li>Prolia (12% of revenue) expires in the U.S. in 2025.</li>\n <li>Otezla (9% of revenue) expires in the U.S. in 2028.</li>\n <li>Xgeva (8% of revenue) expires in the U.S. in 2025.</li>\n</ul>\n<p>The United States has a more-complicated patent system, where drug companies can extend their patents by making minor changes to them. This, combined with the high drug prices charged in the U.S. market, is why domestic sales account for 68% of Amgen's global revenue. As these patents expire over the next decade, the company will&nbsp;need its pipeline to deliver&nbsp;successful products to replace this lost revenue.</p>\n<p>The stock currently trades at a&nbsp;price-to-earnings ratio&nbsp;(P/E) of 12 using analyst estimates for 2021&nbsp;earnings per share&nbsp;(EPS), far less than its historical average of 17. Analysts are calling for growth of 8% per year over the next three to five years, and pharmaceutical companies face political pressure in the United States due to drug prices. These risks probably justify a discounted valuation, and that's just what the stock offers at these levels.</p>\n<p><b>Verdict: thumbs-up</b></p>\n<p><b>2. Merck</b></p>\n<p>A rival to Amgen,<b>Merck</b>&nbsp;develops drugs for cancer, immunology, and virology, as well as vaccine products, along with a separate business unit that develops drugs for veterinary use. The stock has maintained its 11% decline since the beginning of the year.</p>\n<p>Merck doesn't have a patent cliff that's quite as imminent as Amgen's. Its Januvia/Janumet accounts for about 10% of sales, and its patent expires in 2022, but the patents for the rest of Merck's significant drugs like Keytruda (34% of revenue) and Gardasil (15% of revenue) don't expire until 2028.</p>\n<p>The company also released positive results from its clinical trials on molnupiravir, a pill that, when taken at the early stages of COVID-19 infection, can reduce the risk of serious illness by 30%. Merck has already agreed to sell more than $2.2 billion in treatments, so as the omicron variant continues to spread, it could give a spark to Merck's business. Rival&nbsp;<b>Pfizer</b>&nbsp;is also bringing a similar pill to market, but there could be&nbsp;enough demand for both to succeedhere.</p>\n<p>The stock is trading at a P/E of 11, a significant discount to its historical P/E of 27. Analysts are calling for modest growth of 6% per year over the next three to five years, but that might be conservative due to COVID treatments. Investors might not be factoring in the potential business from the COVID pill, and the valuation markdown could provide a margin of safety.</p>\n<p><b>Verdict: thumbs-up</b></p>\n<p><b>3. Verizon Communications</b></p>\n<p>Down 14% year to date, telecom company&nbsp;<b>Verizon Communications</b>&nbsp;is among a select few companies that control the wireless networks in the United States. The infrastructure that supports our nationwide phone network costs billions of dollars and took years to build out, so there is a minor threat from outside competition, even with fierce competitors like&nbsp;<b>AT&amp;T</b>&nbsp;and&nbsp;<b>T-Mobile</b>.</p>\n<p>The stock trades at a P/E of just over 9 based on 2021 EPS estimates. This is a bargain valuation if we look at its historical average, 14. While many would assume that 5G technology would unlock a lot of growth, Verizon has historically been a slow-growing business even with the emergence of 3G and 4G networks over time.</p>\n<p>Analysts estimate the company's three-to-five-year EPS growth at around 3% annually. Defensive investors who want a solid dividend can benefit here: It pays a dividend that yields 5% and needs just half of its profits to afford that payment. Investors focused on total returns probably won't get excited about Verizon, even at this reduced valuation.</p>\n<p><b>Verdict: thumbs-down</b></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Is It Time to Buy the Dow's 3 Worst Performing Stocks This Year?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIs It Time to Buy the Dow's 3 Worst Performing Stocks This Year?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-10 19:28 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/12/10/is-it-time-to-buy-the-dow-jones-3-worst-performing/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The Dow Jones Industrial Average is an index made up of 30 of the largest and most influential companies on U.S. stock exchanges. The index has historically returned around 7.5% each year, so being up...</p>\n\n<a href=\"https://www.fool.com/investing/2021/12/10/is-it-time-to-buy-the-dow-jones-3-worst-performing/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRK":"默沙东","AMGN":"安进","VZ":"威瑞森"},"source_url":"https://www.fool.com/investing/2021/12/10/is-it-time-to-buy-the-dow-jones-3-worst-performing/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1122303970","content_text":"The Dow Jones Industrial Average is an index made up of 30 of the largest and most influential companies on U.S. stock exchanges. The index has historically returned around 7.5% each year, so being up over 15% makes 2021 a year to celebrate.\nNot every stock in the Dow Jones has performed well. The three stocks we'll discuss are all down and have been since the beginning of 2021, despite the index being up so much. We'll look at each one to determine whether they represent an opportunity or are down for a good reason.\n1. Amgen\nBiotech company Amgen has been down about 7% since the beginning of 2021. The company develops and sells drugs aimed at inflammation, cancer, bone health, heart disease, and more.\nImage source: Getty Images.\nWhen a company invents a successful drug, its formula is patented, protecting it from direct competition for many years. Medications can cost millions of dollars to research and develop but can fail when tested in trials. A successful drug sometimes referred to as a blockbuster, can bring in billions in revenue over the length of its patent.\nInvestors can get a feel for the trajectory of a drug company by following when its key products lose their patent protection. Once this happens, generic competitors flood the market at lower prices, significantly reducing the original drug's sales.\nMany of Amgen's primary products could lose sales when their patents expire:\n\nEnbrel (19% of revenue) expires in the U.S. in 2029.\nProlia (12% of revenue) expires in the U.S. in 2025.\nOtezla (9% of revenue) expires in the U.S. in 2028.\nXgeva (8% of revenue) expires in the U.S. in 2025.\n\nThe United States has a more-complicated patent system, where drug companies can extend their patents by making minor changes to them. This, combined with the high drug prices charged in the U.S. market, is why domestic sales account for 68% of Amgen's global revenue. As these patents expire over the next decade, the company will need its pipeline to deliver successful products to replace this lost revenue.\nThe stock currently trades at a price-to-earnings ratio (P/E) of 12 using analyst estimates for 2021 earnings per share (EPS), far less than its historical average of 17. Analysts are calling for growth of 8% per year over the next three to five years, and pharmaceutical companies face political pressure in the United States due to drug prices. These risks probably justify a discounted valuation, and that's just what the stock offers at these levels.\nVerdict: thumbs-up\n2. Merck\nA rival to Amgen,Merck develops drugs for cancer, immunology, and virology, as well as vaccine products, along with a separate business unit that develops drugs for veterinary use. The stock has maintained its 11% decline since the beginning of the year.\nMerck doesn't have a patent cliff that's quite as imminent as Amgen's. Its Januvia/Janumet accounts for about 10% of sales, and its patent expires in 2022, but the patents for the rest of Merck's significant drugs like Keytruda (34% of revenue) and Gardasil (15% of revenue) don't expire until 2028.\nThe company also released positive results from its clinical trials on molnupiravir, a pill that, when taken at the early stages of COVID-19 infection, can reduce the risk of serious illness by 30%. Merck has already agreed to sell more than $2.2 billion in treatments, so as the omicron variant continues to spread, it could give a spark to Merck's business. Rival Pfizer is also bringing a similar pill to market, but there could be enough demand for both to succeedhere.\nThe stock is trading at a P/E of 11, a significant discount to its historical P/E of 27. Analysts are calling for modest growth of 6% per year over the next three to five years, but that might be conservative due to COVID treatments. Investors might not be factoring in the potential business from the COVID pill, and the valuation markdown could provide a margin of safety.\nVerdict: thumbs-up\n3. Verizon Communications\nDown 14% year to date, telecom company Verizon Communications is among a select few companies that control the wireless networks in the United States. The infrastructure that supports our nationwide phone network costs billions of dollars and took years to build out, so there is a minor threat from outside competition, even with fierce competitors like AT&T and T-Mobile.\nThe stock trades at a P/E of just over 9 based on 2021 EPS estimates. This is a bargain valuation if we look at its historical average, 14. While many would assume that 5G technology would unlock a lot of growth, Verizon has historically been a slow-growing business even with the emergence of 3G and 4G networks over time.\nAnalysts estimate the company's three-to-five-year EPS growth at around 3% annually. Defensive investors who want a solid dividend can benefit here: It pays a dividend that yields 5% and needs just half of its profits to afford that payment. Investors focused on total returns probably won't get excited about Verizon, even at this reduced valuation.\nVerdict: thumbs-down","news_type":1},"isVote":1,"tweetType":1,"viewCount":169,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":605082821,"gmtCreate":1639093559363,"gmtModify":1639093559460,"author":{"id":"4094269572113460","authorId":"4094269572113460","name":"Ytyt","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"Pls like","listText":"Pls like","text":"Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/605082821","repostId":"1168862300","repostType":4,"isVote":1,"tweetType":1,"viewCount":146,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":602529513,"gmtCreate":1639043966849,"gmtModify":1639043966947,"author":{"id":"4094269572113460","authorId":"4094269572113460","name":"Ytyt","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"Pls like","listText":"Pls like","text":"Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/602529513","repostId":"2189667447","repostType":4,"repost":{"id":"2189667447","pubTimestamp":1639022040,"share":"https://www.laohu8.com/m/news/2189667447?lang=&edition=full","pubTime":"2021-12-09 11:54","market":"us","language":"en","title":"3 Growth Stocks Down Over 50% To Buy Now","url":"https://stock-news.laohu8.com/highlight/detail?id=2189667447","media":"Motley Fool","summary":"The stock market is offering long-term investors an opportunity to buy these excellent businesses at a discount.","content":"<p>Investing in stocks for the long term can be an effective way to build wealth. However, the path to increasing stock values is rarely an upward straight line. More frequently, it is charted with several peaks and valleys. Long-term investors with the courage and discipline to hold or buy stocks during major crashes are sometimes rewarded with exponential gains.</p>\n<p>If you have extra cash you will not need for several years for life's necessities, you can buy stocks with good long-term prospects that are down due to short-term causes. <b>Chegg</b> (NYSE:CHGG), <b>Peloton</b> (NASDAQ:PTON), and <b>Skillz</b> (NYSE:SKLZ) are three stocks you can buy right now that are down over 50% while their long-term prospects remain intact.</p>\n<h2>Chegg</h2>\n<p>Chegg is an education technology company with a subscription business model. It caters primarily to college students by offering help with course curriculum. Chegg's platform has over 70 million step-by-step solutions to answers that students may have difficulty understanding. Chegg has built this database through student requests. In addition to having full access to existing content, students can ask 20 questions per month answered by subject-matter experts with their subscription. These questions and answers are then added to the database for all students to view.</p>\n<p>That's a lucrative business model because Chegg pays for that content once and gets the benefits for several years. The college curriculum does not change much over the years, so the assets pay dividends for decades. Chegg is already starting to capture the benefits of scaling to a more significant subscriber and revenue base. Indeed, from 2015 to 2020, operating profit grew from a loss of $57 million to a positive $57 million.</p>\n<p>Nevertheless, the stock is down 67.5% in 2021, with most losses coming after Nov. 1. That's when the company lowered the forecast for the rest of the fiscal year, citing a significant drop-off in student enrollment.</p>\n<h2>Peloton</h2>\n<p>Peloton sells interactive exercise equipment and a subscription to live and recorded exercise classes. The company was already gaining popularity before the pandemic increased the demand for in-home exercise equipment. As a result, revenue more than doubled to $4 billion in fiscal 2021.</p>\n<p>Once a customer signs up, they tend to stick around. Peloton boasted a membership retention rate of 92% in its most recent quarter ended Sept. 30. The company has a robust selection of live and recorded classes and makes members feel part of a community.</p>\n<p>Peloton had 2.5 million connected fitness subscribers at the end of the quarter, and management is forecasting that it will grow to 3.4 million by the end of fiscal 2022. Still, that would be a small part of the number of people that regularly exercise -- leaving Peloton with a long runway for growth.</p>\n<p>Peloton's stock is down 72% in 2021, mainly because economic reopening slowed the demand for in-home exercise equipment. That being said, Peloton's sales are growing on top of last years' elevated levels.</p>\n<h2>Skillz</h2>\n<p>Skillz is a gaming company with a unique twist: It allows contestants to wager on their games and doles out cash prizes to winners. The company's business is not considered gambling because the games on its site are based on skill. In other words, winners win because they are better at the game and not because of chance. Of course, if you have money on the line, you engage with the games more seriously than you would otherwise.</p>\n<p>In its most recent quarter,&nbsp;the company boasted 0.51 million monthly active users, up from 0.35 million in the year before. Still, the growth is not pleasing investors because the company is spending so heavily on sales and marketing. Skillz spent 112% of revenue on sales and marketing in its most recent quarter. Investors feel it should be getting better results from that spending. The stock is down 57.8% in 2021.</p>\n<p>Each of these three stocks is down big because of short-term catalysts. That could be an excellent buying opportunity for long-term investors who want to buy these growth stocks at more than 50% off their highs.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Growth Stocks Down Over 50% To Buy Now</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Growth Stocks Down Over 50% To Buy Now\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-09 11:54 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/12/08/3-growth-stocks-down-over-50-to-buy-now/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Investing in stocks for the long term can be an effective way to build wealth. However, the path to increasing stock values is rarely an upward straight line. More frequently, it is charted with ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/12/08/3-growth-stocks-down-over-50-to-buy-now/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"CHGG":"Chegg Inc","BK4548":"巴美列捷福持仓","BK4551":"寇图资本持仓","BK4190":"消闲用品","SKLZ":"Skillz Inc","BK4085":"互动家庭娱乐","BK4566":"资本集团","BK4532":"文艺复兴科技持仓","BK4204":"教育服务","PTON":"Peloton Interactive, Inc."},"source_url":"https://www.fool.com/investing/2021/12/08/3-growth-stocks-down-over-50-to-buy-now/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2189667447","content_text":"Investing in stocks for the long term can be an effective way to build wealth. However, the path to increasing stock values is rarely an upward straight line. More frequently, it is charted with several peaks and valleys. Long-term investors with the courage and discipline to hold or buy stocks during major crashes are sometimes rewarded with exponential gains.\nIf you have extra cash you will not need for several years for life's necessities, you can buy stocks with good long-term prospects that are down due to short-term causes. Chegg (NYSE:CHGG), Peloton (NASDAQ:PTON), and Skillz (NYSE:SKLZ) are three stocks you can buy right now that are down over 50% while their long-term prospects remain intact.\nChegg\nChegg is an education technology company with a subscription business model. It caters primarily to college students by offering help with course curriculum. Chegg's platform has over 70 million step-by-step solutions to answers that students may have difficulty understanding. Chegg has built this database through student requests. In addition to having full access to existing content, students can ask 20 questions per month answered by subject-matter experts with their subscription. These questions and answers are then added to the database for all students to view.\nThat's a lucrative business model because Chegg pays for that content once and gets the benefits for several years. The college curriculum does not change much over the years, so the assets pay dividends for decades. Chegg is already starting to capture the benefits of scaling to a more significant subscriber and revenue base. Indeed, from 2015 to 2020, operating profit grew from a loss of $57 million to a positive $57 million.\nNevertheless, the stock is down 67.5% in 2021, with most losses coming after Nov. 1. That's when the company lowered the forecast for the rest of the fiscal year, citing a significant drop-off in student enrollment.\nPeloton\nPeloton sells interactive exercise equipment and a subscription to live and recorded exercise classes. The company was already gaining popularity before the pandemic increased the demand for in-home exercise equipment. As a result, revenue more than doubled to $4 billion in fiscal 2021.\nOnce a customer signs up, they tend to stick around. Peloton boasted a membership retention rate of 92% in its most recent quarter ended Sept. 30. The company has a robust selection of live and recorded classes and makes members feel part of a community.\nPeloton had 2.5 million connected fitness subscribers at the end of the quarter, and management is forecasting that it will grow to 3.4 million by the end of fiscal 2022. Still, that would be a small part of the number of people that regularly exercise -- leaving Peloton with a long runway for growth.\nPeloton's stock is down 72% in 2021, mainly because economic reopening slowed the demand for in-home exercise equipment. That being said, Peloton's sales are growing on top of last years' elevated levels.\nSkillz\nSkillz is a gaming company with a unique twist: It allows contestants to wager on their games and doles out cash prizes to winners. The company's business is not considered gambling because the games on its site are based on skill. In other words, winners win because they are better at the game and not because of chance. Of course, if you have money on the line, you engage with the games more seriously than you would otherwise.\nIn its most recent quarter, the company boasted 0.51 million monthly active users, up from 0.35 million in the year before. Still, the growth is not pleasing investors because the company is spending so heavily on sales and marketing. Skillz spent 112% of revenue on sales and marketing in its most recent quarter. Investors feel it should be getting better results from that spending. The stock is down 57.8% in 2021.\nEach of these three stocks is down big because of short-term catalysts. That could be an excellent buying opportunity for long-term investors who want to buy these growth stocks at more than 50% off their highs.","news_type":1},"isVote":1,"tweetType":1,"viewCount":116,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":602038601,"gmtCreate":1638937668197,"gmtModify":1638937668319,"author":{"id":"4094269572113460","authorId":"4094269572113460","name":"Ytyt","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"Pls like","listText":"Pls like","text":"Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/602038601","repostId":"1180884235","repostType":4,"repost":{"id":"1180884235","pubTimestamp":1638932278,"share":"https://www.laohu8.com/m/news/1180884235?lang=&edition=full","pubTime":"2021-12-08 10:57","market":"us","language":"en","title":"Dear NIO Stock Fans, Mark Your Calendars for This Potential Catalyst on Dec. 18","url":"https://stock-news.laohu8.com/highlight/detail?id=1180884235","media":"InvestorPlace","summary":"Fans of electric vehicle  stocks are anxiously awaiting Nio Day, which has been confirmed to take place on Dec. 18 in Suzhou, China.Nio is expected to debut at least two new vehicle models and possibly a brand new vehicle brand. During Nio Day 2020, the EV maker unveiled the ET7 sedan to much fanfare. Deliveries for the ET7 sedan are expected to start in 2022 for most countries, although confirmation for this timetable will likely be answered at Nio Day.Without further ado, let’s dive right into","content":"<p>Fans of electric vehicle (EV) stocks are anxiously awaiting&nbsp;Nio Day, which has been confirmed to take place on Dec. 18 in Suzhou, China.<b>Nio</b>(NYSE:<b><u>NIO</u></b>) is expected to debut at least two new vehicle models and possibly a brand new vehicle brand. During Nio Day 2020, the EV maker unveiled the ET7 sedan to much fanfare. Deliveries for the ET7 sedan are expected to start in 2022 for most countries, although confirmation for this timetable will likely be answered at Nio Day.</p>\n<p>Nio also impressed shareholders after releasing its November delivery numbers. The company&nbsp;reported&nbsp;that it had delivered 10,878 vehicles, up nearly 106% year-over-year (YOY). This brings total year deliveries to 80,940 vehicles, up more than 120% YOY. The November numbers were much needed after Nio reported disappointing October deliveries. Those numbers came in lower due to supply-chain issues and chip shortages.<i>InvestorPlace</i>contributor Vandita Jadeja notes that Nio’sexpected fourth-quarter deliveries&nbsp;of 23,500 to 25,500 vehicles will be difficult to accomplish.</p>\n<p>Without further ado, let’s dive right into what investors should know about Nio’s most exciting day of the year.</p>\n<p>Nio Day: What NIO Stock Investors Should Know</p>\n<ol>\n <li>Rumors&nbsp;are flying around that one of the new vehicles to be released during Nio Day is the ET5, a mid-sized sedan. The ET5 will reportedly compete with the&nbsp;<b>BMW</b>(OTCMKTS:<b><u>BMWYY</u></b>) 3-series and the Audi A4 at a lower price (Audi is owned by&nbsp;<b>Volkswagen</b>(OTCMKTS:<b><u>VWAGY</u></b>)).</li>\n <li>The ET5 will likely be priced below the ET7, which has a base cost of around $69,000.</li>\n <li>According to a&nbsp;research note&nbsp;from Deutsche Bank, the second mystery EV is expected to be similar to the&nbsp;<b>Toyota</b>(NYSE:<b><u>TM</u></b>) Alphard, a luxury multi-purpose vehicle (MPV) that “sold 20,000 units in China last year.” Deutsche’s second guess is a high-performance sports coupe.</li>\n <li>Nio recently&nbsp;filed a trademark registration&nbsp;for the name EF9, according to&nbsp;<i>Electric</i>&nbsp;<i>Vehicle</i>&nbsp;<i>Web</i>. This has led many to speculate that the new vehicle will be a convertible version of the EP9.</li>\n <li>CEO William Li confirmed that Nio plans on adding three new models to the Nio Technology Platform 2.0 in 2022. One of the models will be the new ET7 sedan. The other two are still unknown.</li>\n <li>Fans of NIO stock are also waiting for an update on overseas delivery times and availability, especially in European countries. The company will likely answer this question at Nio Day.</li>\n <li>Li confirmed during a Q2 conference call that Nio had assembled a team to work on a new vehicle brand. In regards to the possible new vehicle brand, Li&nbsp;commented, “The relationship between Nio and our new mass-market brand will be like that of Audi-Volkswagen and Lexus-Toyota.”</li>\n</ol>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Dear NIO Stock Fans, Mark Your Calendars for This Potential Catalyst on Dec. 18</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDear NIO Stock Fans, Mark Your Calendars for This Potential Catalyst on Dec. 18\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-08 10:57 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/12/dear-nio-stock-fans-mark-your-calendars-for-this-potential-catalyst/><strong>InvestorPlace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Fans of electric vehicle (EV) stocks are anxiously awaiting Nio Day, which has been confirmed to take place on Dec. 18 in Suzhou, China.Nio(NYSE:NIO) is expected to debut at least two new vehicle ...</p>\n\n<a href=\"https://investorplace.com/2021/12/dear-nio-stock-fans-mark-your-calendars-for-this-potential-catalyst/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NIO":"蔚来"},"source_url":"https://investorplace.com/2021/12/dear-nio-stock-fans-mark-your-calendars-for-this-potential-catalyst/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1180884235","content_text":"Fans of electric vehicle (EV) stocks are anxiously awaiting Nio Day, which has been confirmed to take place on Dec. 18 in Suzhou, China.Nio(NYSE:NIO) is expected to debut at least two new vehicle models and possibly a brand new vehicle brand. During Nio Day 2020, the EV maker unveiled the ET7 sedan to much fanfare. Deliveries for the ET7 sedan are expected to start in 2022 for most countries, although confirmation for this timetable will likely be answered at Nio Day.\nNio also impressed shareholders after releasing its November delivery numbers. The company reported that it had delivered 10,878 vehicles, up nearly 106% year-over-year (YOY). This brings total year deliveries to 80,940 vehicles, up more than 120% YOY. The November numbers were much needed after Nio reported disappointing October deliveries. Those numbers came in lower due to supply-chain issues and chip shortages.InvestorPlacecontributor Vandita Jadeja notes that Nio’sexpected fourth-quarter deliveries of 23,500 to 25,500 vehicles will be difficult to accomplish.\nWithout further ado, let’s dive right into what investors should know about Nio’s most exciting day of the year.\nNio Day: What NIO Stock Investors Should Know\n\nRumors are flying around that one of the new vehicles to be released during Nio Day is the ET5, a mid-sized sedan. The ET5 will reportedly compete with the BMW(OTCMKTS:BMWYY) 3-series and the Audi A4 at a lower price (Audi is owned by Volkswagen(OTCMKTS:VWAGY)).\nThe ET5 will likely be priced below the ET7, which has a base cost of around $69,000.\nAccording to a research note from Deutsche Bank, the second mystery EV is expected to be similar to the Toyota(NYSE:TM) Alphard, a luxury multi-purpose vehicle (MPV) that “sold 20,000 units in China last year.” Deutsche’s second guess is a high-performance sports coupe.\nNio recently filed a trademark registration for the name EF9, according to Electric Vehicle Web. This has led many to speculate that the new vehicle will be a convertible version of the EP9.\nCEO William Li confirmed that Nio plans on adding three new models to the Nio Technology Platform 2.0 in 2022. One of the models will be the new ET7 sedan. The other two are still unknown.\nFans of NIO stock are also waiting for an update on overseas delivery times and availability, especially in European countries. The company will likely answer this question at Nio Day.\nLi confirmed during a Q2 conference call that Nio had assembled a team to work on a new vehicle brand. In regards to the possible new vehicle brand, Li commented, “The relationship between Nio and our new mass-market brand will be like that of Audi-Volkswagen and Lexus-Toyota.”","news_type":1},"isVote":1,"tweetType":1,"viewCount":196,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"hots":[{"id":690090549,"gmtCreate":1639611551274,"gmtModify":1639611551369,"author":{"id":"4094269572113460","authorId":"4094269572113460","name":"Ytyt","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"Pls like","listText":"Pls like","text":"Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":4,"repostSize":0,"link":"https://laohu8.com/post/690090549","repostId":"2191997591","repostType":4,"isVote":1,"tweetType":1,"viewCount":242,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":878664620,"gmtCreate":1637191026384,"gmtModify":1637191026384,"author":{"id":"4094269572113460","authorId":"4094269572113460","name":"Ytyt","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"Pls like","listText":"Pls like","text":"Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":5,"repostSize":0,"link":"https://laohu8.com/post/878664620","repostId":"2184764854","repostType":2,"repost":{"id":"2184764854","pubTimestamp":1637190508,"share":"https://www.laohu8.com/m/news/2184764854?lang=&edition=full","pubTime":"2021-11-18 07:08","market":"us","language":"en","title":"Nvidia forecasts upbeat revenue on metaverse hopes","url":"https://stock-news.laohu8.com/highlight/detail?id=2184764854","media":"CNA","summary":"Nvidia Corp forecast fourth-quarter revenue above analysts' expectations on Wednesday, betting on growth in its data center business as more internet companies set out to invest in artificial intelligence and metaverse.The online realm that uses augmented and virtual reality to help users interact has captured more attention after Facebook, now renamed Meta, said it would boost capital expenditure and shift focus from its social media business.The move will be a big boost for Nvidia, the world's","content":"<p>Nvidia Corp forecast fourth-quarter revenue above analysts' expectations on Wednesday, betting on growth in its data center business as more internet companies set out to invest in artificial intelligence and metaverse.</p>\n<p>The online realm that uses augmented and virtual reality to help users interact has captured more attention after Facebook, now renamed Meta, said it would boost capital expenditure and shift focus from its social media business.</p>\n<p>The move will be a big boost for Nvidia, the world's biggest maker of graphics and AI chips, as metaverse applications would need more computing power and drive demand for chips.</p>\n<p>The company last month released Omniverse Enterprise, which will start at US$9,000 per year, to build powerful computing systems with its chips for corporate customers.</p>\n<p>\"We showed what is possible when we can jump into virtual worlds. ... This is the tip of the iceberg of what's to come,\" Nvidia's chief executive, Jensen Huang, said in a statement on Wednesday.</p>\n<p>Nvidia expects current-quarter revenue of US$7.40 billion, plus or minus 2per cent, above analysts' average estimate of US$6.86 billion, according to IBES data from Refinitiv.</p>\n<p>The company's shares were up nearly 5%&nbsp;in extended trading, after more than doubling this year.</p>\n<p><img src=\"https://static.tigerbbs.com/fabaeec8e31b15f4f1e88a4eec7fa9a0\" tg-width=\"872\" tg-height=\"595\" width=\"100%\" height=\"auto\"></p>\n<p>The company has so far avoided major supply chain problems despite a global chip crunch, but supply chain costs are rising. It said Wednesday that outstanding inventory purchase and long-term supply obligations were US$6.90 billion, up from US$2.57 billion a year earlier and up from US$4.79 billion in the prior quarter.</p>\n<p>A day after British regulators said 6 they were launching an in-depth probe of Nvidia's proposed acquisition of chip technology supplier Arm Ltd, Nvidia disclosed the deal was also under scrutiny in the United States.</p>\n<p>\"Regulators at the US Federal Trade Commission (FTC) have expressed concerns regarding the transaction, and we are engaged in discussions with the FTC regarding remedies to address those concerns,\" Nvidia said in a statement.</p>\n<p>For the reported third quarter, revenue in Nvidia's gaming unit rose 42per cent to US$3.22 billion and data centers surged 55per cent to US$2.94 billion.</p>\n<p>Analysts had expected US$3.13 billion and US$2.75 billion for gaming and data centers, respectively, according to FactSet.</p>\n<p>Overall, revenue rose about 50per cent to US$7.10 billion for the three months ended Oct. 31, above the average estimate of US$6.83 billion, according to IBES data from Refinitiv.</p>","source":"can_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Nvidia forecasts upbeat revenue on metaverse hopes</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNvidia forecasts upbeat revenue on metaverse hopes\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-18 07:08 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.channelnewsasia.com/business/nvidia-forecasts-upbeat-revenue-metaverse-hopes-2321256><strong>CNA</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Nvidia Corp forecast fourth-quarter revenue above analysts' expectations on Wednesday, betting on growth in its data center business as more internet companies set out to invest in artificial ...</p>\n\n<a href=\"https://www.channelnewsasia.com/business/nvidia-forecasts-upbeat-revenue-metaverse-hopes-2321256\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVDA":"英伟达"},"source_url":"https://www.channelnewsasia.com/business/nvidia-forecasts-upbeat-revenue-metaverse-hopes-2321256","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2184764854","content_text":"Nvidia Corp forecast fourth-quarter revenue above analysts' expectations on Wednesday, betting on growth in its data center business as more internet companies set out to invest in artificial intelligence and metaverse.\nThe online realm that uses augmented and virtual reality to help users interact has captured more attention after Facebook, now renamed Meta, said it would boost capital expenditure and shift focus from its social media business.\nThe move will be a big boost for Nvidia, the world's biggest maker of graphics and AI chips, as metaverse applications would need more computing power and drive demand for chips.\nThe company last month released Omniverse Enterprise, which will start at US$9,000 per year, to build powerful computing systems with its chips for corporate customers.\n\"We showed what is possible when we can jump into virtual worlds. ... This is the tip of the iceberg of what's to come,\" Nvidia's chief executive, Jensen Huang, said in a statement on Wednesday.\nNvidia expects current-quarter revenue of US$7.40 billion, plus or minus 2per cent, above analysts' average estimate of US$6.86 billion, according to IBES data from Refinitiv.\nThe company's shares were up nearly 5% in extended trading, after more than doubling this year.\n\nThe company has so far avoided major supply chain problems despite a global chip crunch, but supply chain costs are rising. It said Wednesday that outstanding inventory purchase and long-term supply obligations were US$6.90 billion, up from US$2.57 billion a year earlier and up from US$4.79 billion in the prior quarter.\nA day after British regulators said 6 they were launching an in-depth probe of Nvidia's proposed acquisition of chip technology supplier Arm Ltd, Nvidia disclosed the deal was also under scrutiny in the United States.\n\"Regulators at the US Federal Trade Commission (FTC) have expressed concerns regarding the transaction, and we are engaged in discussions with the FTC regarding remedies to address those concerns,\" Nvidia said in a statement.\nFor the reported third quarter, revenue in Nvidia's gaming unit rose 42per cent to US$3.22 billion and data centers surged 55per cent to US$2.94 billion.\nAnalysts had expected US$3.13 billion and US$2.75 billion for gaming and data centers, respectively, according to FactSet.\nOverall, revenue rose about 50per cent to US$7.10 billion for the three months ended Oct. 31, above the average estimate of US$6.83 billion, according to IBES data from Refinitiv.","news_type":1},"isVote":1,"tweetType":1,"viewCount":75,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":871487502,"gmtCreate":1637106173994,"gmtModify":1637106174132,"author":{"id":"4094269572113460","authorId":"4094269572113460","name":"Ytyt","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"Pls like","listText":"Pls like","text":"Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":4,"repostSize":0,"link":"https://laohu8.com/post/871487502","repostId":"2184881094","repostType":4,"repost":{"id":"2184881094","pubTimestamp":1637103539,"share":"https://www.laohu8.com/m/news/2184881094?lang=&edition=full","pubTime":"2021-11-17 06:58","market":"us","language":"en","title":"Retail boost helps lift S&P 500","url":"https://stock-news.laohu8.com/highlight/detail?id=2184881094","media":"Reuters","summary":"(Reuters) - U.S. stocks closed higher on Tuesday as earnings from Home Depot and retail sales data s","content":"<p>(Reuters) - U.S. stocks closed higher on Tuesday as earnings from Home Depot and retail sales data signaled solid consumer health and eased worries about a Federal Reserve that may have to become more aggressive in the face of rising inflation.</p>\n<p>Data showed retail sales jumped 1.7% in October, the largest gain since March and above the 1.4% estimate, indicating Americans have begun holiday shopping early in an effort to avoid a shortage of goods amid stretched supply chains.</p>\n<p>Retailer Home Depot Inc jumped 5.73% to close at a record high and had its biggest <a href=\"https://laohu8.com/S/AONE.U\">one</a>-day percentage gain since April 2020 after beating quarterly sales estimates by nearly $2 billion and handily topping the earnings per share view.</p>\n<p>\"This does give people a sigh of relief that the retail outlook is still pretty rosy,\" said Brian Jacobsen, senior investment strategist at Allspring Global Investments in Menomonee Falls, Wisconsin.</p>\n<p>\"The outlook is one where prices are rising but consumer spending is still strong and it looks like the supply chains are stressed but still we’re able to get goods on the shelves.\"</p>\n<p>The Dow Jones Industrial Average rose 54.77 points, or 0.15%, to 36,142.22, the S&amp;P 500 gained 18.1 points, or 0.39%, to 4,700.9 and the Nasdaq Composite added 120.01 points, or 0.76%, to 15,973.86.</p>\n<p>The S&amp;P consumer discretionary sector climbed 1.38% and was the best-performing of the 11 major S&amp;P sectors while the S&amp;P 500 retailing index rose 1.24% to close at a record high for a second straight session.</p>\n<p>Walmart Inc, the country's largest brick-and-mortar retailer, raised its annual sales and profit forecasts. Its shares gave up early gains, however, and fell 2.55%, their biggest daily percentage decline since May, as supply-chain woes dented margins and weighed on the consumer staples sector.</p>\n<p>Retailers Target Corp, Macy's Inc and Kohl's Corp are set to report earnings this week.</p>\n<p>Other data on the day showed U.S. manufacturing output surged to a two-and-a-half-year high in October.</p>\n<p>The positive data helped investors look past comments from St. Louis Federal Reserve President James Bullard, who called for a more hawkish stance by the central bank in response to rising inflation.</p>\n<p>In contrast, San Francisco Federal Reserve Bank President Mary Daly on Tuesday called for central bank patience in the face of high inflation which, she predicted, will likely fade on its own as the pandemic recedes.</p>\n<p>Investors have also been eyeing the possibility that President Joe Biden may pick a new head of the Federal Reserve as Chair Jerome Powell's term is set to end in February 2022, with Biden saying on Tuesday afternoon he will make a final decision in about four days.</p>\n<p>Technology shares also moved higher, up 1.07%, lifted in part by a 7.89% gain in chipmaker Qualcomm Inc , which rose after it said German automaker BMW will use its chips in its next generation of driver-assistance and self-driving systems.</p>\n<p>Electric-car maker Tesla Inc posted its first advance in four sessions, even as CEO Elon Musk sold $930 million in shares. The stock had tumbled more than 15% last week after Musk began selling shares.</p>\n<p>JPMorgan Chase &amp; Co also sued Tesla for $162.2 million over a breach of contract related to stock warrants.</p>\n<p>Declining issues outnumbered advancing ones on the NYSE by a 1.22-to-1 ratio; on Nasdaq, a 1.14-to-1 ratio favored decliners.</p>\n<p>The S&amp;P 500 posted 80 new 52-week highs and 3 new lows; the Nasdaq Composite recorded 152 new highs and 189 new lows.</p>\n<p>Volume on U.S. exchanges was 10.53 billion shares, compared with the 11.02 billion average for the full session over the last 20 trading days.</p>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Retail boost helps lift S&P 500</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nRetail boost helps lift S&P 500\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-17 06:58 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/us-stocks-retail-boost-helps-212530164.html><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>(Reuters) - U.S. stocks closed higher on Tuesday as earnings from Home Depot and retail sales data signaled solid consumer health and eased worries about a Federal Reserve that may have to become more...</p>\n\n<a href=\"https://finance.yahoo.com/news/us-stocks-retail-boost-helps-212530164.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"IVV":"标普500指数ETF","SH":"标普500反向ETF","SPXU":"三倍做空标普500ETF","TSLA":"特斯拉","OEX":"标普100","SPY":"标普500ETF","SSO":"两倍做多标普500ETF","WMT":"沃尔玛","UPRO":"三倍做多标普500ETF","OEF":"标普100指数ETF-iShares",".SPX":"S&P 500 Index","HD":"家得宝","SDS":"两倍做空标普500ETF"},"source_url":"https://finance.yahoo.com/news/us-stocks-retail-boost-helps-212530164.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2184881094","content_text":"(Reuters) - U.S. stocks closed higher on Tuesday as earnings from Home Depot and retail sales data signaled solid consumer health and eased worries about a Federal Reserve that may have to become more aggressive in the face of rising inflation.\nData showed retail sales jumped 1.7% in October, the largest gain since March and above the 1.4% estimate, indicating Americans have begun holiday shopping early in an effort to avoid a shortage of goods amid stretched supply chains.\nRetailer Home Depot Inc jumped 5.73% to close at a record high and had its biggest one-day percentage gain since April 2020 after beating quarterly sales estimates by nearly $2 billion and handily topping the earnings per share view.\n\"This does give people a sigh of relief that the retail outlook is still pretty rosy,\" said Brian Jacobsen, senior investment strategist at Allspring Global Investments in Menomonee Falls, Wisconsin.\n\"The outlook is one where prices are rising but consumer spending is still strong and it looks like the supply chains are stressed but still we’re able to get goods on the shelves.\"\nThe Dow Jones Industrial Average rose 54.77 points, or 0.15%, to 36,142.22, the S&P 500 gained 18.1 points, or 0.39%, to 4,700.9 and the Nasdaq Composite added 120.01 points, or 0.76%, to 15,973.86.\nThe S&P consumer discretionary sector climbed 1.38% and was the best-performing of the 11 major S&P sectors while the S&P 500 retailing index rose 1.24% to close at a record high for a second straight session.\nWalmart Inc, the country's largest brick-and-mortar retailer, raised its annual sales and profit forecasts. Its shares gave up early gains, however, and fell 2.55%, their biggest daily percentage decline since May, as supply-chain woes dented margins and weighed on the consumer staples sector.\nRetailers Target Corp, Macy's Inc and Kohl's Corp are set to report earnings this week.\nOther data on the day showed U.S. manufacturing output surged to a two-and-a-half-year high in October.\nThe positive data helped investors look past comments from St. Louis Federal Reserve President James Bullard, who called for a more hawkish stance by the central bank in response to rising inflation.\nIn contrast, San Francisco Federal Reserve Bank President Mary Daly on Tuesday called for central bank patience in the face of high inflation which, she predicted, will likely fade on its own as the pandemic recedes.\nInvestors have also been eyeing the possibility that President Joe Biden may pick a new head of the Federal Reserve as Chair Jerome Powell's term is set to end in February 2022, with Biden saying on Tuesday afternoon he will make a final decision in about four days.\nTechnology shares also moved higher, up 1.07%, lifted in part by a 7.89% gain in chipmaker Qualcomm Inc , which rose after it said German automaker BMW will use its chips in its next generation of driver-assistance and self-driving systems.\nElectric-car maker Tesla Inc posted its first advance in four sessions, even as CEO Elon Musk sold $930 million in shares. The stock had tumbled more than 15% last week after Musk began selling shares.\nJPMorgan Chase & Co also sued Tesla for $162.2 million over a breach of contract related to stock warrants.\nDeclining issues outnumbered advancing ones on the NYSE by a 1.22-to-1 ratio; on Nasdaq, a 1.14-to-1 ratio favored decliners.\nThe S&P 500 posted 80 new 52-week highs and 3 new lows; the Nasdaq Composite recorded 152 new highs and 189 new lows.\nVolume on U.S. exchanges was 10.53 billion shares, compared with the 11.02 billion average for the full session over the last 20 trading days.","news_type":1},"isVote":1,"tweetType":1,"viewCount":23,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":868067397,"gmtCreate":1632555000819,"gmtModify":1632657957683,"author":{"id":"4094269572113460","authorId":"4094269572113460","name":"Ytyt","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"Pls like&nbsp;","listText":"Pls like&nbsp;","text":"Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":5,"repostSize":0,"link":"https://laohu8.com/post/868067397","repostId":"1188909032","repostType":4,"repost":{"id":"1188909032","pubTimestamp":1632531451,"share":"https://www.laohu8.com/m/news/1188909032?lang=&edition=full","pubTime":"2021-09-25 08:57","market":"us","language":"en","title":"5 Top Consumer Stocks To Watch Ahead Of October 2021","url":"https://stock-news.laohu8.com/highlight/detail?id=1188909032","media":"Nasdaq","summary":"Do You Have These Top Consumer Stocks On Your Radar Now?\nThe past trading week has been exciting, to","content":"<p>Do You Have These Top Consumer Stocks On Your Radar Now?</p>\n<p>The past trading week has been exciting, to say the least. Despite all of the ups and downs,consumer stockscontinue to make waves in thestock market today. If anything, the consumer-focused industry continues to hold strong now. This is evident as August’s retail sales figures smashed expectations, rising by 0.7% versus an estimated drop of 0.8%. Moreover, the current broad-based rebound in thestock marketcould indicate that investors’ sentiment on the economy is improving.</p>\n<p>Evidently, we could look at the likes of<b>Roku</b>(NASDAQ: ROKU) right now. Just yesterday, Guggenheim analyst Michael Morris provided a positive update on the stock. Namely, Morris hit ROKU stock with a Buy rating and a price target of $395. Morris cites Roku’s aggressive expansion of its original content and penetration of international markets as core reasons for the upgrade.</p>\n<p>At the same time, there is some interesting movement going on with<b>Nike’s</b>(NYSE: NKE) shares as well. Yesterday, the company posted its first-quarter earnings after the closing bell. In short, Nike reported an earnings per share of $1.16 on revenue of $12.25 billion for the quarter. This is against estimates of $1.11 and $12.46 billion. Investors appear to be focusing on Nike’s revenue miss which is mostly due to temporary supply chain pressures. Regardless, as one of the biggest names in the sports apparel industry globally, some could see opportunity in NKE stocks’ current weakness. With all this activity in the space now, could one of these consumer stocks be worth investing in?</p>\n<p>Best Consumer Stocks To Buy [Or Sell] Today</p>\n<ul>\n <li><b>Beyond Meat Inc.</b>(NASDAQ: BYND)</li>\n <li><b>Trip.com Group Ltd.</b>(NASDAQ: TCOM)</li>\n <li><b>Vail Resorts Inc.</b>(NYSE: MTN)</li>\n <li><b>Costco Wholesale Corporation</b>(NASDAQ: COST)</li>\n <li><b>Stitch Fix Inc.</b>(NASDAQ: SFIX)</li>\n</ul>\n<p>Beyond Meat Inc.</p>\n<p><b>Beyond Meat</b>is a plant-based meat substitutes retailer with headquarters in California. The company offers plant-based options in the beef, poultry, and pork categories. In fact, it is one of the fastest-growing food companies in the U.S. as more people are increasingly alternating to plant-based options. Its products are designed to have the same taste and texture as animal-based meat while being the better option for the environment. BYND stock has almost doubled in valuation since its pandemic era low.</p>\n<p>In August, the company reported its second-quarter financials. Diving in, net revenue for the quarter was $149.4 million, increasing by 31.8% year-over-year. Furthermore, gross profit for the quarter was $47.4 million. The company saw record net revenues and also continues to return to growth in the foodservice industry as its customers welcome consumers back to their venues. Not resting on its laurels, the company also continues to make substantial investments in its long-term growth in the U.S. and abroad. Given all of this, will you consider investing in BYND stock right now?</p>\n<p><img src=\"https://static.tigerbbs.com/875119289e70dc28e620fb5eeb2d291b\" tg-width=\"759\" tg-height=\"468\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\">Source: TD Ameritrade TOS</p>\n<p><b>[Read More]</b>&nbsp;What Stocks To Buy Today? 5 Tech Stocks To Watch</p>\n<p>Trip.com Group Ltd</p>\n<p>Following that, we have multinational online travel company<b>Trip.com</b>, a leading one-stop travel platform globally. It integrates a comprehensive suite of travel products and services and differentiated travel content. It is the go-to destination for travelers in China and around the world. Impressively, it is currently one of the largest online travel agencies in China and also one of the largest travel service providers in the world.</p>\n<p>After yesterday’s closing bell, Trip.com posted solid figures in its second fiscal quarter earnings report. In it, the company saw a total revenue of $912 million for the quarter. This marks a significant year-over-year jump of 86%. In terms of net income, the company saw a 43% increase over the same period. CEO Jane Sun cites Trip.com’s focus on the domestic market as a core contributor to this solid quarter for the company. Overall, given this piece of news, will you consider adding TCOM stock to your portfolio right now?</p>\n<p><img src=\"https://static.tigerbbs.com/781e08ea2e30a4f9c94020727b3e77bc\" tg-width=\"759\" tg-height=\"468\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\">Source: TD Ameritrade TOSVail Resorts Inc.</p>\n<p><b>Vail Resorts</b>is a leading global mountain resort operator. The company and its subsidiaries operate 37 destination mountain resorts and regional ski areas. In essence, it owns and/or manages a collection of casually elegant hotels under the RockResorts brand. It also has a development company that is in the real estate planning and development business. MTN stock is up by over 40% in the past year alone.</p>\n<p>Recently, KeyBanc Capital Markets upgraded Vail Resorts to an Overweight rating from Sector Weight and hit it with a price target of $355. Analyst Brett Andreas says that demand for skiing vacations was exceeding expectations with some bookings already at record levels. Not to mention, the company continues to gain momentum on the financial front. In its fourth fiscal quarterearnings call, Vail reported a net income of $127.9 million, marking a sizable 29.4% year-over-year increase. After considering that pandemic-related factors still weigh on its key operations, the company’s fundamentals are admirable. Moreover, the company also declared a cash dividend of $0.88 per share, to investors’ delight. All things considered, will you buy MTN stock?</p>\n<p><img src=\"https://static.tigerbbs.com/c596fd2c2dc3ef4d15e9c9dfa89b8147\" tg-width=\"759\" tg-height=\"468\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\">Source: TD Ameritrade TOS</p>\n<p><b>[Read More]</b>&nbsp;4 Semiconductor Stocks To Watch Right Now</p>\n<p>Costco Wholesale Corporation</p>\n<p>Next up, we will be taking a look at<b>Costco</b>. For the most part, the multinational consumer staples giant would be another player to consider in thestock market today. The main factor differentiating Costco from its retail competitors would be its membership-only big-box operations. Simply put, the company only caters to members and sells daily necessities in bulk. Amidst the ongoing pandemic and climate crises, Costco’s offerings could see greater demand from consumers.</p>\n<p>By and large, with COST stock sitting on year-to-date gains of over 19%, could it be worth investing in? Well, for one thing, the company beat Wall Streets’ projections across the board in its latest quarterly earnings report. In detail, Costco posted an earnings per share of $3.76 on revenue of $62.7 billion for the quarter. For some perspective, consensus estimates suggest an earnings per share of $3.59 on revenue of $61.6 billion. All in all, would you consider adding COST stock to your portfolio?</p>\n<p><img src=\"https://static.tigerbbs.com/0412ae414ccd0df0d5f93302bd037b56\" tg-width=\"759\" tg-height=\"468\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\">Source: TD Ameritrade TOS</p>\n<p><b>[Read More]</b>&nbsp;Top Stocks To Buy Now? 4 Renewable Energy Stocks For Your Watchlist</p>\n<p>Stitch Fix Inc.</p>\n<p>Another name to know in the consumer stock space now would be<b>Stitch Fix</b>. In brief, it is an online personal styling service. Through a combination of artificial intelligence and data science, Stitch Fix provides customers with personalized e-commerce experiences. Given the prevalence of online shopping throughout the pandemic, SFIX stock could be in focus among investors. In fact, the company’s shares are up by over 15% just this week on account of its solid earnings report.</p>\n<p>Notably, Stitch Fix raked in a total revenue of $571.16 million for the quarter, marking a 28% year-over-year increase. Additionally, the company also reported massive year-over-year spikes of over 145% in both its net income and earnings per share. Despite beating analyst estimates on these fronts, Stitch Fix does not seem to be slowing down anytime soon. This appears to be the case as the company is expanding its services with Stitch Fix Freestyle, a “differentiated shopping experience”. This would give customers a more instant and flexible means of shopping on its platform. As such, could SFIX stock be a top pick in the stock market now?</p>","source":"lsy1603171495471","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>5 Top Consumer Stocks To Watch Ahead Of October 2021</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n5 Top Consumer Stocks To Watch Ahead Of October 2021\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-25 08:57 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.nasdaq.com/articles/5-top-consumer-stocks-to-watch-ahead-of-october-2021-2021-09-24><strong>Nasdaq</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Do You Have These Top Consumer Stocks On Your Radar Now?\nThe past trading week has been exciting, to say the least. Despite all of the ups and downs,consumer stockscontinue to make waves in thestock ...</p>\n\n<a href=\"https://www.nasdaq.com/articles/5-top-consumer-stocks-to-watch-ahead-of-october-2021-2021-09-24\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NKE":"耐克","COST":"好市多","SFIX":"Stitch Fix Inc.","ROKU":"Roku Inc","BYND":"Beyond Meat, Inc.","TCOM":"携程网"},"source_url":"https://www.nasdaq.com/articles/5-top-consumer-stocks-to-watch-ahead-of-october-2021-2021-09-24","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1188909032","content_text":"Do You Have These Top Consumer Stocks On Your Radar Now?\nThe past trading week has been exciting, to say the least. Despite all of the ups and downs,consumer stockscontinue to make waves in thestock market today. If anything, the consumer-focused industry continues to hold strong now. This is evident as August’s retail sales figures smashed expectations, rising by 0.7% versus an estimated drop of 0.8%. Moreover, the current broad-based rebound in thestock marketcould indicate that investors’ sentiment on the economy is improving.\nEvidently, we could look at the likes ofRoku(NASDAQ: ROKU) right now. Just yesterday, Guggenheim analyst Michael Morris provided a positive update on the stock. Namely, Morris hit ROKU stock with a Buy rating and a price target of $395. Morris cites Roku’s aggressive expansion of its original content and penetration of international markets as core reasons for the upgrade.\nAt the same time, there is some interesting movement going on withNike’s(NYSE: NKE) shares as well. Yesterday, the company posted its first-quarter earnings after the closing bell. In short, Nike reported an earnings per share of $1.16 on revenue of $12.25 billion for the quarter. This is against estimates of $1.11 and $12.46 billion. Investors appear to be focusing on Nike’s revenue miss which is mostly due to temporary supply chain pressures. Regardless, as one of the biggest names in the sports apparel industry globally, some could see opportunity in NKE stocks’ current weakness. With all this activity in the space now, could one of these consumer stocks be worth investing in?\nBest Consumer Stocks To Buy [Or Sell] Today\n\nBeyond Meat Inc.(NASDAQ: BYND)\nTrip.com Group Ltd.(NASDAQ: TCOM)\nVail Resorts Inc.(NYSE: MTN)\nCostco Wholesale Corporation(NASDAQ: COST)\nStitch Fix Inc.(NASDAQ: SFIX)\n\nBeyond Meat Inc.\nBeyond Meatis a plant-based meat substitutes retailer with headquarters in California. The company offers plant-based options in the beef, poultry, and pork categories. In fact, it is one of the fastest-growing food companies in the U.S. as more people are increasingly alternating to plant-based options. Its products are designed to have the same taste and texture as animal-based meat while being the better option for the environment. BYND stock has almost doubled in valuation since its pandemic era low.\nIn August, the company reported its second-quarter financials. Diving in, net revenue for the quarter was $149.4 million, increasing by 31.8% year-over-year. Furthermore, gross profit for the quarter was $47.4 million. The company saw record net revenues and also continues to return to growth in the foodservice industry as its customers welcome consumers back to their venues. Not resting on its laurels, the company also continues to make substantial investments in its long-term growth in the U.S. and abroad. Given all of this, will you consider investing in BYND stock right now?\nSource: TD Ameritrade TOS\n[Read More] What Stocks To Buy Today? 5 Tech Stocks To Watch\nTrip.com Group Ltd\nFollowing that, we have multinational online travel companyTrip.com, a leading one-stop travel platform globally. It integrates a comprehensive suite of travel products and services and differentiated travel content. It is the go-to destination for travelers in China and around the world. Impressively, it is currently one of the largest online travel agencies in China and also one of the largest travel service providers in the world.\nAfter yesterday’s closing bell, Trip.com posted solid figures in its second fiscal quarter earnings report. In it, the company saw a total revenue of $912 million for the quarter. This marks a significant year-over-year jump of 86%. In terms of net income, the company saw a 43% increase over the same period. CEO Jane Sun cites Trip.com’s focus on the domestic market as a core contributor to this solid quarter for the company. Overall, given this piece of news, will you consider adding TCOM stock to your portfolio right now?\nSource: TD Ameritrade TOSVail Resorts Inc.\nVail Resortsis a leading global mountain resort operator. The company and its subsidiaries operate 37 destination mountain resorts and regional ski areas. In essence, it owns and/or manages a collection of casually elegant hotels under the RockResorts brand. It also has a development company that is in the real estate planning and development business. MTN stock is up by over 40% in the past year alone.\nRecently, KeyBanc Capital Markets upgraded Vail Resorts to an Overweight rating from Sector Weight and hit it with a price target of $355. Analyst Brett Andreas says that demand for skiing vacations was exceeding expectations with some bookings already at record levels. Not to mention, the company continues to gain momentum on the financial front. In its fourth fiscal quarterearnings call, Vail reported a net income of $127.9 million, marking a sizable 29.4% year-over-year increase. After considering that pandemic-related factors still weigh on its key operations, the company’s fundamentals are admirable. Moreover, the company also declared a cash dividend of $0.88 per share, to investors’ delight. All things considered, will you buy MTN stock?\nSource: TD Ameritrade TOS\n[Read More] 4 Semiconductor Stocks To Watch Right Now\nCostco Wholesale Corporation\nNext up, we will be taking a look atCostco. For the most part, the multinational consumer staples giant would be another player to consider in thestock market today. The main factor differentiating Costco from its retail competitors would be its membership-only big-box operations. Simply put, the company only caters to members and sells daily necessities in bulk. Amidst the ongoing pandemic and climate crises, Costco’s offerings could see greater demand from consumers.\nBy and large, with COST stock sitting on year-to-date gains of over 19%, could it be worth investing in? Well, for one thing, the company beat Wall Streets’ projections across the board in its latest quarterly earnings report. In detail, Costco posted an earnings per share of $3.76 on revenue of $62.7 billion for the quarter. For some perspective, consensus estimates suggest an earnings per share of $3.59 on revenue of $61.6 billion. All in all, would you consider adding COST stock to your portfolio?\nSource: TD Ameritrade TOS\n[Read More] Top Stocks To Buy Now? 4 Renewable Energy Stocks For Your Watchlist\nStitch Fix Inc.\nAnother name to know in the consumer stock space now would beStitch Fix. In brief, it is an online personal styling service. Through a combination of artificial intelligence and data science, Stitch Fix provides customers with personalized e-commerce experiences. Given the prevalence of online shopping throughout the pandemic, SFIX stock could be in focus among investors. In fact, the company’s shares are up by over 15% just this week on account of its solid earnings report.\nNotably, Stitch Fix raked in a total revenue of $571.16 million for the quarter, marking a 28% year-over-year increase. Additionally, the company also reported massive year-over-year spikes of over 145% in both its net income and earnings per share. Despite beating analyst estimates on these fronts, Stitch Fix does not seem to be slowing down anytime soon. This appears to be the case as the company is expanding its services with Stitch Fix Freestyle, a “differentiated shopping experience”. This would give customers a more instant and flexible means of shopping on its platform. As such, could SFIX stock be a top pick in the stock market now?","news_type":1},"isVote":1,"tweetType":1,"viewCount":99,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":696664524,"gmtCreate":1640685161869,"gmtModify":1640685637729,"author":{"id":"4094269572113460","authorId":"4094269572113460","name":"Ytyt","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"Pls like","listText":"Pls like","text":"Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/696664524","repostId":"1138246031","repostType":4,"isVote":1,"tweetType":1,"viewCount":535,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":691954726,"gmtCreate":1640130161579,"gmtModify":1640130161850,"author":{"id":"4094269572113460","authorId":"4094269572113460","name":"Ytyt","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"Pls like","listText":"Pls like","text":"Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/691954726","repostId":"2193663561","repostType":4,"repost":{"id":"2193663561","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1640125936,"share":"https://www.laohu8.com/m/news/2193663561?lang=&edition=full","pubTime":"2021-12-22 06:32","market":"us","language":"en","title":"Wall Street closes up strongly with boost from Nike, Micron, following Omicron slide","url":"https://stock-news.laohu8.com/highlight/detail?id=2193663561","media":"Reuters","summary":"Dec 21  - Wall Street's main indexes ended sharply higher on Tuesday, with strength in travel and tech shares as well as in Nike and Micron Technology following their earnings, as stocks rebounded from a coronavirus-fueled rout the session before.The rapidly spreading Omicron variant of the coronavirus has rattled stock markets around the world, triggering volatility in the final month of 2021, which has otherwise been a strong year for equities.Gains in massive technology and tech-related stock","content":"<ul>\n <li>Energy, tech top-gaining S&amp;P 500 sectors</li>\n <li>Travel stocks surge broadly</li>\n <li>Nike up after beating quarterly estimates</li>\n <li>Micron rises as it sees chip shortages easing</li>\n <li>Indexes up: Dow 1.6%, S&amp;P 1.78%, Nasdaq 2.4%</li>\n</ul>\n<p>Dec 21 (Reuters) - Wall Street's main indexes ended sharply higher on Tuesday, with strength in travel and tech shares as well as in Nike and Micron Technology following their earnings, as stocks rebounded from a coronavirus-fueled rout the session before.</p>\n<p>The rapidly spreading Omicron variant of the coronavirus has rattled stock markets around the world, triggering volatility in the final month of 2021, which has otherwise been a strong year for equities.</p>\n<p>Gains in massive technology and tech-related stocks such as Microsoft&nbsp;and Amazon&nbsp;lifted indexes on Tuesday, as did increases in economically sensitive groups such as energy. Travel-related stocks surged, including Carnival Corp, Las Vegas Sands&nbsp;and <a href=\"https://laohu8.com/S/EXPE\">Expedia</a> Group.</p>\n<p>“It is clearly a risk-on day,\" said David Joy, chief market strategist at Ameriprise Financial in Boston. \"This is clearly, at least for the day, investors saying, 'You know what, we are going to be able to ride through this Omicron surge and come out the other side in pretty good shape.’”</p>\n<p>The Dow Jones Industrial Average&nbsp;rose 560.54 points, or 1.6%, to 35,492.7, the S&amp;P 500&nbsp;gained 81.21 points, or 1.78%, to 4,649.23 and the Nasdaq Composite&nbsp;added 360.14 points, or 2.4%, to 15,341.09.</p>\n<p>Defensive sectors, such as consumer staples&nbsp;and utilities&nbsp;that have led in December, lagged on Tuesday.</p>\n<p>Nike&nbsp;shares rose 6.1% after the sports apparel company's results beat quarterly estimates for profit and revenue, and it said it was more confident that supply chain issues would ease in its next fiscal year.</p>\n<p>Micron Technology&nbsp;shares jumped 10.5% after the chip company forecast second-quarter sales and profits will beat estimates with shortages easing in 2022. The Philadelphia SE Semiconductor index&nbsp;rose 3.4%.</p>\n<p>“If Micron’s forecast is strong, that tells us broadly speaking that demand is strong across many different industries,” said King Lip, chief strategist at Baker Avenue Asset Management, adding that Micron's products \"go into so many different industrial applications.\"</p>\n<p>General Mills&nbsp;shares fell 4% after the consumer staples company missed Wall Street estimates for quarterly profit.</p>\n<p>The benchmark S&amp;P 500 has gained 23.8% so far in 2021.</p>\n<p>Some investors are wary about a tougher environment for equities as the Federal Reserve is expected to start raising interest rates next year.</p>\n<p>\"It's good to see green going into the next year but if you just take a step back and look at the broader picture, you're seeing financial conditions change,\" said Joshua Chastant, senior investment analyst at GuideStone Capital Management.</p>\n<p>Advancing issues outnumbered declining ones on the NYSE by a 4.08-to-1 ratio; on Nasdaq, a 2.95-to-1 ratio favored advancers.</p>\n<p>The S&amp;P 500 posted 11 new 52-week highs and no new lows; the Nasdaq Composite recorded 27 new highs and 99 new lows.</p>\n<p>About 10.1 billion shares changed hands in U.S. exchanges, below the daily average of roughly 12 billion over the last 20 sessions.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Wall Street closes up strongly with boost from Nike, Micron, following Omicron slide</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWall Street closes up strongly with boost from Nike, Micron, following Omicron slide\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-12-22 06:32</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<ul>\n <li>Energy, tech top-gaining S&amp;P 500 sectors</li>\n <li>Travel stocks surge broadly</li>\n <li>Nike up after beating quarterly estimates</li>\n <li>Micron rises as it sees chip shortages easing</li>\n <li>Indexes up: Dow 1.6%, S&amp;P 1.78%, Nasdaq 2.4%</li>\n</ul>\n<p>Dec 21 (Reuters) - Wall Street's main indexes ended sharply higher on Tuesday, with strength in travel and tech shares as well as in Nike and Micron Technology following their earnings, as stocks rebounded from a coronavirus-fueled rout the session before.</p>\n<p>The rapidly spreading Omicron variant of the coronavirus has rattled stock markets around the world, triggering volatility in the final month of 2021, which has otherwise been a strong year for equities.</p>\n<p>Gains in massive technology and tech-related stocks such as Microsoft&nbsp;and Amazon&nbsp;lifted indexes on Tuesday, as did increases in economically sensitive groups such as energy. Travel-related stocks surged, including Carnival Corp, Las Vegas Sands&nbsp;and <a href=\"https://laohu8.com/S/EXPE\">Expedia</a> Group.</p>\n<p>“It is clearly a risk-on day,\" said David Joy, chief market strategist at Ameriprise Financial in Boston. \"This is clearly, at least for the day, investors saying, 'You know what, we are going to be able to ride through this Omicron surge and come out the other side in pretty good shape.’”</p>\n<p>The Dow Jones Industrial Average&nbsp;rose 560.54 points, or 1.6%, to 35,492.7, the S&amp;P 500&nbsp;gained 81.21 points, or 1.78%, to 4,649.23 and the Nasdaq Composite&nbsp;added 360.14 points, or 2.4%, to 15,341.09.</p>\n<p>Defensive sectors, such as consumer staples&nbsp;and utilities&nbsp;that have led in December, lagged on Tuesday.</p>\n<p>Nike&nbsp;shares rose 6.1% after the sports apparel company's results beat quarterly estimates for profit and revenue, and it said it was more confident that supply chain issues would ease in its next fiscal year.</p>\n<p>Micron Technology&nbsp;shares jumped 10.5% after the chip company forecast second-quarter sales and profits will beat estimates with shortages easing in 2022. The Philadelphia SE Semiconductor index&nbsp;rose 3.4%.</p>\n<p>“If Micron’s forecast is strong, that tells us broadly speaking that demand is strong across many different industries,” said King Lip, chief strategist at Baker Avenue Asset Management, adding that Micron's products \"go into so many different industrial applications.\"</p>\n<p>General Mills&nbsp;shares fell 4% after the consumer staples company missed Wall Street estimates for quarterly profit.</p>\n<p>The benchmark S&amp;P 500 has gained 23.8% so far in 2021.</p>\n<p>Some investors are wary about a tougher environment for equities as the Federal Reserve is expected to start raising interest rates next year.</p>\n<p>\"It's good to see green going into the next year but if you just take a step back and look at the broader picture, you're seeing financial conditions change,\" said Joshua Chastant, senior investment analyst at GuideStone Capital Management.</p>\n<p>Advancing issues outnumbered declining ones on the NYSE by a 4.08-to-1 ratio; on Nasdaq, a 2.95-to-1 ratio favored advancers.</p>\n<p>The S&amp;P 500 posted 11 new 52-week highs and no new lows; the Nasdaq Composite recorded 27 new highs and 99 new lows.</p>\n<p>About 10.1 billion shares changed hands in U.S. exchanges, below the daily average of roughly 12 billion over the last 20 sessions.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"SQQQ":"纳指三倍做空ETF","BK4534":"瑞士信贷持仓","BK4146":"鞋类","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4558":"双十一","BK4566":"资本集团","DDM":"道指两倍做多ETF","QID":"纳指两倍做空ETF","DJX":"1/100道琼斯","DOG":"道指反向ETF","UDOW":"道指三倍做多ETF-ProShares","NKE":"耐克","DXD":"道指两倍做空ETF","PSQ":"纳指反向ETF","BK4561":"索罗斯持仓","QLD":"纳指两倍做多ETF","QQQ":"纳指100ETF","MU":"美光科技","TQQQ":"纳指三倍做多ETF",".DJI":"道琼斯","SDOW":"道指三倍做空ETF-ProShares",".IXIC":"NASDAQ Composite",".SPX":"S&P 500 Index"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2193663561","content_text":"Energy, tech top-gaining S&P 500 sectors\nTravel stocks surge broadly\nNike up after beating quarterly estimates\nMicron rises as it sees chip shortages easing\nIndexes up: Dow 1.6%, S&P 1.78%, Nasdaq 2.4%\n\nDec 21 (Reuters) - Wall Street's main indexes ended sharply higher on Tuesday, with strength in travel and tech shares as well as in Nike and Micron Technology following their earnings, as stocks rebounded from a coronavirus-fueled rout the session before.\nThe rapidly spreading Omicron variant of the coronavirus has rattled stock markets around the world, triggering volatility in the final month of 2021, which has otherwise been a strong year for equities.\nGains in massive technology and tech-related stocks such as Microsoft and Amazon lifted indexes on Tuesday, as did increases in economically sensitive groups such as energy. Travel-related stocks surged, including Carnival Corp, Las Vegas Sands and Expedia Group.\n“It is clearly a risk-on day,\" said David Joy, chief market strategist at Ameriprise Financial in Boston. \"This is clearly, at least for the day, investors saying, 'You know what, we are going to be able to ride through this Omicron surge and come out the other side in pretty good shape.’”\nThe Dow Jones Industrial Average rose 560.54 points, or 1.6%, to 35,492.7, the S&P 500 gained 81.21 points, or 1.78%, to 4,649.23 and the Nasdaq Composite added 360.14 points, or 2.4%, to 15,341.09.\nDefensive sectors, such as consumer staples and utilities that have led in December, lagged on Tuesday.\nNike shares rose 6.1% after the sports apparel company's results beat quarterly estimates for profit and revenue, and it said it was more confident that supply chain issues would ease in its next fiscal year.\nMicron Technology shares jumped 10.5% after the chip company forecast second-quarter sales and profits will beat estimates with shortages easing in 2022. The Philadelphia SE Semiconductor index rose 3.4%.\n“If Micron’s forecast is strong, that tells us broadly speaking that demand is strong across many different industries,” said King Lip, chief strategist at Baker Avenue Asset Management, adding that Micron's products \"go into so many different industrial applications.\"\nGeneral Mills shares fell 4% after the consumer staples company missed Wall Street estimates for quarterly profit.\nThe benchmark S&P 500 has gained 23.8% so far in 2021.\nSome investors are wary about a tougher environment for equities as the Federal Reserve is expected to start raising interest rates next year.\n\"It's good to see green going into the next year but if you just take a step back and look at the broader picture, you're seeing financial conditions change,\" said Joshua Chastant, senior investment analyst at GuideStone Capital Management.\nAdvancing issues outnumbered declining ones on the NYSE by a 4.08-to-1 ratio; on Nasdaq, a 2.95-to-1 ratio favored advancers.\nThe S&P 500 posted 11 new 52-week highs and no new lows; the Nasdaq Composite recorded 27 new highs and 99 new lows.\nAbout 10.1 billion shares changed hands in U.S. exchanges, below the daily average of roughly 12 billion over the last 20 sessions.","news_type":1},"isVote":1,"tweetType":1,"viewCount":642,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":608303279,"gmtCreate":1638612247762,"gmtModify":1638612248146,"author":{"id":"4094269572113460","authorId":"4094269572113460","name":"Ytyt","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"Pls like","listText":"Pls like","text":"Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/608303279","repostId":"1140678193","repostType":4,"isVote":1,"tweetType":1,"viewCount":4,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":698432662,"gmtCreate":1640488189966,"gmtModify":1640488190120,"author":{"id":"4094269572113460","authorId":"4094269572113460","name":"Ytyt","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"Pls like","listText":"Pls like","text":"Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/698432662","repostId":"2193917872","repostType":4,"repost":{"id":"2193917872","pubTimestamp":1640398248,"share":"https://www.laohu8.com/m/news/2193917872?lang=&edition=full","pubTime":"2021-12-25 10:10","market":"us","language":"en","title":"3 Best Buffett Stocks to Buy for the Long Haul","url":"https://stock-news.laohu8.com/highlight/detail?id=2193917872","media":"Motley Fool","summary":"Each of these three big pharma stocks are featured in Berkshire Hathaway's massive portfolio.","content":"<p>Since Warren Buffett took full control of <b>Berkshire Hathaway</b> in 1965, it became a diversified holding company with investments in publicly traded companies totaling nearly $345 billion at the time of writing.</p>\n<p>The Oracle of Omaha's reputation of buying the highest quality businesses means that many individual investors could also benefit from adding these stocks to their portfolios. Here are three healthcare stocks that Buffett owns, which you may also want to consider buying and holding for the long run.</p>\n<h2>1. Johnson &amp; Johnson</h2>\n<p>The first pharma stock within Berkshire's portfolio to contemplate purchasing is <b>Johnson &amp; Johnson</b> (NYSE:JNJ). While the stock is one of Buffett's smallest holdings, valued at just under $55 million, this doesn't take away from its 59 consecutive years of dividend increases that make the stock a Dividend King.</p>\n<p>J&amp;J will be spinning off its slower-growing and less profitable consumer health segment in the next 18 to 24 months, which should allow the company to focus on its faster-growing, more profitable pharmaceutical segment.</p>\n<p>J&amp;J has a strong existing drug portfolio, which should be able to make up for the upcoming 2025 to 2026 patent expirations for its top-selling drug known, Stelara. Year to date, the immunology drug made up just 9.9% of J&amp;J's $69 billion in net sales.</p>\n<p>These drugs include the immunology blockbuster Tremfya, which received its first of three U.S. Food and Drug Administration (FDA) approvals to date in July 2017. Another drug that was recently approved by the FDA was the oncology blockbuster called Darzalex, which received its first of nine FDA approvals to date in November 2015. These two drugs have grown their year-to-date revenue at high-40% clips year over year and should remain under patent most of this decade.</p>\n<p>J&amp;J's enviable existing drug portfolio and its nearly four dozen indications in late-stage clinical trials explain why analysts anticipate that the stock will deliver 8% annual non-GAAP (adjusted) earnings per share (EPS) growth over the next five years.</p>\n<p>Income investors can scoop up J&amp;J's 2.5% dividend yield at a forward P/E ratio of just 16.2 times, which makes the steady healthcare stock a great buy for the long term.</p>\n<h2>2. Bristol Myers Squibb</h2>\n<p>Another Buffett stock that could be a great fit in your portfolio is <b>Bristol Myers Squibb</b> (NYSE:BMY). Berkshire's Bristol Myers Squibb stake totals nearly $1.4 billion, making it one of the largest healthcare holdings in Berkshire's portfolio.</p>\n<p>Bristol Myers Squibb's oncology blockbusters Revlimid and Opdivo and the anticoagulant blockbuster co-owned with <b>Pfizer</b> (NYSE:PFE) named Eliquis each face patent expirations later this decade. While looming patent expirations on three drugs that account for approximately two-thirds of your company's total revenue sounds frightening, this is nothing new; it's just the nature of Bristol Myers Squibb's industry.</p>\n<p>What matters most is that a company is proactive in developing and acquiring its next generation of blockbuster drugs to absorb key patent expirations. With more than 50 compounds in over 40 different disease areas currently in development at Bristol Myers Squibb, this is exactly what the company has been doing for years now.</p>\n<p>As a result, analysts are projecting that Bristol Myers Squibb will be able to generate 6% annual earnings growth through the next five years.</p>\n<p>Yield-hungry investors can buy Bristol Myers Squibb's market-crushing 3.5% yield at a ridiculously cheap forward P/E ratio of 7.9, which is what makes the stock a buy for those looking to hedge against inflation.</p>\n<h2>3. AbbVie</h2>\n<p>Finally, a Buffett stock that'd also be a good fit for income investors is <b>AbbVie</b> (NYSE:ABBV). Berkshire currently holds about $1.9 billion worth of AbbVie stock.</p>\n<p>It's well known at this point that the biopharmaceutical's top-selling drug in the world, Humira, will be facing intense biosimilar competition in the U.S. beginning in 2023. Even though the immunology drug's U.S. sales made up 31% of AbbVie's $41.24 billion total year-to-date sales, the company's pipeline should be able to stabilize and grow its net revenue beyond 2023.</p>\n<p>AbbVie has 54 compounds in various stages of clinical trials, which is why analysts are forecasting that the stock will grow its adjusted EPS 4.5% annually in the next five years.</p>\n<p>AbbVie's massive 4.4% dividend yield can be picked up at a forward P/E ratio of only 9.3.&nbsp;This is an attractive valuation for a stock with the ability to fight off inflation with healthy dividend hikes.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Best Buffett Stocks to Buy for the Long Haul</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Best Buffett Stocks to Buy for the Long Haul\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-25 10:10 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/12/24/3-best-buffett-stocks-to-buy-for-the-long-haul/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Since Warren Buffett took full control of Berkshire Hathaway in 1965, it became a diversified holding company with investments in publicly traded companies totaling nearly $345 billion at the time of ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/12/24/3-best-buffett-stocks-to-buy-for-the-long-haul/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ABBV":"艾伯维公司","BMY":"施贵宝","JNJ":"强生"},"source_url":"https://www.fool.com/investing/2021/12/24/3-best-buffett-stocks-to-buy-for-the-long-haul/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2193917872","content_text":"Since Warren Buffett took full control of Berkshire Hathaway in 1965, it became a diversified holding company with investments in publicly traded companies totaling nearly $345 billion at the time of writing.\nThe Oracle of Omaha's reputation of buying the highest quality businesses means that many individual investors could also benefit from adding these stocks to their portfolios. Here are three healthcare stocks that Buffett owns, which you may also want to consider buying and holding for the long run.\n1. Johnson & Johnson\nThe first pharma stock within Berkshire's portfolio to contemplate purchasing is Johnson & Johnson (NYSE:JNJ). While the stock is one of Buffett's smallest holdings, valued at just under $55 million, this doesn't take away from its 59 consecutive years of dividend increases that make the stock a Dividend King.\nJ&J will be spinning off its slower-growing and less profitable consumer health segment in the next 18 to 24 months, which should allow the company to focus on its faster-growing, more profitable pharmaceutical segment.\nJ&J has a strong existing drug portfolio, which should be able to make up for the upcoming 2025 to 2026 patent expirations for its top-selling drug known, Stelara. Year to date, the immunology drug made up just 9.9% of J&J's $69 billion in net sales.\nThese drugs include the immunology blockbuster Tremfya, which received its first of three U.S. Food and Drug Administration (FDA) approvals to date in July 2017. Another drug that was recently approved by the FDA was the oncology blockbuster called Darzalex, which received its first of nine FDA approvals to date in November 2015. These two drugs have grown their year-to-date revenue at high-40% clips year over year and should remain under patent most of this decade.\nJ&J's enviable existing drug portfolio and its nearly four dozen indications in late-stage clinical trials explain why analysts anticipate that the stock will deliver 8% annual non-GAAP (adjusted) earnings per share (EPS) growth over the next five years.\nIncome investors can scoop up J&J's 2.5% dividend yield at a forward P/E ratio of just 16.2 times, which makes the steady healthcare stock a great buy for the long term.\n2. Bristol Myers Squibb\nAnother Buffett stock that could be a great fit in your portfolio is Bristol Myers Squibb (NYSE:BMY). Berkshire's Bristol Myers Squibb stake totals nearly $1.4 billion, making it one of the largest healthcare holdings in Berkshire's portfolio.\nBristol Myers Squibb's oncology blockbusters Revlimid and Opdivo and the anticoagulant blockbuster co-owned with Pfizer (NYSE:PFE) named Eliquis each face patent expirations later this decade. While looming patent expirations on three drugs that account for approximately two-thirds of your company's total revenue sounds frightening, this is nothing new; it's just the nature of Bristol Myers Squibb's industry.\nWhat matters most is that a company is proactive in developing and acquiring its next generation of blockbuster drugs to absorb key patent expirations. With more than 50 compounds in over 40 different disease areas currently in development at Bristol Myers Squibb, this is exactly what the company has been doing for years now.\nAs a result, analysts are projecting that Bristol Myers Squibb will be able to generate 6% annual earnings growth through the next five years.\nYield-hungry investors can buy Bristol Myers Squibb's market-crushing 3.5% yield at a ridiculously cheap forward P/E ratio of 7.9, which is what makes the stock a buy for those looking to hedge against inflation.\n3. AbbVie\nFinally, a Buffett stock that'd also be a good fit for income investors is AbbVie (NYSE:ABBV). Berkshire currently holds about $1.9 billion worth of AbbVie stock.\nIt's well known at this point that the biopharmaceutical's top-selling drug in the world, Humira, will be facing intense biosimilar competition in the U.S. beginning in 2023. Even though the immunology drug's U.S. sales made up 31% of AbbVie's $41.24 billion total year-to-date sales, the company's pipeline should be able to stabilize and grow its net revenue beyond 2023.\nAbbVie has 54 compounds in various stages of clinical trials, which is why analysts are forecasting that the stock will grow its adjusted EPS 4.5% annually in the next five years.\nAbbVie's massive 4.4% dividend yield can be picked up at a forward P/E ratio of only 9.3. This is an attractive valuation for a stock with the ability to fight off inflation with healthy dividend hikes.","news_type":1},"isVote":1,"tweetType":1,"viewCount":538,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":698217515,"gmtCreate":1640405186348,"gmtModify":1640405186490,"author":{"id":"4094269572113460","authorId":"4094269572113460","name":"Ytyt","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"Pls like","listText":"Pls like","text":"Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/698217515","repostId":"2193720178","repostType":4,"repost":{"id":"2193720178","pubTimestamp":1640398065,"share":"https://www.laohu8.com/m/news/2193720178?lang=&edition=full","pubTime":"2021-12-25 10:07","market":"us","language":"en","title":"2 Top Stocks to Buy for the New Year","url":"https://stock-news.laohu8.com/highlight/detail?id=2193720178","media":"Motley Fool","summary":"Two very different companies -- one in tech and one in retail -- offer investors long-term growth potential and durable business models.","content":"<p>With talks of likely interest rate hikes from the Federal Reserve in 2022 and the coronavirus pandemic still making the rounds, one key characteristic investors should look for in investments going into the new year is resilience. In other words, some good traits to look for are valuations that make sense relative to a company's growth trajectory and market opportunity, and durable business models with proven track records. While there's no way to avoid volatility, owning resilient companies can at least help investors better weather near-term challenges (mentally and emotionally) since they know their investments have what it takes to endure.</p>\n<p>Two companies that fit this description are <b><a href=\"https://laohu8.com/S/FB\">Meta Platforms</a></b> (NASDAQ:FB) and <b><a href=\"https://laohu8.com/S/TSCO\">Tractor Supply Company</a></b> (NASDAQ:TSCO). Here's a look at why both of these stocks are good bets for 2022 and beyond.</p>\n<h2>Meta Platforms</h2>\n<p>The case for Meta Platforms is straightforward. The tech stock's valuation is very cheap relative to the company's recent growth. Consider that the Facebook parent's trailing-12-month revenue and net income of $112 billion and $40 billion, respectively, are up from $71 billion and $18 billion in 2019. Even with such staggering recent growth, Meta Platforms trades at only 24 times its current level of earnings.</p>\n<p>While the company is running into some near-term growth headwinds related to <b>Apple</b>'s recent changes to advertising tracking and measurement, it's not like the suppressed growth Meta Platforms is expecting is poor. Management guided for fourth-quarter revenue to be between $31.5 billion and $34 billion. The midpoint of this guidance range represents 17% revenue growth. Further, analysts are still modeling for exceptional earnings-per-share growth over the next five years. On average, analysts currently expect Meta Platforms' earnings per share to compound at a growth rate of 21% annually over this period.</p>\n<p>Meta Platforms' network effect of billions of monthly active users makes its business very durable. Not only has the company's core Facebook platform consistently grown larger with no close challenger, but the company's other social networks with more intense competition (namely Instagram) have shown they can easily deploy features that imitate successful competitors, helping them stay relevant.</p>\n<h2>Tractor Supply Company</h2>\n<p>Some city folk may have never even stepped foot in a Tractor Supply store. But investors shouldn't overlook this investment just because they're not familiar with the retailer. Tractor Supply, which specializes in rural lifestyle, has a strong retail niche and is capitalizing well on several different important growth catalysts, including private label and exclusive brands, pet food, and e-commerce. Its balanced business has helped revenue grow 24% year over year in the trailing 12 months, and helped earnings per share grow 22%.</p>\n<p>Tractor Supply is notably mastering e-commerce in a market where many of its customers live farther apart than people do in the city. These communities come with unique challenges that Tractor Supply is able to develop expertise in, and the company's strategy is working. Tractor Supply said on its most recent earnings call that its e-commerce sales increased at a rate faster than 40% year over year.</p>\n<p>While the stock's price-to-earnings ratio of 29 isn't exactly cheap, the company's positioning as the lead retailer for the rural lifestyle makes this business worth paying up for. Given how specialized Tractor Supply is, it would be very difficult for a competitor to topple it. The company also pays a dividend and is regularly repurchasing shares, supplementing shareholder value creation.</p>\n<p>Facebook and Tractor Supply together represent two solid ideas from very different industries that provide meaningful long-term growth potential for investors.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>2 Top Stocks to Buy for the New Year</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n2 Top Stocks to Buy for the New Year\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-25 10:07 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/12/24/2-top-stocks-to-buy-for-the-new-year/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>With talks of likely interest rate hikes from the Federal Reserve in 2022 and the coronavirus pandemic still making the rounds, one key characteristic investors should look for in investments going ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/12/24/2-top-stocks-to-buy-for-the-new-year/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TSCO":"拖拉机供应公司"},"source_url":"https://www.fool.com/investing/2021/12/24/2-top-stocks-to-buy-for-the-new-year/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2193720178","content_text":"With talks of likely interest rate hikes from the Federal Reserve in 2022 and the coronavirus pandemic still making the rounds, one key characteristic investors should look for in investments going into the new year is resilience. In other words, some good traits to look for are valuations that make sense relative to a company's growth trajectory and market opportunity, and durable business models with proven track records. While there's no way to avoid volatility, owning resilient companies can at least help investors better weather near-term challenges (mentally and emotionally) since they know their investments have what it takes to endure.\nTwo companies that fit this description are Meta Platforms (NASDAQ:FB) and Tractor Supply Company (NASDAQ:TSCO). Here's a look at why both of these stocks are good bets for 2022 and beyond.\nMeta Platforms\nThe case for Meta Platforms is straightforward. The tech stock's valuation is very cheap relative to the company's recent growth. Consider that the Facebook parent's trailing-12-month revenue and net income of $112 billion and $40 billion, respectively, are up from $71 billion and $18 billion in 2019. Even with such staggering recent growth, Meta Platforms trades at only 24 times its current level of earnings.\nWhile the company is running into some near-term growth headwinds related to Apple's recent changes to advertising tracking and measurement, it's not like the suppressed growth Meta Platforms is expecting is poor. Management guided for fourth-quarter revenue to be between $31.5 billion and $34 billion. The midpoint of this guidance range represents 17% revenue growth. Further, analysts are still modeling for exceptional earnings-per-share growth over the next five years. On average, analysts currently expect Meta Platforms' earnings per share to compound at a growth rate of 21% annually over this period.\nMeta Platforms' network effect of billions of monthly active users makes its business very durable. Not only has the company's core Facebook platform consistently grown larger with no close challenger, but the company's other social networks with more intense competition (namely Instagram) have shown they can easily deploy features that imitate successful competitors, helping them stay relevant.\nTractor Supply Company\nSome city folk may have never even stepped foot in a Tractor Supply store. But investors shouldn't overlook this investment just because they're not familiar with the retailer. Tractor Supply, which specializes in rural lifestyle, has a strong retail niche and is capitalizing well on several different important growth catalysts, including private label and exclusive brands, pet food, and e-commerce. Its balanced business has helped revenue grow 24% year over year in the trailing 12 months, and helped earnings per share grow 22%.\nTractor Supply is notably mastering e-commerce in a market where many of its customers live farther apart than people do in the city. These communities come with unique challenges that Tractor Supply is able to develop expertise in, and the company's strategy is working. Tractor Supply said on its most recent earnings call that its e-commerce sales increased at a rate faster than 40% year over year.\nWhile the stock's price-to-earnings ratio of 29 isn't exactly cheap, the company's positioning as the lead retailer for the rural lifestyle makes this business worth paying up for. Given how specialized Tractor Supply is, it would be very difficult for a competitor to topple it. The company also pays a dividend and is regularly repurchasing shares, supplementing shareholder value creation.\nFacebook and Tractor Supply together represent two solid ideas from very different industries that provide meaningful long-term growth potential for investors.","news_type":1},"isVote":1,"tweetType":1,"viewCount":627,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":698333952,"gmtCreate":1640302602178,"gmtModify":1640302602541,"author":{"id":"4094269572113460","authorId":"4094269572113460","name":"Ytyt","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"Pls like","listText":"Pls like","text":"Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/698333952","repostId":"2193078140","repostType":4,"repost":{"id":"2193078140","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1640299360,"share":"https://www.laohu8.com/m/news/2193078140?lang=&edition=full","pubTime":"2021-12-24 06:42","market":"us","language":"en","title":"S&P 500 hits record close as Omicron fears ebb","url":"https://stock-news.laohu8.com/highlight/detail?id=2193078140","media":"Reuters","summary":"* Major indexes climb for 3rd straight session\n* Merck's at-home COVID-19 pill gets U.S. approval\n* ","content":"<p>* Major indexes climb for 3rd straight session</p>\n<p>* Merck's at-home COVID-19 pill gets U.S. approval</p>\n<p>* Weekly jobless claims unchanged at 205,000</p>\n<p>* Consumer spending increases 0.6% in November</p>\n<p>* Indexes up: Dow 0.55%, S&amp;P 0.62%, Nasdaq 0.85%</p>\n<p>Dec 23 (Reuters) - Wall Street's main indexes posted solid gains for a third straight session on Thursday, with the S&amp;P 500 marking a record-high close, as encouraging developments gave investors more ease about the economic impact of the Omicron coronavirus variant.</p>\n<p>Stocks ended the holiday-shortened week on a positive note, lifting sentiment heading into Christmas. Gains were broad among S&amp;P 500 sectors, led by consumer discretionary&nbsp;and industrials, which both rose about 1.2%.</p>\n<p>Vaccine makers <a href=\"https://laohu8.com/S/AZNCF\">AstraZeneca Plc</a>&nbsp;and Novavax Inc&nbsp;said their shots protected against Omicron as UK data suggested it may cause proportionally fewer hospital cases than the Delta variant, though public health experts warned the battle against COVID-19 was far from over.</p>\n<p>The arrival of Omicron has helped ratchet up market volatility for much of the last month of 2021, which has been a strong year for equities.</p>\n<p>“There was a lot of negative sentiment coming into the final part of the year, and investors have likely continued to see pretty strong economic growth and pretty positive developments as it relates to healthcare innovation around COVID and that is putting in a bit of a bid into equities and causing investors to look to allocate capital as they close out the year,” said Matthew Miskin, co-chief investment strategist at John Hancock Investment Management.</p>\n<p>The Dow Jones Industrial Average&nbsp;rose 196.67 points, or 0.55%, to 35,950.56, the S&amp;P 500&nbsp;gained 29.23 points, or 0.62%, to 4,725.79 and the Nasdaq Composite&nbsp;added 131.48 points, or 0.85%, to 15,653.37.</p>\n<p>Defensive sectors, which have mostly outperformed in December, generally lagged on Thursday. The real estate sector&nbsp;fell 0.4%.</p>\n<p>The S&amp;P 500 has gained for three days, after falling in the three prior sessions.</p>\n<p>“People are seeing the strength on Tuesday and Wednesday and all of a sudden everybody is more optimistic again,” said Robert Pavlik, senior portfolio manager at Dakota Wealth Management.</p>\n<p>For the week, the S&amp;P 500 rose 2.3%, the Dow gained about 1.7% and the Nasdaq climbed 3.2%.</p>\n<p>Trading volumes were expected to be thinner than usual ahead of the Christmas and New Year holidays. The stock market will be closed on Friday in observance of the Christmas holiday.</p>\n<p>In another medical development against the pandemic, the United States authorized Merck &amp; Co's&nbsp;antiviral pill for COVID-19 for certain high-risk adult patients, a day after giving a broader go-ahead to a similar but more effective treatment from Pfizer Inc. Merck shares fell 0.6%, while Pfizer dropped 1.4%.</p>\n<p>The number of Americans filing new claims for unemployment benefits held below pre-pandemic levels last week as the labor market tightens, while consumer spending increased solidly, putting the economy on track for a strong finish to 2021.</p>\n<p>Tesla Inc&nbsp;shares rose 5.8%, gaining sharply for a second day after Chief Executive Elon Musk said on Wednesday he was \"almost done\" with his stock sales after selling over $15 billion worth since early November.</p>\n<p>The S&amp;P 500 is up about 26% so far this year. Still, the environment for equities could be changing heading into next year as the Federal Reserve is expected to begin raising interest rates in 2022.</p>\n<p>Advancing issues outnumbered declining ones on the NYSE by a 2.40-to-1 ratio; on Nasdaq, a 2.22-to-1 ratio favored advancers.</p>\n<p>The S&amp;P 500 posted 35 new 52-week highs and no new lows; the Nasdaq Composite recorded 62 new highs and 80 new lows.</p>\n<p>About 8 billion shares changed hands in U.S. exchanges, compared with the 11.8 billion daily average over the last 20 sessions.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>S&P 500 hits record close as Omicron fears ebb</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nS&P 500 hits record close as Omicron fears ebb\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-12-24 06:42</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>* Major indexes climb for 3rd straight session</p>\n<p>* Merck's at-home COVID-19 pill gets U.S. approval</p>\n<p>* Weekly jobless claims unchanged at 205,000</p>\n<p>* Consumer spending increases 0.6% in November</p>\n<p>* Indexes up: Dow 0.55%, S&amp;P 0.62%, Nasdaq 0.85%</p>\n<p>Dec 23 (Reuters) - Wall Street's main indexes posted solid gains for a third straight session on Thursday, with the S&amp;P 500 marking a record-high close, as encouraging developments gave investors more ease about the economic impact of the Omicron coronavirus variant.</p>\n<p>Stocks ended the holiday-shortened week on a positive note, lifting sentiment heading into Christmas. Gains were broad among S&amp;P 500 sectors, led by consumer discretionary&nbsp;and industrials, which both rose about 1.2%.</p>\n<p>Vaccine makers <a href=\"https://laohu8.com/S/AZNCF\">AstraZeneca Plc</a>&nbsp;and Novavax Inc&nbsp;said their shots protected against Omicron as UK data suggested it may cause proportionally fewer hospital cases than the Delta variant, though public health experts warned the battle against COVID-19 was far from over.</p>\n<p>The arrival of Omicron has helped ratchet up market volatility for much of the last month of 2021, which has been a strong year for equities.</p>\n<p>“There was a lot of negative sentiment coming into the final part of the year, and investors have likely continued to see pretty strong economic growth and pretty positive developments as it relates to healthcare innovation around COVID and that is putting in a bit of a bid into equities and causing investors to look to allocate capital as they close out the year,” said Matthew Miskin, co-chief investment strategist at John Hancock Investment Management.</p>\n<p>The Dow Jones Industrial Average&nbsp;rose 196.67 points, or 0.55%, to 35,950.56, the S&amp;P 500&nbsp;gained 29.23 points, or 0.62%, to 4,725.79 and the Nasdaq Composite&nbsp;added 131.48 points, or 0.85%, to 15,653.37.</p>\n<p>Defensive sectors, which have mostly outperformed in December, generally lagged on Thursday. The real estate sector&nbsp;fell 0.4%.</p>\n<p>The S&amp;P 500 has gained for three days, after falling in the three prior sessions.</p>\n<p>“People are seeing the strength on Tuesday and Wednesday and all of a sudden everybody is more optimistic again,” said Robert Pavlik, senior portfolio manager at Dakota Wealth Management.</p>\n<p>For the week, the S&amp;P 500 rose 2.3%, the Dow gained about 1.7% and the Nasdaq climbed 3.2%.</p>\n<p>Trading volumes were expected to be thinner than usual ahead of the Christmas and New Year holidays. The stock market will be closed on Friday in observance of the Christmas holiday.</p>\n<p>In another medical development against the pandemic, the United States authorized Merck &amp; Co's&nbsp;antiviral pill for COVID-19 for certain high-risk adult patients, a day after giving a broader go-ahead to a similar but more effective treatment from Pfizer Inc. Merck shares fell 0.6%, while Pfizer dropped 1.4%.</p>\n<p>The number of Americans filing new claims for unemployment benefits held below pre-pandemic levels last week as the labor market tightens, while consumer spending increased solidly, putting the economy on track for a strong finish to 2021.</p>\n<p>Tesla Inc&nbsp;shares rose 5.8%, gaining sharply for a second day after Chief Executive Elon Musk said on Wednesday he was \"almost done\" with his stock sales after selling over $15 billion worth since early November.</p>\n<p>The S&amp;P 500 is up about 26% so far this year. Still, the environment for equities could be changing heading into next year as the Federal Reserve is expected to begin raising interest rates in 2022.</p>\n<p>Advancing issues outnumbered declining ones on the NYSE by a 2.40-to-1 ratio; on Nasdaq, a 2.22-to-1 ratio favored advancers.</p>\n<p>The S&amp;P 500 posted 35 new 52-week highs and no new lows; the Nasdaq Composite recorded 62 new highs and 80 new lows.</p>\n<p>About 8 billion shares changed hands in U.S. exchanges, compared with the 11.8 billion daily average over the last 20 sessions.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"161125":"标普500","513500":"标普500ETF","SDS":"两倍做空标普500ETF","SH":"标普500反向ETF",".DJI":"道琼斯",".IXIC":"NASDAQ Composite","OEX":"标普100","OEF":"标普100指数ETF-iShares",".SPX":"S&P 500 Index","SPXU":"三倍做空标普500ETF","BK4534":"瑞士信贷持仓","SSO":"两倍做多标普500ETF","UPRO":"三倍做多标普500ETF","SPY":"标普500ETF","BK4559":"巴菲特持仓","BK4550":"红杉资本持仓","IVV":"标普500指数ETF","BK4504":"桥水持仓"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2193078140","content_text":"* Major indexes climb for 3rd straight session\n* Merck's at-home COVID-19 pill gets U.S. approval\n* Weekly jobless claims unchanged at 205,000\n* Consumer spending increases 0.6% in November\n* Indexes up: Dow 0.55%, S&P 0.62%, Nasdaq 0.85%\nDec 23 (Reuters) - Wall Street's main indexes posted solid gains for a third straight session on Thursday, with the S&P 500 marking a record-high close, as encouraging developments gave investors more ease about the economic impact of the Omicron coronavirus variant.\nStocks ended the holiday-shortened week on a positive note, lifting sentiment heading into Christmas. Gains were broad among S&P 500 sectors, led by consumer discretionary and industrials, which both rose about 1.2%.\nVaccine makers AstraZeneca Plc and Novavax Inc said their shots protected against Omicron as UK data suggested it may cause proportionally fewer hospital cases than the Delta variant, though public health experts warned the battle against COVID-19 was far from over.\nThe arrival of Omicron has helped ratchet up market volatility for much of the last month of 2021, which has been a strong year for equities.\n“There was a lot of negative sentiment coming into the final part of the year, and investors have likely continued to see pretty strong economic growth and pretty positive developments as it relates to healthcare innovation around COVID and that is putting in a bit of a bid into equities and causing investors to look to allocate capital as they close out the year,” said Matthew Miskin, co-chief investment strategist at John Hancock Investment Management.\nThe Dow Jones Industrial Average rose 196.67 points, or 0.55%, to 35,950.56, the S&P 500 gained 29.23 points, or 0.62%, to 4,725.79 and the Nasdaq Composite added 131.48 points, or 0.85%, to 15,653.37.\nDefensive sectors, which have mostly outperformed in December, generally lagged on Thursday. The real estate sector fell 0.4%.\nThe S&P 500 has gained for three days, after falling in the three prior sessions.\n“People are seeing the strength on Tuesday and Wednesday and all of a sudden everybody is more optimistic again,” said Robert Pavlik, senior portfolio manager at Dakota Wealth Management.\nFor the week, the S&P 500 rose 2.3%, the Dow gained about 1.7% and the Nasdaq climbed 3.2%.\nTrading volumes were expected to be thinner than usual ahead of the Christmas and New Year holidays. The stock market will be closed on Friday in observance of the Christmas holiday.\nIn another medical development against the pandemic, the United States authorized Merck & Co's antiviral pill for COVID-19 for certain high-risk adult patients, a day after giving a broader go-ahead to a similar but more effective treatment from Pfizer Inc. Merck shares fell 0.6%, while Pfizer dropped 1.4%.\nThe number of Americans filing new claims for unemployment benefits held below pre-pandemic levels last week as the labor market tightens, while consumer spending increased solidly, putting the economy on track for a strong finish to 2021.\nTesla Inc shares rose 5.8%, gaining sharply for a second day after Chief Executive Elon Musk said on Wednesday he was \"almost done\" with his stock sales after selling over $15 billion worth since early November.\nThe S&P 500 is up about 26% so far this year. Still, the environment for equities could be changing heading into next year as the Federal Reserve is expected to begin raising interest rates in 2022.\nAdvancing issues outnumbered declining ones on the NYSE by a 2.40-to-1 ratio; on Nasdaq, a 2.22-to-1 ratio favored advancers.\nThe S&P 500 posted 35 new 52-week highs and no new lows; the Nasdaq Composite recorded 62 new highs and 80 new lows.\nAbout 8 billion shares changed hands in U.S. exchanges, compared with the 11.8 billion daily average over the last 20 sessions.","news_type":1},"isVote":1,"tweetType":1,"viewCount":558,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":874039416,"gmtCreate":1637710367553,"gmtModify":1637710367553,"author":{"id":"4094269572113460","authorId":"4094269572113460","name":"Ytyt","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"Pls like","listText":"Pls like","text":"Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/874039416","repostId":"2185367033","repostType":4,"repost":{"id":"2185367033","pubTimestamp":1637710171,"share":"https://www.laohu8.com/m/news/2185367033?lang=&edition=full","pubTime":"2021-11-24 07:29","market":"us","language":"en","title":"After-Hours Stock Movers: Nordstrom,Gap,Autodesk,Anaplan,HP and more","url":"https://stock-news.laohu8.com/highlight/detail?id=2185367033","media":"StreetInsider","summary":"After-Hours Stock Movers:\nNordstrom (NYSE: JWN) 23.2% LOWER; reported Q3 EPS of $0.39, $0.13 worse t","content":"<p>After-Hours Stock Movers:</p>\n<p>Nordstrom (NYSE: JWN) 23.2% LOWER; reported Q3 EPS of $0.39, $0.13 worse than the analyst estimate of $0.52. Revenue for the quarter came in at $3.53 billion versus the consensus estimate of $3.52 billion. The Company is reaffirming the following financial expectations for fiscal 2021.</p>\n<p>Gap, Inc. (NYSE: GPS) 16.2% LOWER; reported Q3 EPS of $0.27, $0.24 worse than the analyst estimate of $0.51. Revenue for the quarter came in at $3.94 billion versus the consensus estimate of $4.47 billion. Gap, Inc. sees FY2021 EPS of $1.25-$1.40, versus the consensus of $2.20.</p>\n<p>Autodesk (NASDAQ: ADSK) 13.6% LOWER; reported Q3 EPS of $1.33, $0.07 better than the analyst estimate of $1.26. Revenue for the quarter came in at $1.13 billion versus the consensus estimate of $1.12 billion. Autodesk sees Q4 2022 EPS of $1.41-$1.47, versus the consensus of $1.46. Autodesk sees Q4 2022 revenue of $1.185-1.2 billion, versus the consensus of $1.2 billion.</p>\n<p>Pure Storage, Inc. (NYSE: PSTG) 13.3% HIGHER; reported Q3 EPS of $0.22, $0.10 better than the analyst estimate of $0.12. Revenue for the quarter came in at $562.7 million versus the consensus estimate of $530.83 million. Pure Storage, Inc. sees Q4 2022 revenue of $630 million, versus the consensus of $602.24 million. Pure Storage, Inc. sees FY2022 revenue of $2.1 billion, versus the consensus of $2.04 billion.</p>\n<p>Anaplan, Inc. (NYSE: PLAN) 13.6% LOWER; reported Q3 EPS of ($0.05), $0.06 better than the analyst estimate of ($0.11). Revenue for the quarter came in at $155.3 million versus the consensus estimate of $146.29 million. Anaplan, Inc. sees Q4 2022 revenue of $154-155 million, versus the consensus of $152.9 million. Anaplan, Inc. sees FY2022 revenue of $583.5-584.5 million, versus the consensus of $573.5 million.</p>\n<p>HP Inc. (NYSE: HPQ) 8.7% HIGHER; reported Q4 EPS of $0.94, $0.05 better than the analyst estimate of $0.89. Revenue for the quarter came in at $16.68 billion versus the consensus estimate of $15.43 billion. HP Inc. sees FY2022 EPS of $4.07-$4.27, versus the consensus of $3.73.</p>\n<p>Nutanix (NASDAQ: NTNX) 5% HIGHER; reported Q1 EPS of ($0.22), $0.12 better than the analyst estimate of ($0.34). Revenue for the quarter came in at $378.5 million versus the consensus estimate of $367.04 million. Nutanix sees Q2 2022 revenue of $400-410 million, versus the consensus of $399.94 million. Nutanix sees FY2022 revenue of $1.615-1.63 billion, versus the consensus of $1.6 billion.</p>\n<p>Dell Technologies (NYSE: DELL) 1.4% HIGHER; reported Q3 EPS of $2.37, $0.28 better than the analyst estimate of $2.09. Revenue for the quarter came in at $28.4 billion versus the consensus estimate of $27.01 billion.</p>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>After-Hours Stock Movers: Nordstrom,Gap,Autodesk,Anaplan,HP and more</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAfter-Hours Stock Movers: Nordstrom,Gap,Autodesk,Anaplan,HP and more\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-24 07:29 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/dr/news.php?id=19263563><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>After-Hours Stock Movers:\nNordstrom (NYSE: JWN) 23.2% LOWER; reported Q3 EPS of $0.39, $0.13 worse than the analyst estimate of $0.52. Revenue for the quarter came in at $3.53 billion versus the ...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=19263563\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GPS":"盖璞","HPQ":"惠普","JWN":"诺德斯特龙","PSTG":"Pure Storage Inc","ADSK":"欧特克","NTNX":"Nutanix Inc."},"source_url":"https://www.streetinsider.com/dr/news.php?id=19263563","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2185367033","content_text":"After-Hours Stock Movers:\nNordstrom (NYSE: JWN) 23.2% LOWER; reported Q3 EPS of $0.39, $0.13 worse than the analyst estimate of $0.52. Revenue for the quarter came in at $3.53 billion versus the consensus estimate of $3.52 billion. The Company is reaffirming the following financial expectations for fiscal 2021.\nGap, Inc. (NYSE: GPS) 16.2% LOWER; reported Q3 EPS of $0.27, $0.24 worse than the analyst estimate of $0.51. Revenue for the quarter came in at $3.94 billion versus the consensus estimate of $4.47 billion. Gap, Inc. sees FY2021 EPS of $1.25-$1.40, versus the consensus of $2.20.\nAutodesk (NASDAQ: ADSK) 13.6% LOWER; reported Q3 EPS of $1.33, $0.07 better than the analyst estimate of $1.26. Revenue for the quarter came in at $1.13 billion versus the consensus estimate of $1.12 billion. Autodesk sees Q4 2022 EPS of $1.41-$1.47, versus the consensus of $1.46. Autodesk sees Q4 2022 revenue of $1.185-1.2 billion, versus the consensus of $1.2 billion.\nPure Storage, Inc. (NYSE: PSTG) 13.3% HIGHER; reported Q3 EPS of $0.22, $0.10 better than the analyst estimate of $0.12. Revenue for the quarter came in at $562.7 million versus the consensus estimate of $530.83 million. Pure Storage, Inc. sees Q4 2022 revenue of $630 million, versus the consensus of $602.24 million. Pure Storage, Inc. sees FY2022 revenue of $2.1 billion, versus the consensus of $2.04 billion.\nAnaplan, Inc. (NYSE: PLAN) 13.6% LOWER; reported Q3 EPS of ($0.05), $0.06 better than the analyst estimate of ($0.11). Revenue for the quarter came in at $155.3 million versus the consensus estimate of $146.29 million. Anaplan, Inc. sees Q4 2022 revenue of $154-155 million, versus the consensus of $152.9 million. Anaplan, Inc. sees FY2022 revenue of $583.5-584.5 million, versus the consensus of $573.5 million.\nHP Inc. (NYSE: HPQ) 8.7% HIGHER; reported Q4 EPS of $0.94, $0.05 better than the analyst estimate of $0.89. Revenue for the quarter came in at $16.68 billion versus the consensus estimate of $15.43 billion. HP Inc. sees FY2022 EPS of $4.07-$4.27, versus the consensus of $3.73.\nNutanix (NASDAQ: NTNX) 5% HIGHER; reported Q1 EPS of ($0.22), $0.12 better than the analyst estimate of ($0.34). Revenue for the quarter came in at $378.5 million versus the consensus estimate of $367.04 million. Nutanix sees Q2 2022 revenue of $400-410 million, versus the consensus of $399.94 million. Nutanix sees FY2022 revenue of $1.615-1.63 billion, versus the consensus of $1.6 billion.\nDell Technologies (NYSE: DELL) 1.4% HIGHER; reported Q3 EPS of $2.37, $0.28 better than the analyst estimate of $2.09. Revenue for the quarter came in at $28.4 billion versus the consensus estimate of $27.01 billion.","news_type":1},"isVote":1,"tweetType":1,"viewCount":20,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":603096059,"gmtCreate":1638335360861,"gmtModify":1638335360861,"author":{"id":"4094269572113460","authorId":"4094269572113460","name":"Ytyt","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"Pls like","listText":"Pls like","text":"Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/603096059","repostId":"2187216533","repostType":4,"repost":{"id":"2187216533","pubTimestamp":1638327167,"share":"https://www.laohu8.com/m/news/2187216533?lang=&edition=full","pubTime":"2021-12-01 10:52","market":"us","language":"en","title":"These 3 Stocks Have Underperformed the Market This Year. Is Now the Time to Buy?","url":"https://stock-news.laohu8.com/highlight/detail?id=2187216533","media":"Motley Fool","summary":"After their stocks have had a challenging year, how do these companies' long-term prospects stack up?","content":"<p>While the <b>S&amp;P 500 </b>has increased by more than 25% this year, not all stocks have benefited from the market's gain. The following stocks have badly lagged the overall market this year for various reasons.</p>\n<p>While that doesn't necessarily mean this is a good time to buy, each warrants a closer look.</p>\n<h2>1. Johnson &amp; Johnson</h2>\n<p><b>Johnson &amp; Johnson</b>'s (NYSE:JNJ) stock price has gained only 3% this year. This is partly due to the well-publicized issues with its COVID-19 vaccine. Following reports of blood clots, the U.S. Centers for Disease Control and Prevention and the Food and Drug Administration recommended pausing the use of the vaccine.</p>\n<p>However, while last year's results were hurt by COVID-19 for a variety of reasons, this year has been solid. In the third quarter, Johnson &amp; Johnson's adjusted sales increased by 10.6%</p>\n<p>In an effort to unlock shareholder value, the company recently announced a plan to spin off its consumer health business. This is a slower-growing business than the medical devices and pharmaceuticals segments. Consumer health's sales grew by less than 6% in the recent quarter.</p>\n<p>But the new stand-alone business will have powerful brands. These include Band-Aid, Tylenol, Motrin, Nicorette, and Listerine, to name just a few. These products do well no matter the state of the economy.</p>\n<p>Meanwhile, Johnson &amp; Johnson can concentrate on producing newer treatments and products for the faster-growing pharmaceuticals and medical devices businesses.</p>\n<h2>2. Walmart</h2>\n<p><b>Walmart</b>'s (NYSE:WMT) stock has been flat this year. While it's nice not to lose any money, that's far behind the S&amp;P 500's gain.</p>\n<p>Earlier this year, investors were taken aback by management's lukewarm guidance. At that time, Walmart expected flattish adjusted operating income.</p>\n<p>However, its fiscal third-quarter operating income rose by almost 6.5% after excluding divested businesses from last year's results. This covered the period that ended Oct. 31.</p>\n<p>Even better, management increased its expectations a couple of times this year. In August, it raised its operating income guidance to an 11.5% to 14% increase.</p>\n<p>Walmart also plans to spend $13 billion to focus on the supply chain, automation, and customer-facing technology. These steps should help the company keep pace with online competitors, namely <b>Amazon</b>.</p>\n<p>With Walmart's focus on low prices and omnichannel initiatives that allow customers the convenience of buying and receiving goods in a multitude of ways, the company is well positioned for the future.</p>\n<h2>3. Walt Disney</h2>\n<p><b>Walt Disney</b>'s (NYSE:DIS) stock is down by more than 15% this year. There's no getting around the fact that COVID-19 hurt the company's results by shutting down its theme parks, delaying movie releases, and stopping live-action sports that hurt ESPN, its sports network. Out of caution, the board of directors suspended Disney's dividend.</p>\n<p>More recently, investors have been dismayed by slowing growth at its streaming service, Disney+. In 2020, the number of paid subscribers skyrocketed to 94.9 million from the prior year's 30.4 million, undoubtedly helped by people stuck at home. In the recently completed fiscal year, which ended in October, there were 118.1 million subscribers, but this only increased by about 2 million from July. But with a ton of content coming out that will make its way to Disney+, this slowdown will likely prove temporary.</p>\n<p>More importantly, Disney has become a global media empire. So even if the streaming service's growth lags for a while, other pieces of the business will pick up the slack. This includes television networks, theme parks, movie studios like Disney, Pixar, Twentieth Century, and Marvel, and retail stores. Even with its streaming service's slowing subscriber growth, fourth-quarter revenue rose by 26%.</p>\n<p>With such great properties and content, I have no doubt about Disney's long-term prospects.</p>\n<p>These three companies all seem worthy of an investment. Aside from establishing great franchises, each has taken steps to ensure a bright future. Johnson &amp; Johnson is breaking itself into two, but remains a rock-solid business. Walmart, established as the low price leader, continues to invest in technology to keep up with the times. And Disney continues to expand, including buying Twentieth Century Studios and launching its streaming service a couple of years ago.</p>\n<p>Attractive brands and astute moves to position their companies for the future would seem to add up to attractive long-term investment opportunities when you consider their stocks have trailed the market this year.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>These 3 Stocks Have Underperformed the Market This Year. Is Now the Time to Buy?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThese 3 Stocks Have Underperformed the Market This Year. Is Now the Time to Buy?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-01 10:52 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/11/30/these-3-stocks-have-underperformed-the-market-this/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>While the S&P 500 has increased by more than 25% this year, not all stocks have benefited from the market's gain. The following stocks have badly lagged the overall market this year for various ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/11/30/these-3-stocks-have-underperformed-the-market-this/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4524":"宅经济概念","BK4559":"巴菲特持仓","BK4108":"电影和娱乐","BK4561":"索罗斯持仓","BK4155":"大卖场与超市","BK4507":"流媒体概念","BK4534":"瑞士信贷持仓","BK4550":"红杉资本持仓","WMT":"沃尔玛","BK4568":"美国抗疫概念","BK4551":"寇图资本持仓","BK4504":"桥水持仓","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4007":"制药","DIS":"迪士尼","BK4554":"元宇宙及AR概念","BK4532":"文艺复兴科技持仓","JNJ":"强生"},"source_url":"https://www.fool.com/investing/2021/11/30/these-3-stocks-have-underperformed-the-market-this/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2187216533","content_text":"While the S&P 500 has increased by more than 25% this year, not all stocks have benefited from the market's gain. The following stocks have badly lagged the overall market this year for various reasons.\nWhile that doesn't necessarily mean this is a good time to buy, each warrants a closer look.\n1. Johnson & Johnson\nJohnson & Johnson's (NYSE:JNJ) stock price has gained only 3% this year. This is partly due to the well-publicized issues with its COVID-19 vaccine. Following reports of blood clots, the U.S. Centers for Disease Control and Prevention and the Food and Drug Administration recommended pausing the use of the vaccine.\nHowever, while last year's results were hurt by COVID-19 for a variety of reasons, this year has been solid. In the third quarter, Johnson & Johnson's adjusted sales increased by 10.6%\nIn an effort to unlock shareholder value, the company recently announced a plan to spin off its consumer health business. This is a slower-growing business than the medical devices and pharmaceuticals segments. Consumer health's sales grew by less than 6% in the recent quarter.\nBut the new stand-alone business will have powerful brands. These include Band-Aid, Tylenol, Motrin, Nicorette, and Listerine, to name just a few. These products do well no matter the state of the economy.\nMeanwhile, Johnson & Johnson can concentrate on producing newer treatments and products for the faster-growing pharmaceuticals and medical devices businesses.\n2. Walmart\nWalmart's (NYSE:WMT) stock has been flat this year. While it's nice not to lose any money, that's far behind the S&P 500's gain.\nEarlier this year, investors were taken aback by management's lukewarm guidance. At that time, Walmart expected flattish adjusted operating income.\nHowever, its fiscal third-quarter operating income rose by almost 6.5% after excluding divested businesses from last year's results. This covered the period that ended Oct. 31.\nEven better, management increased its expectations a couple of times this year. In August, it raised its operating income guidance to an 11.5% to 14% increase.\nWalmart also plans to spend $13 billion to focus on the supply chain, automation, and customer-facing technology. These steps should help the company keep pace with online competitors, namely Amazon.\nWith Walmart's focus on low prices and omnichannel initiatives that allow customers the convenience of buying and receiving goods in a multitude of ways, the company is well positioned for the future.\n3. Walt Disney\nWalt Disney's (NYSE:DIS) stock is down by more than 15% this year. There's no getting around the fact that COVID-19 hurt the company's results by shutting down its theme parks, delaying movie releases, and stopping live-action sports that hurt ESPN, its sports network. Out of caution, the board of directors suspended Disney's dividend.\nMore recently, investors have been dismayed by slowing growth at its streaming service, Disney+. In 2020, the number of paid subscribers skyrocketed to 94.9 million from the prior year's 30.4 million, undoubtedly helped by people stuck at home. In the recently completed fiscal year, which ended in October, there were 118.1 million subscribers, but this only increased by about 2 million from July. But with a ton of content coming out that will make its way to Disney+, this slowdown will likely prove temporary.\nMore importantly, Disney has become a global media empire. So even if the streaming service's growth lags for a while, other pieces of the business will pick up the slack. This includes television networks, theme parks, movie studios like Disney, Pixar, Twentieth Century, and Marvel, and retail stores. Even with its streaming service's slowing subscriber growth, fourth-quarter revenue rose by 26%.\nWith such great properties and content, I have no doubt about Disney's long-term prospects.\nThese three companies all seem worthy of an investment. Aside from establishing great franchises, each has taken steps to ensure a bright future. Johnson & Johnson is breaking itself into two, but remains a rock-solid business. Walmart, established as the low price leader, continues to invest in technology to keep up with the times. And Disney continues to expand, including buying Twentieth Century Studios and launching its streaming service a couple of years ago.\nAttractive brands and astute moves to position their companies for the future would seem to add up to attractive long-term investment opportunities when you consider their stocks have trailed the market this year.","news_type":1},"isVote":1,"tweetType":1,"viewCount":19,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":605082821,"gmtCreate":1639093559363,"gmtModify":1639093559460,"author":{"id":"4094269572113460","authorId":"4094269572113460","name":"Ytyt","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"Pls like","listText":"Pls like","text":"Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/605082821","repostId":"1168862300","repostType":4,"repost":{"id":"1168862300","pubTimestamp":1639091664,"share":"https://www.laohu8.com/m/news/1168862300?lang=&edition=full","pubTime":"2021-12-10 07:14","market":"us","language":"en","title":"After-Hours Stock Movers: Oracle,Chewy,Broadcom,lululemon and more","url":"https://stock-news.laohu8.com/highlight/detail?id=1168862300","media":"StreetInsider","summary":"After-Hours Stock Movers\nC3.ai, Inc. (NYSE: AI) 27.4% HIGHER; has established a new five-year Produc","content":"<p>After-Hours Stock Movers</p>\n<p><a href=\"https://laohu8.com/S/AI\">C3.ai, Inc.</a> (NYSE: AI) 27.4% HIGHER; has established a new five-year Production-Other Transaction Agreement with the U.S. Department of Defense (DoD).</p>\n<p><a href=\"https://laohu8.com/S/AOUT\">American Outdoor Brands, Inc.</a> (NASDAQ: AOUT) 17.9% LOWER; reported Q2 EPS of $0.58, $0.18 worse than the analyst estimate of $0.76. Revenue for the quarter came in at $70.8 million versus the consensus estimate of $82.55 million. American Outdoor Brands sees FY2022 EPS of $2.02-$2.21, versus the consensus of $2.27. American Outdoor Brands sees FY2022 revenue of $280-285 million, versus the consensus of $294.1 million.</p>\n<p><a href=\"https://laohu8.com/S/ORCL\">Oracle</a> (NYSE: ORCL) 9.7% HIGHER; reported Q2 EPS of $1.21, $0.10 better than the analyst estimate of $1.11. Revenue for the quarter came in at $10.4 billion versus the consensus estimate of $10.21 billion.</p>\n<p><a href=\"https://laohu8.com/S/CHWY\">Chewy, Inc.</a> (NYSE: CHWY) 7% LOWER; reported Q3 EPS of ($0.08), $0.04 worse than the analyst estimate of ($0.04). Revenue for the quarter came in at $2.21 billion versus the consensus estimate of $2.21 billion. Chewy sees Q4 2021 revenue of $2.4-2.44 billion, versus the consensus of $2.43 billion.</p>\n<p><a href=\"https://laohu8.com/S/AVGO\">Broadcom</a> (NASDAQ: AVGO) 6.7% HIGHER; reported Q4 EPS of $7.81, $0.40 better than the analyst estimate of $7.41. Revenue for the quarter came in at $7.6 billion, may not compare versus the consensus estimate of $7.36 billion. Broadcom sees Q1 2022 revenue of $7.6 billion, versus the consensus of $7.25 billion. First quarter Adjusted EBITDA guidance of approximately 61.5 percent of projected revenue.</p>\n<p><a href=\"https://laohu8.com/S/RRD\">R.R.Donnelley</a> (NYSE: RRD) 3.9% HIGHER; Chatham Asset Management Increases Offer to $10.85 Per Share in Cash</p>\n<p><a href=\"https://laohu8.com/S/EPAY\">Bottomline</a> (NASDAQ: EPAY) 3% HIGHER; is exploring a sale, according to Bloomberg, citing people with knowledge of the matter.</p>\n<p><a href=\"https://laohu8.com/S/CCK\">Crown</a> (NYSE: CCK) 2% HIGHER; announced today that its Board of Directors authorized the repurchase of an aggregate amount of up to $3.0 billion of Company stock through the end of 2024.</p>\n<p><a href=\"https://laohu8.com/S/LULU\">Lululemon Athletica</a> (NASDAQ: LULU) 2% LOWER; reported Q3 EPS of $1.62, $0.21 better than the analyst estimate of $1.41. Revenue for the quarter came in at $1.5 billion versus the consensus estimate of $1.43 billion. lululemon athletica sees Q4 2021 EPS of $3.25-$3.32, versus the consensus of $3.30. lululemon athletica sees Q4 2021 revenue of $2.125-2.165 billion, versus the consensus of $2.17 billion.</p>\n<p><a href=\"https://laohu8.com/S/BCRX\">Biocryst Pharmaceuticals</a> (NASDAQ: BCRX) 1.5% HIGHER; Oppenheimer initiates coverage with an Outperform rating and a price target of $16.00.</p>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>After-Hours Stock Movers: Oracle,Chewy,Broadcom,lululemon and more</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAfter-Hours Stock Movers: Oracle,Chewy,Broadcom,lululemon and more\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-10 07:14 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/dr/news.php?id=19334268><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>After-Hours Stock Movers\nC3.ai, Inc. (NYSE: AI) 27.4% HIGHER; has established a new five-year Production-Other Transaction Agreement with the U.S. Department of Defense (DoD).\nAmerican Outdoor Brands,...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=19334268\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ORCL":"甲骨文","AI":"C3.ai, Inc.","LULU":"lululemon athletica","BRCM":"博通","CHWY":"Chewy, Inc."},"source_url":"https://www.streetinsider.com/dr/news.php?id=19334268","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1168862300","content_text":"After-Hours Stock Movers\nC3.ai, Inc. (NYSE: AI) 27.4% HIGHER; has established a new five-year Production-Other Transaction Agreement with the U.S. Department of Defense (DoD).\nAmerican Outdoor Brands, Inc. (NASDAQ: AOUT) 17.9% LOWER; reported Q2 EPS of $0.58, $0.18 worse than the analyst estimate of $0.76. Revenue for the quarter came in at $70.8 million versus the consensus estimate of $82.55 million. American Outdoor Brands sees FY2022 EPS of $2.02-$2.21, versus the consensus of $2.27. American Outdoor Brands sees FY2022 revenue of $280-285 million, versus the consensus of $294.1 million.\nOracle (NYSE: ORCL) 9.7% HIGHER; reported Q2 EPS of $1.21, $0.10 better than the analyst estimate of $1.11. Revenue for the quarter came in at $10.4 billion versus the consensus estimate of $10.21 billion.\nChewy, Inc. (NYSE: CHWY) 7% LOWER; reported Q3 EPS of ($0.08), $0.04 worse than the analyst estimate of ($0.04). Revenue for the quarter came in at $2.21 billion versus the consensus estimate of $2.21 billion. Chewy sees Q4 2021 revenue of $2.4-2.44 billion, versus the consensus of $2.43 billion.\nBroadcom (NASDAQ: AVGO) 6.7% HIGHER; reported Q4 EPS of $7.81, $0.40 better than the analyst estimate of $7.41. Revenue for the quarter came in at $7.6 billion, may not compare versus the consensus estimate of $7.36 billion. Broadcom sees Q1 2022 revenue of $7.6 billion, versus the consensus of $7.25 billion. First quarter Adjusted EBITDA guidance of approximately 61.5 percent of projected revenue.\nR.R.Donnelley (NYSE: RRD) 3.9% HIGHER; Chatham Asset Management Increases Offer to $10.85 Per Share in Cash\nBottomline (NASDAQ: EPAY) 3% HIGHER; is exploring a sale, according to Bloomberg, citing people with knowledge of the matter.\nCrown (NYSE: CCK) 2% HIGHER; announced today that its Board of Directors authorized the repurchase of an aggregate amount of up to $3.0 billion of Company stock through the end of 2024.\nLululemon Athletica (NASDAQ: LULU) 2% LOWER; reported Q3 EPS of $1.62, $0.21 better than the analyst estimate of $1.41. Revenue for the quarter came in at $1.5 billion versus the consensus estimate of $1.43 billion. lululemon athletica sees Q4 2021 EPS of $3.25-$3.32, versus the consensus of $3.30. lululemon athletica sees Q4 2021 revenue of $2.125-2.165 billion, versus the consensus of $2.17 billion.\nBiocryst Pharmaceuticals (NASDAQ: BCRX) 1.5% HIGHER; Oppenheimer initiates coverage with an Outperform rating and a price target of $16.00.","news_type":1},"isVote":1,"tweetType":1,"viewCount":146,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":877944023,"gmtCreate":1637883487346,"gmtModify":1637883487346,"author":{"id":"4094269572113460","authorId":"4094269572113460","name":"Ytyt","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"Pls like","listText":"Pls like","text":"Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/877944023","repostId":"1122037796","repostType":4,"repost":{"id":"1122037796","pubTimestamp":1637849010,"share":"https://www.laohu8.com/m/news/1122037796?lang=&edition=full","pubTime":"2021-11-25 22:03","market":"us","language":"en","title":"7 stocks with the most Thanksgiving exposure, according to Bank of America","url":"https://stock-news.laohu8.com/highlight/detail?id=1122037796","media":"finance.yahoo","summary":"Thanksgiving feasts will likely draw larger crowds than last year and incur higher costs.\nA recent B","content":"<p>Thanksgiving feasts will likely draw larger crowds than last year and&nbsp;incur higher costs.</p>\n<p>A recent Bank of America note detailed which companies have the most exposure to the top holiday dishes amid supply chain bottlenecks, inflation, lingering COVID concerns, low inventories, and evolving consumer behaviors.</p>\n<p>Those companies are Campbell's Soup Company (CPB), General Mills (GIS), The Kraft Heinz Company (KHC), Conagra Brands (CAG), Hormel Foods Corporation (HRL), McCormick &amp; Company (MKC), and The Duckhorn Portfolio, Inc. (NAPA).</p>\n<p>\"We looked at companies’ exposure to the top Thanksgiving dishes: turkey, stuffing, dinner rolls, gravy, green bean casserole, potatoes, mac &amp; cheese dessert and wine,\" the analysts stated. \"Overall CPB, GIS, KHC, CAG, MKC, HRL and NAPA are the most exposed. KHC and NAPA are our favorite stocks in this group.\"</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/39aa902f366c0bd07e076520c33cdf52\" tg-width=\"705\" tg-height=\"409\" width=\"100%\" height=\"auto\"><span>Key companies exposed to Thanksgiving meal trends. (Source: BofA)Thanksgiving 'center of the plate' items see more pricing power</span></p>\n<p>People appear to be gathering around the table again, the analysts stated, as data from social media conversations found mentions of \"vaccines\" on the rise while mentions of \"FaceTime,\" \"social distancing,\" and \"canceled\" declined. (\"Friendsgiving\" and \"day drinking\" also saw increases.)</p>\n<p>And whether consumers opt for turkey or ham, mashed potatoes or marshmallow-topped sweet potatoes, traditional orplant-based options, they're likely to pay more with inflation hitting food prices.</p>\n<p>The&nbsp;American Farm Bureau Thanksgiving cost index&nbsp;projects a 14% year-over-year increase for 2021, led by a 24% increase in turkey prices.</p>\n<p>“When you look at more of the center of the plate sort of food items, typically, there has not historically been a lot of pricing power,” Bryan Spillane, a senior food and beverage analyst at BofA Global Research, told Yahoo Finance Live (video above). “But what's unusual this year is that there has been. Food companies, in particular, began raising prices the middle of the year, and there's virtually been no elasticity.”</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/8e60ff60917eb4db45a68c41bd19a337\" tg-width=\"705\" tg-height=\"529\" width=\"100%\" height=\"auto\"><span>Frozen turkeys in Philadelphia, Wednesday, Nov. 17, 2021. (AP Photo/Matt Rourke)</span></p>\n<p>That said, Spillane added, consumer behavior is expected to change at some point.</p>\n<p>“Something that we're really watching as we move into next year is: At what point does the consumer begin to push back and do we begin to see some trading down or other behavior that demonstrates that consumers are feeling that pinch?” Spillane said.</p>\n<p>Investor appetite for food and beverage companies</p>\n<p>The top company with the most upside or downside potential is Campbell's, which BofA gave an \"underperform\" rating.</p>\n<p>“Campbell's struggling from a few issues,” Spillane said. “One is they are experiencing a material amount of inflation. They have a product portfolio that's a little bit more skewed… to kind of middle and low-income households. So, that's, maybe, an area where there may be some sensitivity around passing those prices through.”</p>\n<p>The iconic soup company also has a lot of direct and indirect exposure to labor shortages and higher labor costs, Spillane added.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/be1718627f49a5fcc29f52e9e322313f\" tg-width=\"705\" tg-height=\"470\" width=\"100%\" height=\"auto\"><span>Cans of Campbell's Soup are displayed in a supermarket in New York City, U.S. February 15, 2017. REUTERS/Brendan McDermid</span></p>\n<p>BofA also gave seasoning-maker McCormick &amp; Company an \"underperform\" rating, with an $84 price target.</p>\n<p>McCormick is “still trading at a premium valuation,” Spillane said, adding that while it has benefitted from people having cooked at home more in the last 18 months, “at some point, as things moderate, you're going to see less of that cooking at home behavior. And that's going to create an overhang for McCormick.”</p>\n<p>On the flip side, “Hershey [HSY] is well-positioned,” Spillane said, especially when it comes to the inflationary environment.</p>\n<p>“The combination of a category that's still growing very strongly where there's still a lot of product innovation and where there's been demonstrated pricing power, we think that Hershey is set up really well to be able to maybe even more than protect margins, maybe potentially grow margins as we cycle through some of this inflation,” he explained.</p>\n<p>BofA also awarded Stove Top stuffing-maker Kraft Heinz a buy rating with a $46 price objective.</p>\n<p>“We believe this is justified based our view that KHC is well positioned to capture growth associated with changing consumer demand patterns related to recessions and pantry stocking offset by higher than average debt levels,” the analysts wrote.</p>","source":"lsy1612507957220","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>7 stocks with the most Thanksgiving exposure, according to Bank of America</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n7 stocks with the most Thanksgiving exposure, according to Bank of America\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-25 22:03 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/7-stocks-thanksgiving-exposure-bank-of-america-134505457.html><strong>finance.yahoo</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Thanksgiving feasts will likely draw larger crowds than last year and incur higher costs.\nA recent Bank of America note detailed which companies have the most exposure to the top holiday dishes amid ...</p>\n\n<a href=\"https://finance.yahoo.com/news/7-stocks-thanksgiving-exposure-bank-of-america-134505457.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GIS":"通用磨坊","MKC":"味好美","HRL":"荷美尔","CPB":"金宝汤","NAPA":"The Duckhorn Portfolio, Inc.","CAG":"康尼格拉","KHC":"卡夫亨氏"},"source_url":"https://finance.yahoo.com/news/7-stocks-thanksgiving-exposure-bank-of-america-134505457.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1122037796","content_text":"Thanksgiving feasts will likely draw larger crowds than last year and incur higher costs.\nA recent Bank of America note detailed which companies have the most exposure to the top holiday dishes amid supply chain bottlenecks, inflation, lingering COVID concerns, low inventories, and evolving consumer behaviors.\nThose companies are Campbell's Soup Company (CPB), General Mills (GIS), The Kraft Heinz Company (KHC), Conagra Brands (CAG), Hormel Foods Corporation (HRL), McCormick & Company (MKC), and The Duckhorn Portfolio, Inc. (NAPA).\n\"We looked at companies’ exposure to the top Thanksgiving dishes: turkey, stuffing, dinner rolls, gravy, green bean casserole, potatoes, mac & cheese dessert and wine,\" the analysts stated. \"Overall CPB, GIS, KHC, CAG, MKC, HRL and NAPA are the most exposed. KHC and NAPA are our favorite stocks in this group.\"\nKey companies exposed to Thanksgiving meal trends. (Source: BofA)Thanksgiving 'center of the plate' items see more pricing power\nPeople appear to be gathering around the table again, the analysts stated, as data from social media conversations found mentions of \"vaccines\" on the rise while mentions of \"FaceTime,\" \"social distancing,\" and \"canceled\" declined. (\"Friendsgiving\" and \"day drinking\" also saw increases.)\nAnd whether consumers opt for turkey or ham, mashed potatoes or marshmallow-topped sweet potatoes, traditional orplant-based options, they're likely to pay more with inflation hitting food prices.\nThe American Farm Bureau Thanksgiving cost index projects a 14% year-over-year increase for 2021, led by a 24% increase in turkey prices.\n“When you look at more of the center of the plate sort of food items, typically, there has not historically been a lot of pricing power,” Bryan Spillane, a senior food and beverage analyst at BofA Global Research, told Yahoo Finance Live (video above). “But what's unusual this year is that there has been. Food companies, in particular, began raising prices the middle of the year, and there's virtually been no elasticity.”\nFrozen turkeys in Philadelphia, Wednesday, Nov. 17, 2021. (AP Photo/Matt Rourke)\nThat said, Spillane added, consumer behavior is expected to change at some point.\n“Something that we're really watching as we move into next year is: At what point does the consumer begin to push back and do we begin to see some trading down or other behavior that demonstrates that consumers are feeling that pinch?” Spillane said.\nInvestor appetite for food and beverage companies\nThe top company with the most upside or downside potential is Campbell's, which BofA gave an \"underperform\" rating.\n“Campbell's struggling from a few issues,” Spillane said. “One is they are experiencing a material amount of inflation. They have a product portfolio that's a little bit more skewed… to kind of middle and low-income households. So, that's, maybe, an area where there may be some sensitivity around passing those prices through.”\nThe iconic soup company also has a lot of direct and indirect exposure to labor shortages and higher labor costs, Spillane added.\nCans of Campbell's Soup are displayed in a supermarket in New York City, U.S. February 15, 2017. REUTERS/Brendan McDermid\nBofA also gave seasoning-maker McCormick & Company an \"underperform\" rating, with an $84 price target.\nMcCormick is “still trading at a premium valuation,” Spillane said, adding that while it has benefitted from people having cooked at home more in the last 18 months, “at some point, as things moderate, you're going to see less of that cooking at home behavior. And that's going to create an overhang for McCormick.”\nOn the flip side, “Hershey [HSY] is well-positioned,” Spillane said, especially when it comes to the inflationary environment.\n“The combination of a category that's still growing very strongly where there's still a lot of product innovation and where there's been demonstrated pricing power, we think that Hershey is set up really well to be able to maybe even more than protect margins, maybe potentially grow margins as we cycle through some of this inflation,” he explained.\nBofA also awarded Stove Top stuffing-maker Kraft Heinz a buy rating with a $46 price objective.\n“We believe this is justified based our view that KHC is well positioned to capture growth associated with changing consumer demand patterns related to recessions and pantry stocking offset by higher than average debt levels,” the analysts wrote.","news_type":1},"isVote":1,"tweetType":1,"viewCount":41,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":844483184,"gmtCreate":1636451479785,"gmtModify":1636452238051,"author":{"id":"4094269572113460","authorId":"4094269572113460","name":"Ytyt","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"Pls like","listText":"Pls like","text":"Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/844483184","repostId":"1104683977","repostType":4,"repost":{"id":"1104683977","pubTimestamp":1636418694,"share":"https://www.laohu8.com/m/news/1104683977?lang=&edition=full","pubTime":"2021-11-09 08:44","market":"us","language":"en","title":"Short squeezes are pushing these stocks to the moon","url":"https://stock-news.laohu8.com/highlight/detail?id=1104683977","media":"CNN","summary":"New York (CNN Business)The individual investor army on Reddit that helped push GameStop and AMC to u","content":"<p><a href=\"https://laohu8.com/S/NWY\">New York</a> (CNN Business)The individual investor army on Reddit that helped push <a href=\"https://laohu8.com/S/GME\">GameStop</a> and AMC to unprecedented heights earlier this year has found some more companies to rally around.</p>\n<p>Several stocks that have enjoyed extraordinary pops lately, such as <a href=\"https://laohu8.com/S/CAR\">Avis Budget</a> (<a href=\"https://laohu8.com/S/00699\">CAR</a>) and Bed Bath &amp; Beyond (BBBY), have become so-called meme stocks that many professional investors have bet against ... and have gotten burned for because of what's known as a short squeeze.</p>\n<p>Avis Budget reported solid earnings last week. But the strength of the stock's 108% surge the day after reporting results surprised many. Shares were up as much as 218% at <a href=\"https://laohu8.com/S/AONE.U\">one</a> point.</p>\n<p>Bed Bath and Beyond skyrocketed nearly 50% in a matter of a few days last week after announcing a partnership to sell some of its products at grocery store chain <a href=\"https://laohu8.com/S/KR\">Kroger</a> (KR).</p>\n<p>Both Avis Budget and Bed Bath &amp; Beyond have something in common with AMC (AMC) and GameStop (GME).</p>\n<p>All of these stocks, along with other meme darlings such as <a href=\"https://laohu8.com/S/BBRY\">BlackBerry</a> (BB), electric van maker <a href=\"https://laohu8.com/S/WKHS\">Workhorse</a> (WKHS) and cannabis company Sundial Growers (SNDL), have been targets of so-called short sellers.</p>\n<p>More than 20% of the shares of Avis Budget and Bed Bath &amp; Beyond are being held by short sellers, aka shorts.</p>\n<p>Shorts, often big hedge funds and other large institutional firms, will borrow a stock and sell it with the hopes that the price will fall and they can buy it back for less. The short seller then pockets the difference between what they sold at and the repurchase price.</p>\n<p>So say a short sells a borrowed stock when it's trading at $20 and it falls to $10. If the short seller buys the stock back at $10 and returns it to the lender, they make a $10 profit. It's known as covering their short position.</p>\n<p>But here's where short sellers can run into trouble. If a stock that's being shorted starts to go up for some reason — such as a good earnings report or news of a strategic partnership — short sellers may be forced to buy back shares en masse or risk incurring massive losses.</p>\n<p>Back to the $20 short seller example, if the company reports good news and the stock goes up to $30, the short seller is looking at a potential $10 loss if they cover at the price. The losses increase as the stock heads higher. If it hits $40, that's a $20 loss, and so on — for every share they've shorted.</p>\n<p>Plus, short sellers have to eventually return the shares they've borrowed. So if they wait too long to cover the short position, they could face major losses. The so-called apes on Reddit have figured this out.</p>\n<p>\"This is what a short squeeze looks like,\" wrote one Reddit user last week about Avis Budget. \"Good (nee, STELLAR) earnings caused sudden and hard upward price movement ... No recourse other than to cover.\"</p>\n<p>That's why fans of stocks like GameStop, AMC and more recently Avis Budget and Bed Bath &amp; Beyond aggressively call for retail traders to start buying heavily shorted stocks to push them even higher.</p>\n<p>They realize that they are inflicting damage on the short sellers by doing so. But that helps push the shares even higher since the short sellers have to start joining the buying frenzy too.</p>\n<p>\"Short Squeeze Stocks Season is Back!\" declared one poster on Reddit in a video last week, referring specifically to <a href=\"https://laohu8.com/S/BB\">BlackBerry</a>, Avis Budget, Bed Bath &amp; Beyond, AMC and GameStop.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Short squeezes are pushing these stocks to the moon</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nShort squeezes are pushing these stocks to the moon\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-09 08:44 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://edition.cnn.com/2021/11/08/investing/short-squeeze-stocks/index.html><strong>CNN</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>New York (CNN Business)The individual investor army on Reddit that helped push GameStop and AMC to unprecedented heights earlier this year has found some more companies to rally around.\nSeveral stocks...</p>\n\n<a href=\"https://edition.cnn.com/2021/11/08/investing/short-squeeze-stocks/index.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AMC":"AMC院线","CAR":"安飞士","KR":"克罗格","GME":"游戏驿站","BBBY":"3B家居"},"source_url":"https://edition.cnn.com/2021/11/08/investing/short-squeeze-stocks/index.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1104683977","content_text":"New York (CNN Business)The individual investor army on Reddit that helped push GameStop and AMC to unprecedented heights earlier this year has found some more companies to rally around.\nSeveral stocks that have enjoyed extraordinary pops lately, such as Avis Budget (CAR) and Bed Bath & Beyond (BBBY), have become so-called meme stocks that many professional investors have bet against ... and have gotten burned for because of what's known as a short squeeze.\nAvis Budget reported solid earnings last week. But the strength of the stock's 108% surge the day after reporting results surprised many. Shares were up as much as 218% at one point.\nBed Bath and Beyond skyrocketed nearly 50% in a matter of a few days last week after announcing a partnership to sell some of its products at grocery store chain Kroger (KR).\nBoth Avis Budget and Bed Bath & Beyond have something in common with AMC (AMC) and GameStop (GME).\nAll of these stocks, along with other meme darlings such as BlackBerry (BB), electric van maker Workhorse (WKHS) and cannabis company Sundial Growers (SNDL), have been targets of so-called short sellers.\nMore than 20% of the shares of Avis Budget and Bed Bath & Beyond are being held by short sellers, aka shorts.\nShorts, often big hedge funds and other large institutional firms, will borrow a stock and sell it with the hopes that the price will fall and they can buy it back for less. The short seller then pockets the difference between what they sold at and the repurchase price.\nSo say a short sells a borrowed stock when it's trading at $20 and it falls to $10. If the short seller buys the stock back at $10 and returns it to the lender, they make a $10 profit. It's known as covering their short position.\nBut here's where short sellers can run into trouble. If a stock that's being shorted starts to go up for some reason — such as a good earnings report or news of a strategic partnership — short sellers may be forced to buy back shares en masse or risk incurring massive losses.\nBack to the $20 short seller example, if the company reports good news and the stock goes up to $30, the short seller is looking at a potential $10 loss if they cover at the price. The losses increase as the stock heads higher. If it hits $40, that's a $20 loss, and so on — for every share they've shorted.\nPlus, short sellers have to eventually return the shares they've borrowed. So if they wait too long to cover the short position, they could face major losses. The so-called apes on Reddit have figured this out.\n\"This is what a short squeeze looks like,\" wrote one Reddit user last week about Avis Budget. \"Good (nee, STELLAR) earnings caused sudden and hard upward price movement ... No recourse other than to cover.\"\nThat's why fans of stocks like GameStop, AMC and more recently Avis Budget and Bed Bath & Beyond aggressively call for retail traders to start buying heavily shorted stocks to push them even higher.\nThey realize that they are inflicting damage on the short sellers by doing so. But that helps push the shares even higher since the short sellers have to start joining the buying frenzy too.\n\"Short Squeeze Stocks Season is Back!\" declared one poster on Reddit in a video last week, referring specifically to BlackBerry, Avis Budget, Bed Bath & Beyond, AMC and GameStop.","news_type":1},"isVote":1,"tweetType":1,"viewCount":36,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":693917743,"gmtCreate":1639960563499,"gmtModify":1639960563638,"author":{"id":"4094269572113460","authorId":"4094269572113460","name":"Ytyt","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"Pls like","listText":"Pls like","text":"Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/693917743","repostId":"1154958924","repostType":4,"isVote":1,"tweetType":1,"viewCount":508,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":690400755,"gmtCreate":1639698264965,"gmtModify":1639698265074,"author":{"id":"4094269572113460","authorId":"4094269572113460","name":"Ytyt","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"Pls like&nbsp;","listText":"Pls like&nbsp;","text":"Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/690400755","repostId":"2192942001","repostType":4,"repost":{"id":"2192942001","pubTimestamp":1639697332,"share":"https://www.laohu8.com/m/news/2192942001?lang=&edition=full","pubTime":"2021-12-17 07:28","market":"us","language":"en","title":"After-Hours Stock Movers: Spruce Biosciences,Rivian,FedEx,General Motors and more","url":"https://stock-news.laohu8.com/highlight/detail?id=2192942001","media":"StreetInsider","summary":"After-Hours Stock Movers:\nSpruce Biosciences, Inc. (NASDAQ: SPRB) 26.6% HIGHER; Oppenheimer initiate","content":"<p>After-Hours Stock Movers:</p>\n<p><a href=\"https://laohu8.com/S/SPRB\">Spruce Biosciences, Inc.</a> (NASDAQ: SPRB) 26.6% HIGHER; Oppenheimer initiates coverage with an Outperform rating and a price target of $15.00.</p>\n<p>Eloxx Pharma (NASDAQ: ELOX) 7.7% HIGHER; Oppenheimer initiates coverage with an Outperform rating and a price target of $4.00.</p>\n<p>Rivian Automotive (NASDAQ: RIVN) 10.2% LOWER; reported Q3 EPS of ($12.21), versus ($2.88) reported last year. Announces 71K net preorders for R1 in U.S. and Canada. Sees planned ~200K annual capacity at Normal, IL, and estimated 400K annual capacity at Georgia facility.</p>\n<p>Steelcase (NYSE: SCS) 6.2% LOWER; reported Q3 EPS of $0.08, $0.01 worse than the analyst estimate of $0.09. Revenue for the quarter came in at $738.2 million versus the consensus estimate of $767.62 million. Steelcase sees Q4 2022 EPS of $0.00, versus the consensus of $0.12. Steelcase sees Q4 2022 revenue of $740-765 million, versus the consensus of $770.77 million.</p>\n<p>FedEx (NYSE: FDX) 4.8% HIGHER; reported Q2 EPS of $4.83, $0.56 better than the analyst estimate of $4.27. Revenue for the quarter came in at $23.5 billion versus the consensus estimate of $22.44 billion. FedEx (NYSE: FDX) sees FY 2022 EPS of $20.50 to $21.50, versus the consensus of $19.64.</p>\n<p><a href=\"https://laohu8.com/S/FOUR\">Shift4 Payments, Inc.</a> (NYSE: FOUR) 3.8% HIGHER; authorized the commencement of a stock repurchase program. The stock repurchase program authorizes the Company to repurchase up to $100 million of the Companys Class A common stock, par value $0.0001 (Common Stock) and will expire on December 31, 2022, subject to market conditions, contractual restrictions and other factors.</p>\n<p>General Motors Company (NYSE: GM) 2.9% LOWER; Dan Ammann, the CEO of the self-driving division Cruise, is leaving the company, with Kyle Vogt, the President and CTO of Cruise to serve as an interim CEO.</p>\n<p>United States Steel Corporation (NYSE: X) 5.3% LOWER; provided fourth quarter 2021 guidance. Fourth quarter 2021 adjusted EBITDA is expected to be approximately $1.65 billion.</p>\n<p>Biomea Fusion Inc. (NASDAQ: BMEA) 2.8% HIGHER; Oppenheimer initiates coverage with an Outperform rating and a price target of $22.00.</p>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>After-Hours Stock Movers: Spruce Biosciences,Rivian,FedEx,General Motors and more</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAfter-Hours Stock Movers: Spruce Biosciences,Rivian,FedEx,General Motors and more\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-17 07:28 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/dr/news.php?id=19364278><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>After-Hours Stock Movers:\nSpruce Biosciences, Inc. (NASDAQ: SPRB) 26.6% HIGHER; Oppenheimer initiates coverage with an Outperform rating and a price target of $15.00.\nEloxx Pharma (NASDAQ: ELOX) 7.7% ...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=19364278\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"SCS":"Steelcase Inc.","RIVN":"Rivian Automotive, Inc.","GM":"通用汽车","X":"美国钢铁","BK4135":"资产管理与托管银行","BK4007":"制药","BK4099":"汽车制造商","ELOX":"Eloxx制药","SPRB":"Spruce Biosciences, Inc.","FOUR":"Shift4 Payments, Inc.","BK4516":"特朗普概念","BK4211":"区域性银行","BK4139":"生物科技","FDX":"联邦快递","OWL":"Blue Owl Capital Inc."},"source_url":"https://www.streetinsider.com/dr/news.php?id=19364278","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2192942001","content_text":"After-Hours Stock Movers:\nSpruce Biosciences, Inc. (NASDAQ: SPRB) 26.6% HIGHER; Oppenheimer initiates coverage with an Outperform rating and a price target of $15.00.\nEloxx Pharma (NASDAQ: ELOX) 7.7% HIGHER; Oppenheimer initiates coverage with an Outperform rating and a price target of $4.00.\nRivian Automotive (NASDAQ: RIVN) 10.2% LOWER; reported Q3 EPS of ($12.21), versus ($2.88) reported last year. Announces 71K net preorders for R1 in U.S. and Canada. Sees planned ~200K annual capacity at Normal, IL, and estimated 400K annual capacity at Georgia facility.\nSteelcase (NYSE: SCS) 6.2% LOWER; reported Q3 EPS of $0.08, $0.01 worse than the analyst estimate of $0.09. Revenue for the quarter came in at $738.2 million versus the consensus estimate of $767.62 million. Steelcase sees Q4 2022 EPS of $0.00, versus the consensus of $0.12. Steelcase sees Q4 2022 revenue of $740-765 million, versus the consensus of $770.77 million.\nFedEx (NYSE: FDX) 4.8% HIGHER; reported Q2 EPS of $4.83, $0.56 better than the analyst estimate of $4.27. Revenue for the quarter came in at $23.5 billion versus the consensus estimate of $22.44 billion. FedEx (NYSE: FDX) sees FY 2022 EPS of $20.50 to $21.50, versus the consensus of $19.64.\nShift4 Payments, Inc. (NYSE: FOUR) 3.8% HIGHER; authorized the commencement of a stock repurchase program. The stock repurchase program authorizes the Company to repurchase up to $100 million of the Companys Class A common stock, par value $0.0001 (Common Stock) and will expire on December 31, 2022, subject to market conditions, contractual restrictions and other factors.\nGeneral Motors Company (NYSE: GM) 2.9% LOWER; Dan Ammann, the CEO of the self-driving division Cruise, is leaving the company, with Kyle Vogt, the President and CTO of Cruise to serve as an interim CEO.\nUnited States Steel Corporation (NYSE: X) 5.3% LOWER; provided fourth quarter 2021 guidance. Fourth quarter 2021 adjusted EBITDA is expected to be approximately $1.65 billion.\nBiomea Fusion Inc. (NASDAQ: BMEA) 2.8% HIGHER; Oppenheimer initiates coverage with an Outperform rating and a price target of $22.00.","news_type":1},"isVote":1,"tweetType":1,"viewCount":63,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":607882573,"gmtCreate":1639525208395,"gmtModify":1639525208529,"author":{"id":"4094269572113460","authorId":"4094269572113460","name":"Ytyt","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"Pls like","listText":"Pls like","text":"Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/607882573","repostId":"2191784951","repostType":4,"repost":{"id":"2191784951","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1639522244,"share":"https://www.laohu8.com/m/news/2191784951?lang=&edition=full","pubTime":"2021-12-15 06:50","market":"us","language":"en","title":"Wall Street ends down, investors eye inflation and Omicron","url":"https://stock-news.laohu8.com/highlight/detail?id=2191784951","media":"Reuters","summary":"* Fed policy decision awaited on Wednesday\n* November PPI logs highest rise since 2010\n* Tech leads ","content":"<p>* Fed policy decision awaited on Wednesday</p>\n<p>* November PPI logs highest rise since 2010</p>\n<p>* Tech leads declines, financials rally</p>\n<p>* Indexes: Dow -0.30%, S&amp;P 500 -0.75%, Nasdaq -1.14%</p>\n<p>Dec 14 (Reuters) - Wall Street ended lower on Tuesday after data showed producer prices increased more than expected in November, solidifying expectations the Federal Reserve this week will announce a faster wind-down of asset purchases.</p>\n<p>The fast-spreading Omicron coronavirus variant also dampened investor sentiment after the S&amp;P 500 index hit an all-time closing high late last week.</p>\n<p>Declines were led by megacap tech-related stocks, with <a href=\"https://laohu8.com/S/CRM\">Salesforce</a>.com, Microsoft Corp, <a href=\"https://laohu8.com/S/ADBE\">Adobe</a> and Alphabet Inc pulling down the S&amp;P 500 and Nasdaq.</p>\n<p>Apple Inc ended down 0.8%, but off its session lows, after the iPhone maker said it would require customers and employees to wear masks at its U.S. retail stores as COVID-19 cases surge.</p>\n<p>The Dow Jones Industrial Average fell 0.3% to end at 35,544.18 points, while the S&amp;P 500 lost 0.75% to 4,634.09.</p>\n<p>The Nasdaq Composite dropped 1.14% to 15,237.64.</p>\n<p>Data from the Labor Department showed the producer price index (PPI) for final demand in the 12 months through November shot up 9.6%, clocking its largest gain since November 2010. That followed an 8.8% increase in October.</p>\n<p>About two-thirds of Nasdaq stocks traded below their 200-day moving average, according to Refinitiv data, suggesting many stocks within the index are struggling, even as the overall index remains only about 6% below its November record high close.</p>\n<p>\"COVID plus inflation is the Grinch that stole Christmas,\" said Jake Dollarhide, chief executive officer at Longbow Asset Management. \"I don’t underestimate the fact that there are some big Nasdaq names giving up some of their big gains. When the leaders sell off, it's not a good sign.\"</p>\n<p>Ten of the 11 major S&amp;P 500 sector indexes fell, with tech putting on the worst performance, down 1.6%. Financials gained 0.6% as investors bet on a hawkish tone from the Fed at the end of its two-day meeting on Wednesday.</p>\n<p>Berkshire Hathaway and Bank of America both gained more than 1% and helped keep the S&amp;P 500 from falling further.</p>\n<p>Many investors expect the U.S. central bank to signal a faster wind-down of asset purchases, and thus, a quicker start to interest rate hikes in order to contain the rapid rise in prices.</p>\n<p>\"I would say this meeting is when we start to get some clarity on how they're (the Fed) going to address this idea of inflation that has remained elevated and most likely will remain an issue going into next year,\" said David Keller, chief market strategist at StockCharts.com.</p>\n<p>A Reuters poll of economists sees the central bank hiking interest rates from near zero to 0.25%-0.50% in the third quarter of next year, followed by another in the fourth quarter.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/a6ea56cda700f032a3421aa26db08524\" tg-width=\"596\" tg-height=\"500\" width=\"100%\" height=\"auto\"><span>Inflation</span></p>\n<p>Beyond Meat Inc rallied 9.3% after Piper Sandler upgraded the plant-based meat maker's stock to \"neutral\" from \"underweight.\"</p>\n<p>Pfizer gained 0.6% after saying its antiviral COVID-19 pill showed near 90% efficacy in preventing hospitalizations and deaths in high-risk patients, and that lab data suggests the drug retains its effectiveness against the Omicron variant.</p>\n<p>Declining issues outnumbered advancing ones on the NYSE by a 2.70-to-1 ratio; on Nasdaq, a 2.59-to-1 ratio favored decliners.</p>\n<p>The S&amp;P 500 posted 15 new 52-week highs and 2 new lows; the Nasdaq Composite recorded 18 new highs and 408 new lows.</p>\n<p>Volume on U.S. exchanges was 10.8 billion shares, compared with the 11.5 billion average over the last 20 trading days.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Wall Street ends down, investors eye inflation and Omicron</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWall Street ends down, investors eye inflation and Omicron\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-12-15 06:50</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>* Fed policy decision awaited on Wednesday</p>\n<p>* November PPI logs highest rise since 2010</p>\n<p>* Tech leads declines, financials rally</p>\n<p>* Indexes: Dow -0.30%, S&amp;P 500 -0.75%, Nasdaq -1.14%</p>\n<p>Dec 14 (Reuters) - Wall Street ended lower on Tuesday after data showed producer prices increased more than expected in November, solidifying expectations the Federal Reserve this week will announce a faster wind-down of asset purchases.</p>\n<p>The fast-spreading Omicron coronavirus variant also dampened investor sentiment after the S&amp;P 500 index hit an all-time closing high late last week.</p>\n<p>Declines were led by megacap tech-related stocks, with <a href=\"https://laohu8.com/S/CRM\">Salesforce</a>.com, Microsoft Corp, <a href=\"https://laohu8.com/S/ADBE\">Adobe</a> and Alphabet Inc pulling down the S&amp;P 500 and Nasdaq.</p>\n<p>Apple Inc ended down 0.8%, but off its session lows, after the iPhone maker said it would require customers and employees to wear masks at its U.S. retail stores as COVID-19 cases surge.</p>\n<p>The Dow Jones Industrial Average fell 0.3% to end at 35,544.18 points, while the S&amp;P 500 lost 0.75% to 4,634.09.</p>\n<p>The Nasdaq Composite dropped 1.14% to 15,237.64.</p>\n<p>Data from the Labor Department showed the producer price index (PPI) for final demand in the 12 months through November shot up 9.6%, clocking its largest gain since November 2010. That followed an 8.8% increase in October.</p>\n<p>About two-thirds of Nasdaq stocks traded below their 200-day moving average, according to Refinitiv data, suggesting many stocks within the index are struggling, even as the overall index remains only about 6% below its November record high close.</p>\n<p>\"COVID plus inflation is the Grinch that stole Christmas,\" said Jake Dollarhide, chief executive officer at Longbow Asset Management. \"I don’t underestimate the fact that there are some big Nasdaq names giving up some of their big gains. When the leaders sell off, it's not a good sign.\"</p>\n<p>Ten of the 11 major S&amp;P 500 sector indexes fell, with tech putting on the worst performance, down 1.6%. Financials gained 0.6% as investors bet on a hawkish tone from the Fed at the end of its two-day meeting on Wednesday.</p>\n<p>Berkshire Hathaway and Bank of America both gained more than 1% and helped keep the S&amp;P 500 from falling further.</p>\n<p>Many investors expect the U.S. central bank to signal a faster wind-down of asset purchases, and thus, a quicker start to interest rate hikes in order to contain the rapid rise in prices.</p>\n<p>\"I would say this meeting is when we start to get some clarity on how they're (the Fed) going to address this idea of inflation that has remained elevated and most likely will remain an issue going into next year,\" said David Keller, chief market strategist at StockCharts.com.</p>\n<p>A Reuters poll of economists sees the central bank hiking interest rates from near zero to 0.25%-0.50% in the third quarter of next year, followed by another in the fourth quarter.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/a6ea56cda700f032a3421aa26db08524\" tg-width=\"596\" tg-height=\"500\" width=\"100%\" height=\"auto\"><span>Inflation</span></p>\n<p>Beyond Meat Inc rallied 9.3% after Piper Sandler upgraded the plant-based meat maker's stock to \"neutral\" from \"underweight.\"</p>\n<p>Pfizer gained 0.6% after saying its antiviral COVID-19 pill showed near 90% efficacy in preventing hospitalizations and deaths in high-risk patients, and that lab data suggests the drug retains its effectiveness against the Omicron variant.</p>\n<p>Declining issues outnumbered advancing ones on the NYSE by a 2.70-to-1 ratio; on Nasdaq, a 2.59-to-1 ratio favored decliners.</p>\n<p>The S&amp;P 500 posted 15 new 52-week highs and 2 new lows; the Nasdaq Composite recorded 18 new highs and 408 new lows.</p>\n<p>Volume on U.S. exchanges was 10.8 billion shares, compared with the 11.5 billion average over the last 20 trading days.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4534":"瑞士信贷持仓","SPY":"标普500ETF","SH":"标普500反向ETF","BK4559":"巴菲特持仓","IVV":"标普500指数ETF","BK4550":"红杉资本持仓","UPRO":"三倍做多标普500ETF","OEF":"标普100指数ETF-iShares","BK4079":"房地产服务","COMP":"Compass, Inc.","SSO":"两倍做多标普500ETF","BK4504":"桥水持仓","SPXU":"三倍做空标普500ETF","AAPL":"苹果",".DJI":"道琼斯","BK4539":"次新股",".IXIC":"NASDAQ Composite","SDS":"两倍做空标普500ETF",".SPX":"S&P 500 Index","OEX":"标普100"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2191784951","content_text":"* Fed policy decision awaited on Wednesday\n* November PPI logs highest rise since 2010\n* Tech leads declines, financials rally\n* Indexes: Dow -0.30%, S&P 500 -0.75%, Nasdaq -1.14%\nDec 14 (Reuters) - Wall Street ended lower on Tuesday after data showed producer prices increased more than expected in November, solidifying expectations the Federal Reserve this week will announce a faster wind-down of asset purchases.\nThe fast-spreading Omicron coronavirus variant also dampened investor sentiment after the S&P 500 index hit an all-time closing high late last week.\nDeclines were led by megacap tech-related stocks, with Salesforce.com, Microsoft Corp, Adobe and Alphabet Inc pulling down the S&P 500 and Nasdaq.\nApple Inc ended down 0.8%, but off its session lows, after the iPhone maker said it would require customers and employees to wear masks at its U.S. retail stores as COVID-19 cases surge.\nThe Dow Jones Industrial Average fell 0.3% to end at 35,544.18 points, while the S&P 500 lost 0.75% to 4,634.09.\nThe Nasdaq Composite dropped 1.14% to 15,237.64.\nData from the Labor Department showed the producer price index (PPI) for final demand in the 12 months through November shot up 9.6%, clocking its largest gain since November 2010. That followed an 8.8% increase in October.\nAbout two-thirds of Nasdaq stocks traded below their 200-day moving average, according to Refinitiv data, suggesting many stocks within the index are struggling, even as the overall index remains only about 6% below its November record high close.\n\"COVID plus inflation is the Grinch that stole Christmas,\" said Jake Dollarhide, chief executive officer at Longbow Asset Management. \"I don’t underestimate the fact that there are some big Nasdaq names giving up some of their big gains. When the leaders sell off, it's not a good sign.\"\nTen of the 11 major S&P 500 sector indexes fell, with tech putting on the worst performance, down 1.6%. Financials gained 0.6% as investors bet on a hawkish tone from the Fed at the end of its two-day meeting on Wednesday.\nBerkshire Hathaway and Bank of America both gained more than 1% and helped keep the S&P 500 from falling further.\nMany investors expect the U.S. central bank to signal a faster wind-down of asset purchases, and thus, a quicker start to interest rate hikes in order to contain the rapid rise in prices.\n\"I would say this meeting is when we start to get some clarity on how they're (the Fed) going to address this idea of inflation that has remained elevated and most likely will remain an issue going into next year,\" said David Keller, chief market strategist at StockCharts.com.\nA Reuters poll of economists sees the central bank hiking interest rates from near zero to 0.25%-0.50% in the third quarter of next year, followed by another in the fourth quarter.\nInflation\nBeyond Meat Inc rallied 9.3% after Piper Sandler upgraded the plant-based meat maker's stock to \"neutral\" from \"underweight.\"\nPfizer gained 0.6% after saying its antiviral COVID-19 pill showed near 90% efficacy in preventing hospitalizations and deaths in high-risk patients, and that lab data suggests the drug retains its effectiveness against the Omicron variant.\nDeclining issues outnumbered advancing ones on the NYSE by a 2.70-to-1 ratio; on Nasdaq, a 2.59-to-1 ratio favored decliners.\nThe S&P 500 posted 15 new 52-week highs and 2 new lows; the Nasdaq Composite recorded 18 new highs and 408 new lows.\nVolume on U.S. exchanges was 10.8 billion shares, compared with the 11.5 billion average over the last 20 trading days.","news_type":1},"isVote":1,"tweetType":1,"viewCount":281,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":609993491,"gmtCreate":1638229590687,"gmtModify":1638229831743,"author":{"id":"4094269572113460","authorId":"4094269572113460","name":"Ytyt","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"Pls like","listText":"Pls like","text":"Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/609993491","repostId":"2187306464","repostType":4,"repost":{"id":"2187306464","pubTimestamp":1638222370,"share":"https://www.laohu8.com/m/news/2187306464?lang=&edition=full","pubTime":"2021-11-30 05:46","market":"us","language":"en","title":"US STOCKS-Wall Street rebounds after virus-related sell-off","url":"https://stock-news.laohu8.com/highlight/detail?id=2187306464","media":"Reuters","summary":"Wall Street stocks closed higher on Monday, regaining some of the ground they lost in Friday's sell-off, as investors were hopeful that the Omicron coronavirus variant would not lead to lockdowns after reassurance from U.S. President Joe Biden.The Nasdaq led gains among the major averages with help from the technology sector, while the S&P and the Dow advanced after suffering their biggest one-day percentage declines in months in Friday's holiday-shortened session as investors worried that the l","content":"<p>Wall Street stocks closed higher on Monday, regaining some of the ground they lost in Friday's sell-off, as investors were hopeful that the Omicron coronavirus variant would not lead to lockdowns after reassurance from U.S. President Joe Biden.</p>\n<p>The Nasdaq led gains among the major averages with help from the technology sector, while the S&amp;P and the Dow advanced after suffering their biggest one-day percentage declines in months in Friday's holiday-shortened session as investors worried that the latest COVID-19 variant would cause economic disruption.</p>\n<p>Biden said on Monday that Omicron-related lockdowns were off the table for now and he urged Americans not to panic about the variant. However, he did recommend vaccination and mask wearing indoors to combat the virus and said the United States was working with pharmaceutical companies to make contingency plans if new vaccines were needed.</p>\n<p>Those comments and indications from drug companies that they are taking the variant seriously were reassuring for investors, who had been anxious about the potential for further COVID restrictions.</p>\n<p>\"Friday was a major de-risking event. You had the market go back to its worst fears of COVID spreading and the return of lockdowns,\" said Edward Moya, senior market analyst at OANDA.</p>\n<p>\"Now you're starting to see there is some optimism when you listen to the President, when you listen to the Pfizer CEO. The Omicron panic is easing, and we're into a period of wait and see.\"</p>\n<p>Vaccine makers such as Pfizer, its partner BioNTech and their rivals Moderna and Johnson &amp; Johnson said Monday they are working on vaccines that specifically target Omicron in case existing shots are not effective against the variant.</p>\n<p>\"It's not like the start of the pandemic all over again,\" said Carol Schleif, deputy chief investment officer for the BMO family office in Minneapolis who also noted that after Friday's knee-jerk reaction, investors have been trained this year to buy the dip. \"People are willing to just take a deep breath and try to reassess, be a little more patient.\"</p>\n<p>The Dow Jones Industrial Average rose 236.6 points, or 0.68%, to 35,135.94, the S&amp;P 500 gained 60.65 points, or 1.32%, to 4,655.27 and the Nasdaq Composite added 291.18 points, or 1.88%, to 15,782.83.</p>\n<p>Among the S&amp;P's 11 major sectors, technology was the leading percentage gainer, up 2.6%, followed by the consumer discretionary sector, which closed up 1.6%, with boosts from Amazon.com and Tesla Inc.</p>\n<p>Other big boosts from single stocks in the S&amp;P came from Microsoft and Apple Inc, which gained ground after HSBC raised its price target for the iPhone maker.</p>\n<p>While the Dow advanced, it underperformed its peers with pressure from Merck &amp; Co Inc, which closed down 5.4%. The drugmaker extended losses from Friday when updated data from a study of its experimental COVID-19 pill showed lower efficacy in reducing risk of hospitalization and deaths than previously reported.</p>\n<p>Britain said it would offer a COVID-19 booster vaccine to all adults and give second doses to children aged between 12 and 15, in light of concern about the spread of the Omicron variant. It also said Moderna and Pfizer vaccines were the preferred boosters.</p>\n<p>After the U.S. market close, the U.S. Centers for Disease Control and Prevention said everyone aged 18 years and older should get boosters six months after Pfizer or Moderna COVID vaccines or two months after a Johnson &amp; Johnson shot.</p>\n<p>Moderna rose 11.8% on the day, while Pfizer fell almost 3% and Johnson &amp; Johnson rose 0.34%.</p>\n<p>The Philadelphia semiconductor index outperformed the broader market with a 4% gain as chipstocks rose broadly. Nvidia provided the biggest boost with a 5.9% gain.</p>\n<p>Tesla's shares gained 5% after a report that chief Elon Musk urged employees to reduce the cost of vehicle deliveries.</p>\n<p>Twitter Inc closed down 2.7%, reversing early gains after the social media firm said CEO Jack Dorsey will step down and be succeeded by Chief Technology Officer Parag Agrawal. Dorsey had been in the unusual position of having the CEO job at two major technology companies, the second being digital payments firm Square Inc.</p>\n<p>Advancing issues outnumbered declining ones on the NYSE by a 1.31-to-1 ratio; on Nasdaq, a 1.35-to-1 ratio favored decliners.</p>\n<p>The S&amp;P 500 posted 16 new 52-week highs and 21 new lows; the Nasdaq Composite recorded 39 new highs and 344 new lows.</p>\n<p>On U.S. exchanges, 11.13 billion shares changed hands on Monday compared with the 10.84 billion average for the last 20 sessions. </p>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>US STOCKS-Wall Street rebounds after virus-related sell-off</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nUS STOCKS-Wall Street rebounds after virus-related sell-off\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-30 05:46 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/us-stocks-wall-street-rebounds-214610786.html><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Wall Street stocks closed higher on Monday, regaining some of the ground they lost in Friday's sell-off, as investors were hopeful that the Omicron coronavirus variant would not lead to lockdowns ...</p>\n\n<a href=\"https://finance.yahoo.com/news/us-stocks-wall-street-rebounds-214610786.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4504":"桥水持仓","BK4568":"美国抗疫概念","PFE":"辉瑞","BK4007":"制药","BK4532":"文艺复兴科技持仓","BK4550":"红杉资本持仓","BK4559":"巴菲特持仓","COMP":"Compass, Inc.","JNJ":"强生","BK4534":"瑞士信贷持仓","MRNA":"Moderna, Inc.","BK4533":"AQR资本管理(全球第二大对冲基金)"},"source_url":"https://finance.yahoo.com/news/us-stocks-wall-street-rebounds-214610786.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2187306464","content_text":"Wall Street stocks closed higher on Monday, regaining some of the ground they lost in Friday's sell-off, as investors were hopeful that the Omicron coronavirus variant would not lead to lockdowns after reassurance from U.S. President Joe Biden.\nThe Nasdaq led gains among the major averages with help from the technology sector, while the S&P and the Dow advanced after suffering their biggest one-day percentage declines in months in Friday's holiday-shortened session as investors worried that the latest COVID-19 variant would cause economic disruption.\nBiden said on Monday that Omicron-related lockdowns were off the table for now and he urged Americans not to panic about the variant. However, he did recommend vaccination and mask wearing indoors to combat the virus and said the United States was working with pharmaceutical companies to make contingency plans if new vaccines were needed.\nThose comments and indications from drug companies that they are taking the variant seriously were reassuring for investors, who had been anxious about the potential for further COVID restrictions.\n\"Friday was a major de-risking event. You had the market go back to its worst fears of COVID spreading and the return of lockdowns,\" said Edward Moya, senior market analyst at OANDA.\n\"Now you're starting to see there is some optimism when you listen to the President, when you listen to the Pfizer CEO. The Omicron panic is easing, and we're into a period of wait and see.\"\nVaccine makers such as Pfizer, its partner BioNTech and their rivals Moderna and Johnson & Johnson said Monday they are working on vaccines that specifically target Omicron in case existing shots are not effective against the variant.\n\"It's not like the start of the pandemic all over again,\" said Carol Schleif, deputy chief investment officer for the BMO family office in Minneapolis who also noted that after Friday's knee-jerk reaction, investors have been trained this year to buy the dip. \"People are willing to just take a deep breath and try to reassess, be a little more patient.\"\nThe Dow Jones Industrial Average rose 236.6 points, or 0.68%, to 35,135.94, the S&P 500 gained 60.65 points, or 1.32%, to 4,655.27 and the Nasdaq Composite added 291.18 points, or 1.88%, to 15,782.83.\nAmong the S&P's 11 major sectors, technology was the leading percentage gainer, up 2.6%, followed by the consumer discretionary sector, which closed up 1.6%, with boosts from Amazon.com and Tesla Inc.\nOther big boosts from single stocks in the S&P came from Microsoft and Apple Inc, which gained ground after HSBC raised its price target for the iPhone maker.\nWhile the Dow advanced, it underperformed its peers with pressure from Merck & Co Inc, which closed down 5.4%. The drugmaker extended losses from Friday when updated data from a study of its experimental COVID-19 pill showed lower efficacy in reducing risk of hospitalization and deaths than previously reported.\nBritain said it would offer a COVID-19 booster vaccine to all adults and give second doses to children aged between 12 and 15, in light of concern about the spread of the Omicron variant. It also said Moderna and Pfizer vaccines were the preferred boosters.\nAfter the U.S. market close, the U.S. Centers for Disease Control and Prevention said everyone aged 18 years and older should get boosters six months after Pfizer or Moderna COVID vaccines or two months after a Johnson & Johnson shot.\nModerna rose 11.8% on the day, while Pfizer fell almost 3% and Johnson & Johnson rose 0.34%.\nThe Philadelphia semiconductor index outperformed the broader market with a 4% gain as chipstocks rose broadly. Nvidia provided the biggest boost with a 5.9% gain.\nTesla's shares gained 5% after a report that chief Elon Musk urged employees to reduce the cost of vehicle deliveries.\nTwitter Inc closed down 2.7%, reversing early gains after the social media firm said CEO Jack Dorsey will step down and be succeeded by Chief Technology Officer Parag Agrawal. Dorsey had been in the unusual position of having the CEO job at two major technology companies, the second being digital payments firm Square Inc.\nAdvancing issues outnumbered declining ones on the NYSE by a 1.31-to-1 ratio; on Nasdaq, a 1.35-to-1 ratio favored decliners.\nThe S&P 500 posted 16 new 52-week highs and 21 new lows; the Nasdaq Composite recorded 39 new highs and 344 new lows.\nOn U.S. exchanges, 11.13 billion shares changed hands on Monday compared with the 10.84 billion average for the last 20 sessions.","news_type":1},"isVote":1,"tweetType":1,"viewCount":69,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":600870740,"gmtCreate":1638142886234,"gmtModify":1638142886322,"author":{"id":"4094269572113460","authorId":"4094269572113460","name":"Ytyt","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"Pls like","listText":"Pls like","text":"Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/600870740","repostId":"2187132972","repostType":4,"repost":{"id":"2187132972","weMediaInfo":{"introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"media_name":"Dow Jones","id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"pubTimestamp":1638142200,"share":"https://www.laohu8.com/m/news/2187132972?lang=&edition=full","pubTime":"2021-11-29 07:30","market":"us","language":"en","title":"U.S. stock futures rise following Friday's omicron-sparked selloff","url":"https://stock-news.laohu8.com/highlight/detail?id=2187132972","media":"Dow Jones","summary":"U.S. stock futures rose late Sunday, following a steep selloff Friday sparked by fears of the global","content":"<p>U.S. stock futures rose late Sunday, following a steep selloff Friday sparked by fears of the global economic impact of a worrisome new strain of COVID-19.</p>\n<p>Dow Jones Industrial Average futures gained about 150 points, or 0.4%, as of 6:10 p.m. Eastern. S&amp;P 500 futures and Nasdaq-100 futures also showed gains of about 0.5%.</p>\n<p>On Friday, Wall Street suffered its worst day in more than a year amid growing concerns over the new omicron variant of COVID-19. The World Health Organization's technical advisory group on Friday declared it a \"variant of concern,\" and a number of countries imposed flight bans from countries in southern Africa, where the variant was first discovered.</p>\n<p>Little is known about omicron, but investors Friday braced for bad news.</p>\n<p>\"The pandemic and COVID variants remain <a href=\"https://laohu8.com/S/AONE.U\">one</a> of the biggest risks to markets, and are likely to continue to inject volatility over the next year(s),\" Keith Lerner, co-chief investment officer and chief market strategist at Truist Advisory Services, wrote in a Friday note. \"It's hard to say at this point how lasting or impactful this latest variant will be for markets.\"</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>U.S. stock futures rise following Friday's omicron-sparked selloff</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nU.S. stock futures rise following Friday's omicron-sparked selloff\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2021-11-29 07:30</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<p>U.S. stock futures rose late Sunday, following a steep selloff Friday sparked by fears of the global economic impact of a worrisome new strain of COVID-19.</p>\n<p>Dow Jones Industrial Average futures gained about 150 points, or 0.4%, as of 6:10 p.m. Eastern. S&amp;P 500 futures and Nasdaq-100 futures also showed gains of about 0.5%.</p>\n<p>On Friday, Wall Street suffered its worst day in more than a year amid growing concerns over the new omicron variant of COVID-19. The World Health Organization's technical advisory group on Friday declared it a \"variant of concern,\" and a number of countries imposed flight bans from countries in southern Africa, where the variant was first discovered.</p>\n<p>Little is known about omicron, but investors Friday braced for bad news.</p>\n<p>\"The pandemic and COVID variants remain <a href=\"https://laohu8.com/S/AONE.U\">one</a> of the biggest risks to markets, and are likely to continue to inject volatility over the next year(s),\" Keith Lerner, co-chief investment officer and chief market strategist at Truist Advisory Services, wrote in a Friday note. \"It's hard to say at this point how lasting or impactful this latest variant will be for markets.\"</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".IXIC":"NASDAQ Composite",".SPX":"S&P 500 Index",".DJI":"道琼斯"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2187132972","content_text":"U.S. stock futures rose late Sunday, following a steep selloff Friday sparked by fears of the global economic impact of a worrisome new strain of COVID-19.\nDow Jones Industrial Average futures gained about 150 points, or 0.4%, as of 6:10 p.m. Eastern. S&P 500 futures and Nasdaq-100 futures also showed gains of about 0.5%.\nOn Friday, Wall Street suffered its worst day in more than a year amid growing concerns over the new omicron variant of COVID-19. The World Health Organization's technical advisory group on Friday declared it a \"variant of concern,\" and a number of countries imposed flight bans from countries in southern Africa, where the variant was first discovered.\nLittle is known about omicron, but investors Friday braced for bad news.\n\"The pandemic and COVID variants remain one of the biggest risks to markets, and are likely to continue to inject volatility over the next year(s),\" Keith Lerner, co-chief investment officer and chief market strategist at Truist Advisory Services, wrote in a Friday note. \"It's hard to say at this point how lasting or impactful this latest variant will be for markets.\"","news_type":1},"isVote":1,"tweetType":1,"viewCount":14,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"lives":[]}